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Life is short, and Art long; the crisis fleeting; experience perilous, and decision difficult. 
 
Hippocrates 
iv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
ABSTRACT 
Appropriate and well-timed decision-making is mandatory to change the goal of care 
from life-prolonging therapies to high-quality end-of-life (EOL) care in order to 
prevent non-beneficial treatments and relieve suffering. The decisions include, but 
are not limited to, statements on cardiopulmonary resuscitation, parenteral fluids, 
and diagnostic tests. This decision-making is a challenging process as physicians have 
to strike a balance between the wishes of the patient and family, legal and ethical 
aspects, and the potential benefits, harms and costs of care. Decision-making should 
be based on similar principles in the same types of clinical situations regardless of 
the specialty, experience or attitudes of the physician who is responsible for the care 
of the patient. Therefore, all physicians should have the skills to recognize the need 
for palliative care and approaching death. 
Concurrently with the growing status of palliative care, discussions about the 
ethical justification of hastened death due to unbearable suffering have been ongoing 
for many years around the world. Public support for euthanasia and physician-
assisted suicide is mounting all over Western Europe. This changing atmosphere 
may modify the practices and ethics of EOL decision-making. 
This study was conducted to examine the decision-making and attitudes of 
physicians and medical students regarding the EOL care of cancer patients, and 
whether there have been changes in these issues over the past sixteen years. 
A questionnaire including seven hypothetical patient scenarios was sent to 1 182 
and 1 327 Finnish physicians in 1999 and 2015, respectively. In addition, the 
questionnaire was offered to all graduating Finnish medical students (n=639) during 
their last year of medical school in 2015-2016. For this thesis five of the cancer 
patient scenarios were included. The first scenario presented an 82-year-old prostate 
cancer patient with bone metastases and a deteriorating overall condition. 
Responders were asked to choose a palliative, active or intensive care approach. The 
second patient scenario presented a 68-year-old breast cancer patient with bone 
metastases wishing a voucher for hospice. The responders’ willingness to issue a 
voucher was evaluated. The third scenario presented a 60-year-old prostate cancer 
patient with metastases and paraparesis, who asked for doubling his morphine dose 
which might lead to a hastened death. The responders’ acceptance for increasing the 
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morphine dose was investigated. The fourth patient scenario presented a 32-year-old 
female with an inoperable, late-stage brain cancer having a cardiac arrest. The 
responders were asked whether they would resuscitate the patient or not. The fifth 
scenario presented a 62-year-old male patient with a metastatic end-stage lung 
cancer. The responders’ willingness to withhold or withdraw different treatment 
options were questioned. The attitudes, values and background factors of the 
responders were also enquired and taken into account. 
In total, 1 763 valid responses were received, giving an overall response rate of 
56%. Decision-making was influenced by the year of the survey (1999 vs 2015), by 
whether the physician had special competency in palliative medicine (cPM) or not 
and by the clinical experience of the responder. The physicians with cPM chose less 
aggressive options in EOL care, although the impact of cPM on decision-making 
varied among treatments. The graduating medical students were more unwilling to 
withhold and withdraw therapies suggested to be futile in EOL care than were the 
experienced general practitioners (GPs), but there was no difference between the 
students and the GPs when choosing a palliative care approach in EOL situations 
or in the willingness to issue a voucher for hospice. In 2015, the physicians accepted 
the risk of hastened death with increasing morphine dose more frequently than in 
1999. The experienced GPs were more willing to accept the risk of hastened death 
compared to the medical students, even though the students considered euthanasia 
and assisted suicide less reprehensible than the GPs. Physicians’ decisions to choose 
palliative care approaches significantly increased from 1999 to 2015. When making 
this decision, the physicians answering in 2015 were more influenced by the patient’s 
benefit and less influenced by the family’s benefit than in 1999. Physicians were also 
more willing to issue a voucher for hospice in 2015. Physicians’ attitudes and values 
influencing EOL decision-making have changed over the past sixteen years; for 
example, euthanasia was considered to be less reprehensible and religion less 
influential in 2015 than in 1999. 
The changing public atmosphere, advances in medicine, growing knowledge of 
the benefits of palliative care and education in palliative medicine might have 
significant influence on the essential decision-making in EOL care, although the 
impact of these aspects has not yet been investigated. Based on the results of this 
thesis, the attitudes, education and experience of a physician seem to play an 
important part in their EOL decision-making. To ensure that all patients receive 
equal and high-quality EOL care, education in EOL decision-making, including 
ethical and juridical aspects, should be mandatory for all medical students and 
physicians in specialty training. 
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TIIVISTELMÄ 
Asianmukainen ja oikea-aikainen päätös muuttaa hoidon tavoite elämää pitkittävistä 
hoidoista korkealaatuiseen saattohoitoon on tärkeää hyödyttömien hoitojen 
välttämiseksi ja kärsimyksen lievittämiseksi. Näihin päätöksiin sisältyy esimerkiksi 
kannanotot elvytyksestä, suonensisäisestä nesteytyksestä ja diagnostisista 
tutkimuksista. Päätöksenteossa lääkärit joutuvat huomioimaan potilaan ja läheisten 
toiveet, lainsäädännön ja eettiset näkökulmat sekä arvioimaan hoitojen hyötyjä, 
haittoja ja kustannuksia. Päätöksenteon pitäisi olla yhdenmukaista samanlaisissa 
kliinisissä tilanteissa ja palliatiivisen hoidon tarve tulisi tunnistaa riippumatta 
hoitovastuussa olevan lääkärin erikoisalasta tai kokemuksesta.  
Samanaikaisesti palliatiivisen hoidon aseman paranemisen kanssa eutanasian ja 
avustetun itsemurhan kannatus on nousussa läntisessä Euroopassa. Tämä muuttuva 
ympäristö saattaa muokata vallitsevia elämän loppuvaiheen päätöksenteon 
käytänteitä ja etiikkaa. 
Tämän tutkimuksen tavoitteena oli tutkia lääkäreiden ja lääketieteen 
opiskelijoiden elämän loppuvaiheen päätöksentekoa ja suhtautumista 
syöpäpotilaiden elämän loppuvaiheen hoitoon sekä näissä mahdollisesti tapahtuneita 
muutoksia edeltävien kuudentoista vuoden aikana.  
Seitsemän hypoteettista potilastapausta sisältänyt kysely lähetettiin 1 182 ja 1 327 
suomalaiselle lääkärille vuosina 1999 ja 2015 sekä jaettiin valmistuville lääketieteen 
opiskelijoille (n=639) vuosina 2015-2016. Tähän väitöskirjatutkimukseen 
sisällytettiin viisi syöpäpotilastapausta. Ensimmäinen potilastapaus oli luustoon 
levinnyttä eturauhassyöpää sairastava 82-vuotias mies, jonka yleisvointi on nopeasti 
heikentynyt. Vastaajia pyydettiin valitsemaan joko palliatiivinen hoito, aktiivinen 
hoito tai tehohoito. Toinen potilastapaus oli luustoon levinnyttä rintasyöpää 
sairastava 68-vuotias nainen, joka on hoidossa terveyskeskuksen vuodeosastolla ja 
toivoo pääsyä saattohoitokotiin. Vastaajilta kysyttiin halukkuutta myöntää 
maksusitoumus hoitokotiin. Kolmas potilastapaus oli 60-vuotias mies, jolla on 
luustoon levinneen eturauhassyövän aiheuttama alaraajahalvaus. Hän pyytää 
nostamaan morfiiniannoksensa tasolle, jonka arvellaan jouduttavan potilaan 
kuolemaa. Vastaajilta kysyttiin, hyväksyisivätkö he morfiiniannoksen noston. Neljäs 
potilastapaus oli 32-vuotias nainen, jolla on leikkaushoidon ulkopuolella oleva, 
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pitkälle edennyt aivokasvain. Hän menee elottomaksi päivystyksessä ja vastaajilta 
kysyttiin, aloittaisivatko he elvytyksen vai eivätkö. Viides potilastapaus oli 62-vuotias 
mies, jolla on loppuvaiheen levinnyt keuhkosyöpä. Hänen kohdallaan vastaajia 
pyydettiin arvioimaan, kuinka todennäköisesti he lopettaisivat tai eivät aloittaisi eri 
hoitovaihtoehtoja. Lisäksi kysyttiin vastaajien mielipiteitä, arvoja ja taustatietoja. 
Kyselyyn saatiin yhteensä 1 763 vastausta ja kokonaisvastausprosentti oli 56. 
Päätöksentekoon vaikutti merkittävästi kyselyyn vastaamisen vuosi, lääkärin 
palliatiivisen lääketieteen erityispätevyys ja vastaajan kliininen kokemus. Lääkärit, 
joilla oli palliatiivisen lääketieteen erityispätevyys, tekivät vähemmän hoidollisesti 
aggressiivisia päätöksiä elämän loppuvaiheessa, mutta erityispätevyyden ja erikoisalan 
vaikutus päätökseen vaihteli hoidosta riippuen. Valmistuvat lääketieteen opiskelijat 
olivat haluttomampia lopettamaan ja olemaan aloittamatta hyödyttömiksi ajateltuja 
hoitoja elämän loppuvaiheessa verrattuna kokeneisiin yleislääkäreihin, mutta 
palliatiivisen hoidon valinnassa tai maksusitoumuksen myöntämisessä 
saattohoitokotiin ei ollut eroa. Vuonna 2015 lääkärit valitsivat palliatiivisen hoidon 
useammin kuin aktiivisen tai tehohoidon. Tätä päätöstä tehdessään heihin vaikutti 
vuonna 2015 enemmän potilaan etu ja vähemmän perheen etu kuin vuonna 1999. 
Lääkärit myös myönsivät maksusitoumuksen saattohoitokotiin useammin vuonna 
2015 kuin 1999. Vuonna 2015 lääkärit olivat valmiimpia hyväksymään mahdollisen 
kuoleman jouduttamisen morfiiniannosta nostamalla kuin vuonna 1999. Lisäksi 
kokeneet yleislääkärit olivat valmiimpia hyväksymään mahdollisen kuoleman 
jouduttamisen morfiiniannosta nostamalla kuin lääketieteen opiskelijat, vaikka 
opiskelijat pitivät eutanasiaa ja avustettua itsemurhaa vähemmän tuomittavina kuin 
nämä kokeneet yleislääkärit. Lääkäreiden mielipiteet ja arvot, jotka vaikuttavat 
elämän loppuvaiheen päätöksentekoon ovat muuttuneet kuudentoista vuoden 
aikana. Esimerkiksi eutanasiaa pidettiin vähemmän tuomittavana ja uskontoa 
vähemmän päätöksiin vaikuttavana vuonna 2015 kuin 1999. 
Muuttuvat yleiset mielipiteet, lääketieteen kehitys, kasvava ymmärrys palliatiivisen 
hoidon hyödyistä ja palliatiivisen lääketieteen koulutus vaikuttanevat elämän 
loppuvaiheen päätöksentekoon, vaikka aiempi tutkimustieto tästä on ollut vähäistä.  
Tämän tutkimuksen perusteella lääkärin kokemus, asenteet ja koulutus näyttävät 
vaikuttavan merkittävästi elämän loppuvaiheen päätöksentekoon, vaikka tämä 
vaihtelee merkittävästi riippuen kliinisestä tilanteesta ja eettisistä näkökulmista. Jotta 
yhdenmukainen ja korkealaatuinen saattohoito voitaisiin taata kaikille potilaille, 
elämän loppuvaiheen päätöksenteon opetuksen, joka sisältää myös eettiset ja juridiset 
näkökohdat, pitäisi kuulua pakollisena lääketieteen perusopetukseen sekä lääkärien 
erikoistumiskoulutukseen.  
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1 INTRODUCTION 
The World Health Organization (WHO) has defined that palliative care aims to 
improve patients’ and their families’ quality of life when they are facing life-
threatening illness1. Palliative care intends neither to hasten nor postpone death1. 
Approximately 20 million people worldwide are annually in need of palliative care at 
their end-of-life (EOL)2. This demand is highest in Europe due to the ageing 
population and the increase of noncommunicable diseases2. 
Well-timed palliative care improves patient quality of life and symptom control, 
reduces invasive procedures and costs, and might even improve survival3-11. 
Although the awareness of the benefits of high-quality palliative care is rising, the 
use of non-beneficial and even futile treatments is common in EOL care12. In recent 
years, medical developments have led to increased possibilities to prolong life in 
patients suffering from very advanced diseases13. However, attempts to prolong life 
at any cost may be futile and done at the expense of quality of life14. This complexity 
makes it even more challenging to choose worthwhile therapies for each patient 
especially in EOL care. 
Appropriate decision-making is mandatory in high-quality EOL care to prevent 
non-beneficial treatments, to relieve suffering and to utilize resources to the most 
valuable treatment modalities. Decisions include, but are not limited to, statements 
on cardiopulmonary resuscitation, parenteral fluids, and diagnostic tests. Decision-
making in EOL care is a challenging process involving many ethical, legal, medical 
and psychological aspects15-22. The background characteristics, specialties, attitudes 
and values of physicians all play a part in this complex process16-18,23-26. The education 
and experience of a physician also influences the decision-making in EOL care27-32. 
Although newly graduated physicians often feel unprepared for providing EOL care, 
they face the complexity of the decision-making process just as the senior physicians 
do27,28,30. Nevertheless, decision-making should be consistent in the same types of 
clinical situations in EOL care regardless of the physician who is responsible for the 
care of the patient. 
Most patients wish for their closest loved ones to be involved in the decision-
making and, therefore, discussions with family members are essential33-35. Physicians’ 
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decision-making is influenced by families’ opinions, although discordance between 
a patient’s wishes, the caregiver’s preferences and the caregiver’s predictions of the 
patient’s preferences may exist18,35-38. Advance directives reinforces patient 
participation and commonly make decision-making easier17,18,36,37,39. However, 
concerns have been raised as to whether advance directives genuinely express a 
patient’s own will, and there is variation on how advance directives are understood 
and taken into account in clinical practice5,40,41. 
When taking care of dying patients, physicians are forced to make decisions 
regarding forgoing different therapies. In EOL decision-making, withdrawing and 
withholding treatments are generally considered ethically and legally equivalent, but 
medical professionals feel that withdrawing treatment is more difficult and ethically 
more problematic than withholding it13,42-46. Studies also show that decisions to 
withdraw are taken less frequently than decisions to withhold42-46. In addition, these 
decisions vary between different therapies or treatments47,48. For example, 
intravenous hydration is often continued in EOL care whereas antibiotics are more 
frequently discontinued47,48. 
Today, shared decision-making and patient-centred care are preferred by most 
physicians and patients; this might reflect the changing atmosphere due to the rise 
of individualism, autonomy and human dignity in western countries49-57. At the same 
time, concerns have been raised about the excessive autonomy of patients, which 
can result in costly, ineffective and even futile treatments58. The 1948 Universal 
Declaration of Human Rights made by the United Nations General Assembly sets a 
basis for patient rights59. After this declaration, several countries, including Finland, 
ratified international conventions in which human and patient rights were 
prominent52,53,56,57. The right of the patient to be involved in treatment decisions was 
included in Finnish law in 199260. In the United States the Patient Self-
Determination Act was passed by the US congress only two years earlier61. 
Respecting the wishes of a patient is also one of the fundamental principles in the 
ethical guidelines of the Finnish Medical Association62. However, the Finnish 
National Supervisory Authority for Welfare and Health (VALVIRA) has stated that 
ineffective or futile therapies should not be used even though the patient requests 
them63. 
Discussions about the ethical justification of hastened death due to unbearable 
suffering have been ongoing for many years around the world. Thus far, assisted 
dying through euthanasia or physician-assisted suicide (PAS) has been legalized in 
seven countries (and in five states in the United States of America)64. In addition, 
public support for euthanasia and PAS is mounting across Western Europe, while 
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some decline has been observed in the USA and Eastern Europe64. Hastening death 
in end-of-life care is even more complex and ethically ambivalent than euthanasia 
and physician-assisted suicide. Withdrawing life-sustaining treatments (LSTs), 
euthanasia and physician-assisted suicide are sometimes mixed up among the public 
and physicians alike; for example, terminating life-sustaining treatment is sometimes 
considered to be euthanasia65. Further, the term ‘double effect’ has been used when 
the ethics of hastening death are discussed. It applies to situations in which an act 
intended to do good turns to a foreseeable danger of harm or risk of death66.  
There is a gap of knowledge on how the changing public atmosphere, advances 
in medicine, growing knowledge of the benefits of palliative care and education in 
palliative medicine influence the essential decision-making in EOL care. In this 
study, a cross-sectional survey with a questionnaire including hypothetical and 
ethically complex patient scenarios was used to evaluate the decision-making of 
physicians and medical students regarding the EOL care of cancer patients and the 
factors influencing this decision-making. 
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2 REVIEW OF THE LITERATURE 
2.1 Palliative care and end-of-life care 
2.1.1 Definitions of palliative care and end-of-life care 
Palliative care and end-of-life care have evolved from the hospice movement started 
in 1960’s by Dame Cicely Saunders in England13,67. Terminology around hospice 
care, terminal care, supportive care, palliative care and end-of-life (EOL) care has 
changed over the past decades68,69. Currently, the term palliative care has an 
established status and it is defined by the World Health Organization (WHO) as an 
approach that improves the quality of life of patients and their families facing the 
problem associated with life-threatening illness, through the prevention and relief of 
suffering by means of early identification and impeccable assessment and treatment 
of pain and other problems, physical, psychosocial and spiritual1. Although this clear 
definition from WHO is widely accepted, different definitions with slight variations 
between the content exist. For example, a review from 2012 and another from 2013 
found 16 and 24 different definitions of palliative care, respectively68,70. The most 
commonly used definitions are summarized in Table 1. In spite of the well-
established status of palliative care, a lack of awareness and misperceptions are 
common. In a recent study from the USA, only 27% of community-dwelling adults 
were able to define palliative care, and of those, only 26% mentioned that it provided 
symptom management to patients; more than 50% had misperceptions, for example, 
that palliative care is only for the elderly and is applicable only at the end-of-life71. 
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Table 1.  Different definitions for palliative care. 
 
As well as the use of the term palliative care, the use of the term EOL care has 
increased in recent years68. However, there is no exact definition of EOL, probably 
because of the difficulty of prognostication of the illness trajectory69. The USA 
National Institutes of Health suggests, based on evidence, the following components 
of EOL: (1) the presence of a chronic disease(s) or symptoms or functional 
impairments that persist, but may also fluctuate; and (2) symptoms or impairments 
resulting from the underlying irreversible disease requiring formal (paid, 
professional) or informal (unpaid) care and can lead to death69. Older age and frailty 
may be surrogates for life-threatening illness and comorbidity; however, there is 
insufficient evidence for understanding these variables as components of EOL.69 
The European Association for Palliative Care (EAPC) stated in 2009 that EOL care 
may be used synonymously with palliative care or hospice care if the end of life is 
The World Health Organization1 Palliative care is an approach that improves the quality of life of patients and their 
families facing the problem associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and 
spiritual. 
The European Association for 
Palliative Care72 
Palliative care is the active, total care of the patient whose disease is not responsive 
to curative treatment. Control of pain, of other symptoms, and of social, 
psychological and spiritual problems is paramount. Palliative care is interdisciplinary 
in its approach and encompasses the patient, the family and the community in its 
scope. In a sense, palliative care is to offer the most basic concept of care – that of 
providing for the needs of the patient wherever he or she is cared for, either at home 
or in the hospital. Palliative care affirms life and regards dying as a normal process; 
it neither hastens nor postpones death. It sets out to preserve the best possible 
quality of life until death.  
The International Association for 
Hospice and Palliative Care73 
Palliative care is the care of patients with active, progressive, far-advanced disease, 
for whom the focus of care is the relief and prevention of suffering and the quality of 
life.  
The American Society of Clinical 
Oncology74 
The integration into cancer care of therapies that address the multiple issues that 
cause suffering for patients and their families and impact their life quality.  
The American Academy of 
Hospice and Palliative Medicine75 
Palliative care focuses on improving a patient's quality of life by managing pain and 
other distressing symptoms of a serious illness. Palliative care should be provided 
along with other medical treatments.  
The National Comprehensive 
Cancer Network76 
Both a philosophy of care and an organized highly structured system for delivering 
care to persons with life-threatening or debilitating illness. Palliative care is patient 
and family centered care that focuses on effective management of pain and other 
distressing symptoms, while incorporating psychosocial and spiritual care according 
to patient/family needs, values, beliefs, and cultures.  
The National Supervisory 
Authority for Welfare and Health 
(Valvira)77 
Palliatiivinen eli oireenmukainen hoito on kuolemaan johtavan tai henkeä 
uhkaavan sairautta sairastavan potilaan ja hänen läheistensä aktiivista 
kokonaisvaltaista hoitoa, jolla pyritään ehkäisemään ja lievittämään kärsimystä ja 
vaalimaan elämänlaatua.  
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understood as an extended period of one to two years during which the 
patient/family and health professionals become aware of the life-limiting nature of 
the illness72. In addition, according to EAPC, it also may be understood more 
specifically as the comprehensive care for dying patients in the last few hours or days 
of life72. In contrast to the long time period set by the EAPC, in a review by Hui et 
al., one of the key features defining end-of-life was an expected survival time 
presented in terms of months or less78. This wide range of timeframe makes the use 
of the term EOL challenging in scientific literature; therefore, a more detailed 
definition is called for. 
In Finland, the definition of palliative care, as “palliatiivinen hoito” in Finnish, is 
adapted from the definition of WHO (Palliatiivisella hoidolla tarkoitetaan 
parantumattomasti sairaan tai henkeä uhkaavaa sairautta sairastavan potilaan ja 
hänen läheistensä aktiivista kokonaisvaltaista hoitoa. Palliatiivisen hoidon 
tarkoituksena on vaalia elämänlaatua ja ehkäistä ja lievittää kärsimystä. Kärsimyksellä 
tarkoitetaan niin fyysistä, psykososiaalista kuin eksistentiaalista kärsimystä.)77,79. The 
term end-of-life care is translated as “saattohoito”79,80. “Saattohoito” in Finland is 
defined as part of palliative care occurring close to a patient’s death (last weeks or 
days)80,81. 
Compared to the terms palliative and EOL care the previously used term terminal 
care (“terminaalihoito”) is considered to be old fashioned and inapropriate72. 
Nevertheless, it is still occasionally used by physicians together with the term 
terminally ill, which is described most often as life-limiting disease with irreversible 
decline and a survival of less than six months78. 
2.1.2 Practices in palliative care 
2.1.2.1 Globally 
Symptom control has been an essential and crucial part of medicine since the very 
beginning of the profession, as it was stated in the Oath of Hippocrates: “I will use 
treatment to help the sick according to my ability and judgement”. However, the 
modern history of palliative care started in the UK, where the first hospices were 
opened over a century ago13,67. The palliative care and hospice movement rose in the 
1960s through the work of Dame Cicely Saunders13,67. The number of hospices 
increased around the western world, and hospital palliative care teams began to form 
in the late 1970s13,67. Further, the EAPC was established in 1988 in Milan, Italy and 
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the International Association for Hospice and Palliative Care (IAHCP) was 
established in the mid 1990s in the US13,67. Today, WHO considers palliative care to 
be a human right, but only 20 countries globally (9%) have achieved the advanced 
integration of palliative care within the wider health services, which is characterized 
by the following: the development of a critical mass of palliative care activism in a 
wide range of locations; comprehensive provision of all types of palliative care by 
multiple service providers; broad awareness of palliative care on the part of health 
professionals, local communities and society in general; unrestricted availability of 
morphine and all other strong pain-relieving medicines; substantial impact of 
palliative care upon policy, in particular upon public health policy; the development 
of recognized education centres; academic links forged with universities; and the 
existence of a national palliative care association2. In 2011, 136 of the world’s 234 
countries (58%) had one or more hospices or other palliative care services 
established2. 
Palliative care should be applicable already in the early course of illness; it is no 
longer thought to be an option for other treatment modalities, but rather a parallel 
model of care1,13,82. There are numerous ways of delivering specialized palliative care 
including inpatient palliative care units, inpatient hospices and palliative care 
consultant teams in hospitals, home care, palliative outpatient services, day care and 
short-term integrated palliative care13. The idea is to operate across all of the settings 
where patients and their families need support13. The way of delivering these services 
depends largely on the country in question, but some principles and values are 
common such as a holistic and multidisciplinary approach based on a need13,82. A 
recent review from 2017 concluded that a wide range of different models of 
providing palliative care are used, but comparing them is difficult mainly because of 
under-reporting of the components that are included in the interventions and 
comparator models83. However, different models appear to show benefits and can 
even reduce total healthcare costs83. WHO has calculated that approximately 377 
adults out of 100 000 will require palliative care at the end-of-life2,82. 
2.1.2.2 Finland 
In Finland, the first steps towards palliative care were the publication of guidelines 
for terminal care by the National Health board in 1982 and the founding of the first 
hospice in 1988 in Tampere84. Today there are four hospices, specialist palliative care 
units in all five university hospitals and a national guideline for palliative and EOL 
care (updated in 2018)80,85. The Ministry of Social Affairs and Health has recently 
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published recommendations for providing palliative and EOL care in Finland79. In 
these recommendations, it is stated that palliative care should be equally available to 
all citizens based on their need79. Although specialized palliative care services are 
needed, the vast majority of dying patients in Finland are cared for by general 
practitioners (GPs) in wards of the community hospitals, at home or in nursing 
homes. 
In Finland there are two associations that, work to promote palliative medicine 
and care. The Finnish Association for Palliative Medicine (Suomen palliatiivisen 
lääketieteen yhdistys) founded in 2003 aims to promote physicians’ knowledge and 
education of palliative medicine86. The Finnish Association for Palliative Care 
(Suomen Palliatiivisen Hoidon Yhdistys ry) established in 1995 aims to develop the 
multi-professional care of people with an incurable disease, as well as terminally ill 
patients87. 
2.1.3 Ethics in palliative care 
The word ethics comes from a Greek word ēthikós meaning "relating to one's 
character". Ethics is a sub-branch of philosophy that examines rights and wrongs 
and seeks to understand how human beings should behave88. Many of the ethical 
issues that arise in palliative care are similar to issues that also arise in other areas of 
health care, such as the four main principles: non-maleficence (do no harm), 
beneficence (doing good), autonomy (the right of self-determination), justice (e.g. 
appropriate use and allocation of health care resources), as well as truth telling and 
confidentiality, decision-making authority in the professional–patient relationship, 
the conduct of research and the focus on ethical responsibility when care is provided 
by a team13,15,88,89. Other ethical issues are more commonly associated with EOL 
care, such as decision-making for incompetent patients, withholding and 
withdrawing life sustaining treatments (LSTs), and hastening death13,88. Respecting 
life can be considered as one of the fundamental principles of medicine62,81,88,90. This 
may, however, create an ethical paradigm in EOL care, if interpreted as a synonym 
for prolonging life as long as possible81. On the other hand, respecting life can also 
be seen as a value that reinforces the relief from suffering in palliative care81. In the 
Finnish ethical guidelines for physicians, six main ethical principles are highlighted: 
respecting life, respecting human dignity, self-determination, caring (including 
benevolence, beneficence and non-maleficence), justice and benefit62. In the Charter 
of Fundamental Rights of the European Union, human dignity is called out in the 
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first article, and in Finland, the National Advisory Board on Social Welfare and 
Health Care Ethics (ETENE) raised the term human dignity to an important ethical 
principle especially in EOL situations54,91,92. The ethics of decision-making and 
hastening death are further discussed in the following paragraphs: 2.2.5. Ethics of 
end-of-life decision-making and 2.3.4. Complexities of hastened death. 
A major question in palliative care and especially in EOL care, is how to define a 
good death, dying well or dying with dignity? There are no right, wrong, universal or 
all-inclusive answers to this question. People differ in their willingness to face the 
reality of their death and how they wish to deal with different aspects of dying. For 
example, how one balances pain relief against alertness and how one desires to talk 
about feelings with friends, family, or caregivers differs between individuals13,88. It 
can be concluded that a good death, dying well and dying with dignity are all regarded 
differently by individuals13,88. This personal variability requires health care 
professionals to approach patients and families as individuals in an effort to provide 
care that is consistent both with the patient’s and family’s values and with their own 
conscience88. 
2.1.4 Education in palliative medicine 
The growing need for high-quality palliative care due to the world’s ageing 
population and the increasing number of patients suffering from cancer and other 
diseases leading to death demands systematic education in palliative medicine (PM)2. 
This education of health care professionals is considered to be highly important by 
the EAPC93. Therefore, the EAPC has made recommendations for an undergraduate 
curriculum (40-hours) in different aspects of PM to be utilized at medical schools in 
Europe93. In addition, palliative medicine has evolved to a medical specialty in some 
countries, such as in the UK (1987) and the US (2006)94. 
In Finland, five universities have a faculty of medicine. Tampere University has 
had a chair in PM since 1999 and University of Helsinki since 2014. Both these 
universities have also established a curriculum in PM, while the other three 
universities with a faculty of medicine lack both professorship and a curriculum in 
PM95. In addition to undergraduate education in PM at medical schools, a 
postgraduate training in PM has been available since 2007 in Finland. This training 
leads to a certification for a special competency in palliative medicine (cPM) awarded 
by the Finnish Medical Association96. Finnish physicians are allowed to start this 
postgraduate training after working for at least 2 years as a licensed physician96. The 
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special training consists of a minimum of 150 hours of theoretical education in 
different aspects of palliative medicine, 200 patient encounters in palliative care, 2 
years of clinical practice, including a working period in a specialized palliative care 
unit for a minimum of 6 months, and a final written examination96. 
Throughout the world, medical students and junior physicians have been found 
to lack confidence and to feel underprepared for having discussions about EOL care 
and for providing this care to a patient and their family27,30,97-99. Furthermore, their 
knowledge about assisted dying, do-not-resuscitate (DNR) orders, advance 
directives (ADs) and many other aspects of PM is still known to be inadequate100-103. 
On the other hand, undergraduate curricula in PM increases students’ knowledge on 
palliative care and their attitudes towards EOL care change after an observational 
experience in a hospice28,95,104,105. Physicians also report having insufficient 
knowledge and training in PM106-109. Postgraduate education of physicians in 
palliative and EOL care enhances the knowledge and skills needed to perform high-
quality EOL care, including appropriate decision-making29,31,32,110-113. 
2.2 Decision-making in palliative care 
2.2.1 Principles of decision-making in palliative care 
Medical decision-making is a fundamental part of practising medicine, as it occurs at 
each stage of the diagnostic and therapeutic process114. In Goldman’s Cecil Medicine 
the decision-making process is described as a blend of science and art in which the 
physician must synthesize a variety of concerns including the patient’s most likely 
outcome, various management strategies, the patient’s worst possible outcome, and 
the patient’s preferences among these strategies115. Decision-making should be 
evidence-based, but much of the medical decision-making relies on good clinical 
judgement, as relevant evidence is not always available114,116. 
Appropriate decision-making is mandatory in high-quality palliative and EOL 
care to prevent non-beneficial treatments and relieve suffering. Physicians have to 
strike a balance between the wishes of the patient and family, consider legal and 
ethical aspects and evaluate the benefit, harm and cost of the care. Paternalism was 
the previous method of making medical decisions, where a physician made the 
decision based on the medical evidence and what he or she thought to be best for a 
patient117,118. In an informed (patient-centred) model, the patient makes the decision 
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based on the information given by a physician117,118. Concerns have been raised 
about the excessive autonomy of patients, which can result in costly, ineffective and 
even futile treatments58. Thus, today, shared decision-making has emerged as the 
ideal model for complex decision-making19,117,119-121. At a minimum a physician and 
a patient are involved in the decision-making process, but family members, 
caregivers and other important persons such as friends can all take part, if it is a 
patient’s wish119. Before the actual decision-making both the patient and the 
physician share information and discuss with each other119. Thereafter, the patient 
(and family members, etc.) and the physician take part in the decision-making 
process and make informed decisions regarding the medical care together119. 
However, it is also possible and allowed for the patient to take a more passive role 
as the shared decision-making is considered to be a continuum rather than a rigid 
model19,119,121. Today, this shared decision-making is known to be preferred by most 
physicians and patients49,51,122. 
Multiple guidelines and frameworks have been established to ease the decision-
making process in challenging medical situations117,123-126. The purpose of these 
guidelines and frameworks is to enhance ethical deliberation in the decision-making 
and to provide practical and educational tools for health care professionals when 
they are faced with complex decision-making situations. For example, the guide from 
the Council of Europe gives a practical step-by-step model for decision-making 
regarding medical treatment in EOL situations123. In addition to guidelines, different 
interventions, such as videos, digital video discs (DVDs) and web-based tools, have 
been created to support shared decision-making, but the evidence of the benefits of 
these tools is scarce and inconsistent127. 
In practice, medical EOL decisions frequently precede dying in Europe, and 
patients and relatives are generally involved in this decision-making128. In a study 
from Switzerland, 77% of EOL decisions were made through a shared decision-
making process in 2013129. Patient-related factors are known to influence the 
decisions about withholding or withdrawing LSTs, with age being the most 
frequently investigated factor24,130-133. In a review article by Frost et al., age was the 
most commonly identified factor predicting the intensity of the EOL care after 
adjusting for other variables in cohort studies24. Among survey studies, age was the 
second most commonly identified determinant after patient wishes24. 
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2.2.2 Advance care planning 
When a patient is faced with a life-threatening illness, it is important to be prepared 
for the possibility of losing his or her capacity to take part in medical decisions. 
Advance care planning (ACP) is a way for preparing for situations in which a patient 
is no longer able to participate in decision-making134-139. There was no unified formal 
definition of ACP until 2017, when two multidisciplinary Delphi panels published 
consensus definitions for ACP137,140. The first definition, approved by the EAPC, 
defines ACP as the ability to enable individuals to define goals and preferences for 
future medical treatment and care, to discuss these goals and preferences with family 
and health care providers and to record and review these preferences if 
appropriate137. The second definition states that ACP is a process that supports 
adults at any age or stage of health in understanding and sharing their personal 
values, life goals, and preferences regarding future medical care140. The goal of ACP 
is to ensure that people receive medical care that is consistent with their values, goals 
and preferences during serious and chronic illness140. Originally, ACP focused on 
completing written documents such as ADs but has then evolved into an ongoing 
social process of also preparing for death and dying, involving not only the patient 
and healthcare professionals, but also family members and loved ones139. One of the 
most important transitions is the movement from a single discussion about goals of 
care to an evolving process, which requires constant updating136,137,139,140. The ethical 
grounds for ACP are in patient’s self-determination, respect for an individual, and 
the exercise for control even when a patient loses his or her capacity138,139,141. In the 
US, the amount of ACP among community-dwelling individuals aged 50 and older 
has steadily risen from 36% to 61% between 2002 and 2010142. 
Recent reviews show that ACP can positively impact the quality of EOL care and 
that complex ACP interventions may be more effective in meeting patient 
preferences than written documents alone134,135,143-145. According to the studies, ACP 
decreases the number of hospitalizations, allowing especially older patients to die in 
nursing homes, increases the number of DNR orders, improves concordance 
between preferences for care and delivered care, and increases the use of hospice 
care134,135,143-145. There is some data that ACP could potentially reduce the net costs 
of care, although this is, in most studies, associated with the reduced demand for 
hospital care146,147. Despite the mounting evidence of the benefits of ACP, 
implementing it in practice can be challenging. The lack of knowledge among 
healthcare professionals and the public regarding ACP is an obstacle to implement 
ACP in practice148. Other barriers against taking up ACP include having a diagnosis 
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of a non-malignant disease, having dependent children, being African American, 
having uncertainty about ACP and its legal status, and poor documentation149,150. 
Several tools, including electronic health records, games and videos, have been 
created to facilitate ACP151-154. Some of these have a positive impact on the initiation 
and implementation of ACP to standard, every day practice151-154. However, a recent 
systematic review by Myers et al. concludes that instead of tools, an effective ACP 
conversation at both the population and the individual level requires provider 
education and communication skill development, standardized and accessible 
documentation, quality improvement initiatives, and system-wide coordination to 
create an impact at the population level153. 
On the other hand, the effect and utility of ACP has also been under debate in 
recent years155-158. There are studies in which ACP has not improved quality of life 
or reached other pursued goals159,160. It has been proposed that meaningful 
improvements in EOL care will not result from the institutionalization of ACP, but 
from more significant changes to the design and delivery of care155. At the same time, 
the risk of routinization and turning ACP into just another protocol, undermines the 
importance of an open ethical dialogue where no correct answers exist156,157. 
The Finnish national guideline for palliative and EOL care recommends the 
following topics to be covered in ACP (“Pitkälle edenneen sairauden 
hoitosuunnitelma”): 1) Patient (and loved ones) wishes, fears and understanding of 
the disease trajectory now and in the future; 2) Goals of care; 3) Treatment modalities 
and needs; 4) Decisions to withhold treatments; and 5) EOL care80. A recent article 
in a national medical journal, Duodecim, introduced the same elements of ACP as 
mentioned above and highlighted the importance of conducting ACP for all patients 
suffering from an advance disease161. A Finnish study showed that even modest 
investments in resources for palliative care can induce an objective change in the 
allocation of health care resources and improve the ACP for cancer patients at their 
EOL162. Visits to a palliative outpatient clinic have been shown to correlate with a 
higher frequency of DNR orders, better connection to primary care and better 
documented goals of care162. 
2.2.3 Advance directives 
The first proposal for ADs was made by the Euthanasia Society of America in 1967, 
and Luis Kutner, a human rights lawyer from Chicago who represented the society, 
described this concept in his article published in 1969163. He suggested that the 
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individual should indicate in writing ahead of time the extent to which he or she 
would consent to treatment163. Since 1976, when the first living will statute was 
adopted in California, the number of living will laws has increased rapidly163. In many 
countries, AD statutes require witnesses or a notary to be legally binding163-165. As in 
the case of ACP, the ethical basis for ADs rests in a patient’s autonomy138,164. 
The prevalence of ADs varies widely. In the US, the prevalence of ADs seems to 
have increased from approximately 10% up to 21–55% among the elderly in the last 
10 years, while a Finnish study from 2004 showed that only 12% of the home-
dwelling elderly had a living will166-168. In another study from Finland from 2003, 
only 1.5% of patients suffering from cardiac arrest without resuscitation being 
initiated had a living will.169 The place of care also influences the prevalence of ADs. 
A recent Australian study demonstrated, that the prevalence of ADs was higher in 
residential aged care facilities (48%) than in hospitals (16%) or in general practices 
(3%), reflecting differences in the patient cohorts in these facilities170. 
Although ADs reinforce patient participation in EOL discussions, patients often 
wish for their physician to initiate the discussion39,171. ADs are shown to increase the 
decision to forgo medical interventions, including in complex situations where the 
patient’s health care proxy disagrees with the statements in the AD36,37. This is 
further supported by a very recent review where twenty-one out of the twenty-eight 
studies reported that individuals with living wills received significantly less medical 
management of which the authors meant cardio-pulmonary resuscitation, 
mechanical ventilation, hospitalization or admissions to an intensive care unit 
(ICU)172. 
Concerns have been raised as to whether ADs express the genuine will of a 
patient at an exact moment40. Although the stability of EOL preferences is 
demonstrated in a recent study by van Wijmen et al., this was not supported by 
another recent study by Gallo et al., showing that transitions in preferences do 
happen highlighting the need for reassessments173,174. There is also variation in how 
ADs are implemented in daily practice. In a study made among palliative care 
physicians in Japan, most of the responders considered ADs to be important, but 
only one third actually recommended patients to complete their ADs5. Health care 
professionals report positive perceptions of the use of advance care documentation, 
but it is not clear how ADs are implemented in EOL discussions in daily practice or 
whether it increases engagement in EOL discussions to have access to previously 
formulated wishes175. Physicians are more likely to follow patient ADs, if the 
decisions are in line with their own clinical views176. 
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In a Finnish study from 2004, a majority of physicians answering a questionnaire 
had a positive attitude towards (92%), and respect for (86%), living wills, and 72% 
reported situations in which such a will would have been helpful177. In Finland, ADs 
are considered legally binding upon physicians and other health care professionals 
based on the Act on the Status and Rights of Patients which states that a competent 
person has a right to refuse any planned or ongoing treatment upon receiving 
adequate information or refusing to take this information60,62,81,178,179. All physicians, 
no matter where they practice medicine, should follow a patient’s wishes expressed 
in an AD (except for wishes regarding futile therapies)62,81,180. Thus, ADs ought to 
be transferred into patient records as clearly as possible62,81,180. In Finland, it is also 
possible for a patient to have a legal representative who has a right to make medical 
decisions on their behalf181. 
2.2.4 Withholding and withdrawing treatment 
Withholding LST is the deliberate decision not to initiate treatment aimed at 
prolonging life, whereas withdrawing LST involves removing a medical intervention 
without which life is not expected to continue due to the patient’s underlying health 
status13,182. Withholding or withdrawing LST is therefore considered to lead to a 
patient death due to the natural progression of their underlying illness, not by 
hastening death13. The similar result of both of these decisions has led to the 
conclusion that from a Western bioethical perspective, there is no moral or ethical 
reason to differentiate between withholding and withdrawing LST13,183-185. However, 
this perspective has been challenged in several articles in recent decades, reasoning, 
for example, that withholding is passive and withdrawing is active or that a 
physician’s duty to care for a patient makes it unethical to withdraw a treatment once 
started46,184,186-188. 
The legality of withholding or withdrawing LST differs between countries. In 
most western countries, withholding or withdrawing LST is legal; this is in contrast 
to the developing world where these actions are either of uncertain status or are 
illegal13. In Finland, the physician is responsible for the medical care of the patient, 
including medical examination, diagnosis and treatment of disease179. Based on the 
Act on the Status and Rights of Patients, a competent person has a right to refuse 
any planned or ongoing treatment upon receiving adequate information or refusing 
to take this information60,178. It is stated in the Act on the Status and Rights of 
Patients and in the main principles of Physician’s Ethics, the ethical guideline for 
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Finnish physicians, that a physician must treat a patient in agreement with and in a 
mutual understanding60,62. However, futile therapies should not be used (even if a 
patient or families have requested them), as stated by the Finnish National 
Supervisory Authority for Welfare and Health and the Act on Health Care 
Professionals63,179. As the physician is responsible for the care of a patient, it is legal 
in Finland to withhold or withdraw life-sustaining treatments, if they are considered 
futile63,81,179. This is a medical decision made by the treating physician, but it should 
be discussed with the patient63,81,179. In cases where the patient is incompetent, 
decisions should be discussed with relatives, other loved ones or with a legal 
representative, if the latter is legally defined63,81,179. Although it is very important to 
make sure that decisions concerning withholding treatments are included in the 
patient record, there is still no uniform way of doing this in Finland due to different 
electronic health care records and health care keepers across the country. A new 
electronic national health care data base (Kanta) in Finland is trying to gather 
information from different sources into one location where important information 
about patients can be found more easily189. 
Physicians’ knowledge of the law on withholding and withdrawing LST may have 
significant gaps22,190,191. False perceptions, such as forgoing LST for patients without 
decision-making capacity requires evidence that this was the patient’s actual wish or 
that the withholding or withdrawing of artificial fluids and nutrition from a terminally 
ill patient is illegal, can impair the delivery of the best possible palliative care for 
patients at their EOL22,190,191. 
Although it is generally accepted that the withholding and withdrawing of LST 
are morally and ethically equivalent, physicians decide to withdraw therapy less 
frequently than to withhold it, probably because they feel that withdrawal is more 
difficult and ethically problematic than withholding42-45,182,186. The physicians’ 
decisions regarding LST also vary between different treatment modalities; the most 
common reasons for withholding or withdrawing treatments in EOL care are a poor 
prognosis and futility of the treatment in question23,42,47,48,133,192,193. In a Scandinavian 
study, 57% of intensive care physicians would continue intravenous hydration, but 
only 5% of them measured blood glucose during EOL care48. Another study 
conducted with Slovenian ICU physicians had similar results, where 76% of 
responders reported never having  terminated intravenous hydration, but antibiotics 
where withdrawn by most of the responders (86%) in EOL situations47. Almost all 
of these studies were conducted in an ICU setting and with ICU physicians or 
intensivists48,130,133,192-194. Thus, it is not clear how well these results would translate 
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to a much larger palliative care patient population who are cared for outside of ICUs 
and emergency departments. 
It is true that some medical interventions such as resuscitation or mechanical 
ventilation are clearly intended to prolong life when used in EOL care, whereas 
intravenous hydration, antibiotics and supplementary oxygen can be considered as 
symptom management rather than just LSTs. Artificial nutrition or medically assisted 
hydration have not been shown to improve survival, quality of life or symptoms in 
EOL care, although the evidence about this is scarce195-199. However, some studies 
have raised concerns about the potential harm, such as increased respiratory 
secretions, related to hydration during EOL care200. The use of antibiotics in EOL 
care is controversial, but there is some evidence that antibiotics might relieve 
symptoms without having serious side-effects201,202. Supplementary oxygen is used 
in more than 70% of patients in EOL care, although the evidence to support this is 
lacking203-209. The benefits of transfusions in palliative care are experienced briefly 
and remain controversial210. The symptomatic relief gained from treatment such as 
a red blood cell transfusion is often short-lived, or even absent, if given very near 
death210. 
2.2.4.1 Do-not-resuscitate orders 
As discussed previously, ACP is a broad entity, but DNR or do not attempt 
cardiopulmonary resuscitation (DNACPR) orders are in many ways an important 
part of these discussions134,136,211,212. The issue of resuscitation raises fundamental 
ethical questions about autonomy (a patient’s wishes and choices), beneficence 
(doing good), non-maleficence (harm avoidance) and justice (allocation of limited 
resources and appropriate decision-making)213. Thus, the ethical basis for these 
orders can be seen as what is in the best interest of the patient, as DNR orders 
presumably allow dying patients to die with dignity178,214. 
Multiple studies have shown that the outcomes of cardiopulmonary resuscitation 
(CPR) are poor, especially in cancer patients, whose overall survival after CPR for 
hospital discharge is less than 10%14,214-217. Despite recent medical advances, CPR 
survival in the cancer patient population has not changed14. The survival from CPR 
declines towards zero as the cancer spreads and the performance status lowers, 
resulting in the fact that attempting CPR for a cancer patient with widespread 
incurable cancer and a low performance status is indeed futile218. Although the 
evidence of poor CPR outcomes among cancer patients is consistent, 
misconceptions about DNR orders still exist among the public and physicians. In a 
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small study by Sundar et al., responders significantly overestimated the chance of a 
successful CPR outcome in a terminally ill cancer patient; 50% believed that CPR 
has at least a 30% chance of successfully resuscitating a hypothetical 60-year-old 
patient with widespread cancer, who is in hospice and has exhausted all 
chemotherapy options219. In a Finnish questionnaire study to physicians from 2004, 
a DNR order was interpreted by one third (30%) of the responders that only 
palliative (symptom oriented) care was required177. ACP and other interventions, 
such as structured discussions, involving family members, which commonly enable 
better communication between patients, their loved ones and physicians, increase 
the prevalence of DNR orders9,134,220-223. 
In our country, the decision not to resuscitate is a medical decision made by a 
physician, although there is no legislation regarding DNR orders178,224. However, the 
ethical guidelines of the Finnish Medical Association, the Finnish National 
Supervisory Authority for Welfare and Health and the Act on the Status and Rights 
of Patients all oblige physicians to discuss DNR orders with the patient and if the 
patient is incompetent with his or her loved ones or with a legal 
reprensentavive60,62,224. The goal is to achieve an agreement about this decision and 
a mutual understanding62,224. Documentation of both the discussions around the 
decision and the decision itself is crucial62,224. 
2.2.5 Ethics of end-of-life decision-making 
Decision-making at the EOL is a complex process involving many ethical 
aspects15,124,225-227. Guidance on the decision-making process regarding medical 
treatment in EOL situations published in 2014 by the Council of Europe states that 
the main principles for the ethical framework regarding the decision-making process 
are autonomy, beneficence, non-maleficence and justice123. Thus, these are again the 
same ethical principles that, are considered to be the ethical back bone of all 
medicine88,90. According to this guidance, the principle of autonomy is implemented 
in particular through the exercise of free (without any undue constraints or pressure) 
and informed (following the provision of information appropriate to the proposed 
action) consent123. The principles of beneficence and non-maleficence include the 
obligation to deliver only appropriate treatment and the concept of needless or 
disproportionate treatment is likely to be limited or withdrawn123. The principle of 
justice means equitable access to health care123. In addition to these ethical principles, 
medical professionals have raised other ethical issues concerning decision-making, 
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including responsibility, integrity, and dignity227. As mentioned before, human 
dignity is considered to be a fundamental value in Europe, as it is included in the 
first article in the Charter of Fundamental Rights of the European Union54. 
In a recent article by Forte et al., a bioethical framework introducing alternative 
ethical principles to guide the decision-making process in the care of seriously ill 
patients compared to the well-known ones used in the Council of Europe guide123,124. 
In this framework, decision-making is divided into four steps: 1st step: Ethics of 
accuracy referring to accuracy in the diagnosis, prognosis and success and failure 
rates of possible treatments; 2nd step: Ethics of comprehension, meaning to 
comprehend and be empathetic to the patient’s values and views of suffering; 3rd 
step: Ethics of situational awareness, meaning applying scientific evidence to the 
specific situation of the patient by the healthcare multidisciplinary team; 4th step: 
Ethics of deliberation, meaning that goals of care are established in a consensual 
patient–provider relationship, where the patient’s values are respected and 
scientifically acceptable practices are used124. These guidelines and other studies 
focusing on ethical dilemmas in EOL care emphasize individual decision-making, 
where the needs, preferences, and values of the patient and family are at the core, 
but acknowledge that medical decisions must also be based on evidence and futile 
therapies should not be used123,124,225-228. 
Rapid medical developments have led to a growing gap between treatment 
possibilities and resources. In Finland, this has led to a situation where society has a 
growing need to control the medical profession62. As a result, medical ethics and 
medical decision-making can be seen as a part of a larger social discussion trying to 
balance the medical profession, the patient–physician relationship and equal care for 
all patients62. Finland was the first country in Europe to include the right of the 
patient to be involved in treatment decisions into law, highlighting the importance 
of communication60,62. Physicians are the experts in medicine, although 
unambiguously right answers rarely exist, and the patient is the expert of his- or 
herself62. Thus, both information and decision-making must happen in an optimal 
interaction and under agreement between a patient and a physician62. 
2.2.6 Patient and family preferences 
In a review by Chewing et al., 71% of patients preferred shared decision-making in 
studies performed after 2000 compared to 50% in studies performed before 200049. 
In another review that, included only cancer patients, almost all patients wished for 
 36 
full information, but only about two-thirds wished to actively participate in decision-
making229. Patients’ informational needs appear to be consistently high in studies 
concerning patient preferences towards EOL decision-making, but actual 
participation in the decision-making and taking part in the final decision varies 
among individuals, depending, for example, on a patient’s openness to EOL 
discussions230-232. However, the preferred and actual participation in the EOL 
decision-making does not always correspond, as previous studies have shown that 
patients want to be more involved in the decision-making than they actually are120,233. 
Most patients want their loved ones to be involved in EOL decision-making, and 
having discussions with both patients and their family is shown to increase 
satisfaction with EOL care33,34. Despite the fact that family members and caregivers 
are often involved in the decision-making, discordance between the patient’s wishes, 
caregiver’s preferences and caregiver’s predictions of the patient’s preferences do 
exist35,38,234,235. Hence, discussions about EOL preferences and wishes should be 
encouraged within families to facilitate a common understanding and to increase the 
satisfaction with EOL care. 
2.2.7 Physician-related factors in end-of-life decision-making 
Significant differences have been discovered in studies examining the EOL decision-
making by physicians23,128,236. Many physician-related factors, including age, 
experience, specialty, education, personal attitudes and values, have been shown to 
influence EOL decision-making5,16-18,23,24,237. 
The age of the physician seems to be an incongruous factor in decision-making24. 
In some studies, older age has been associated with more decisions to withhold or 
withdraw interventions, while in other studies, younger physicians or trainees make 
less aggressive decisions17,23,25,45,236,238,239. Further, there are studies in which the age 
of a physician was not found to influence the decision to withhold or withdraw 
LST26,240. Younger physicians have less experience in EOL care, but on the other 
hand, education in PM is currently included in the curriculum of many medical 
schools, increasing younger colleagues’ knowledge of the benefits of palliative care. 
Many studies have shown that the physician’s gender does not influence their 
decision-making23,239,241,242. However, in some studies, female gender has been found 
to be associated with more active and intensive treatment decisions17,25,243. Female 
physicians communicate more often and for longer in a patient-centred manner than 
male physicians, but whether this translates into differences in actual decision-
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making remains unclear244. In general, gender does not seem to be an important 
influential factor in EOL care decision-making24. 
Experience with EOL care, death, dying and making decisions to withhold or 
withdraw therapy seems to be associated with more decisions to withhold or 
withdraw therapy in EOL care23-25,240. Education in palliative care increases the 
knowledge and skills needed to provide high-quality EOL care28,29,31,32,95,112,113. 
However, it is not clear how training in PM influences EOL decision-making. 
Löfmark et al. reported that having had training in palliative care resulted in more 
experience with EOL decisions including decisions about withholding or 
withdrawing potentially life-prolonging treatment and more acceptance for 
alleviating pain or other symptoms with a concomitant possible life-shortening 
effect25. The specialty of a physician impacts decision-making18,25,236. Oncologists 
have been shown to be more willing to withhold or withdraw futile treatments in 
EOL care and to choose a palliative care approach more often than other 
specialists17,18,25. In a study by Alemayehu et al., family physicians were more likely 
than specialists to choose more conservative treatment options236. 
It has been shown that religion is associated with the unwillingness to withdraw 
life-supportive care23-26,45,245,246. Although religion has an enormous effect on 
decisions to forgo LST, religiousness did not influence physicians’ decisions to 
choose palliative care approaches over active or intensive care approaches in a study 
by Hinkka et al.17. This finding was suggested to be due to the uniform religious 
background of Finnish physicians, as approximately 90% of Finnish people 
belonged to the Lutheran Church at the time of the study in the end of 199017. 
ADs and a health care proxy or a family’s opinion have been shown to have 
marked influence on physicians’ decision-making17,18,36,37,40,45. A patient’s AD or a 
proxy opinion to forgo medical intervention significantly increased the odds of 
forgoing these interventions in a randomized vignette trial36. This result is well in 
line with the previous studies by Hinkka et al., where after finding a patient’s AD, 
physicians’ decisions to withhold and withdraw medical treatments increased and 
choosing active or intensive care decreased17,18. In another study by Escher et al., the 
patient’s AD had more influence on physicians’ decisions to forgo medical 
intervention than did the proxy opinion when the AD and proxy opinion disagreed 
with each other37. In a study by Vincent et al., a family’s wish for everything to be 
done was more influential to physicians’ decisions than their request to withhold and 
withdraw treatment45. A similar influence of a family’s appeal in choosing aggressive 
treatment options has also been shown in the studies by Hinkka et al.17,18. 
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Physicians’, patients’ and families’ attitudes regarding EOL decisions concerning 
themselves differ from each other247. In a European study conducted with ICU 
physicians, patients surviving ICU and families of ICU patients found that physicians 
held quality of life to be more important and valued life as less important for 
themselves in their own EOL decisions than did the patients and families answering 
a similar questionnaire247. If diagnosed with a terminal illness, physicians reported 
that they would prefer fewer ICU admissions and less use of CPR and mechanical 
ventilation for themselves than did the patients and families247. Physicians also 
preferred being at home or in a hospice significantly more often than the patients 
and the families if they had a short life-expectancy247. 
2.2.8 Decision-making among medical students 
EOL decision-making among medical students is poorly described and studied 
compared to physicians’ EOL decision-making. In a large Brazilian study, 46% of 
the students responding to a controversial ethical questionnaire reported that they 
did not have object to the withdrawal of artificial life support248. In that study, 
student age had only a small influence on this decision, but religious beliefs 
significantly increased the objection to withdrawal of LSTs248. In another study from 
Puerto Rico, 68% of the medical students said that they would support withholding 
or withdrawing life-sustaining treatments for dying patients with an informed 
consent249. Gruber et al. studied changes in medical students’ attitudes towards EOL 
decisions and found that the fifth-year students accepted forgoing of CPR and 
discontinuation of LST more often than the first-year students250. One third of the 
medical students from Germany and France classified withdrawal of medical 
measures as ‘‘active euthanasia’’, while 65% of the students from Germany and 47% 
from France knew that forgoing or limiting life-sustaining therapy could be legal251. 
Almost all responders knew that ending a patient’s life on request was illegal251. In 
many studies, medical students report feeling unprepared and lack confidence in 
EOL decision-making27,30,252. Therefore, medical students generally desire more 
support and role modelling from residents and attendings252. 
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2.3 Hastened death 
2.3.1 Definitions 
The word euthanasia (εὐθανασία) is a combination of two Greek words: eu (εὖ) 
meaning well or good and thanatos (θάνατος) meaning death. Thus, literally and 
etymologically euthanasia means “good death”. Today, it is understood as killing a 
person after an explicit request81,253. Clear definitions have been specified for 
euthanasia and PAS, which lead to a clearly assisted death whereas hastened death 
lack a specific definition253. Definitions used in this thesis are summarized in Table 
2. 
 
Table 2.   Definitions for different aspect of hastened death in this thesis. 
 
2.3.2 Current practices and legislation 
Euthanasia is legal in five countries worldwide: the Netherlands, Belgium, 
Luxembourg, Canada and Colombia64. In addition to these countries, PAS is legal in 
Switzerland and in five states in the USA (Oregon, Washington, Montana, Vermont, 
and California)64. In Switzerland, assisted suicide may be legally performed by 
persons other than physicians and that practice is also available for Swiss 
nonresidents64. In most of the other countries assisted suicide not performed by a 
physician is illegal13,64. According to Finnish Criminal law, taking someone else’s life 
is a punishable criminal act254. Thus, euthanasia is illegal in Finland. However, the 
Euthanasia253 A physician (or other person) intentionally kills a person by the administration 
of drugs, at that person’s voluntary and competent request. 
(Physician-) assisted suicide253 A person (or a physician) intentionally helps another person to terminate his or 
her life (by providing drugs for self-administration), at that person’s voluntary 
and competent request. 
Assisted death13 Euthanasia and (physician-) assisted suicide. 
Hastened death Assisted death or causing a patient’s death unintentionally, but by 
acknowledging/accepting the risk of death through a certain treatment. 
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Ministry of Social Affairs and Health has currently set up an expert group to consider 
legal options for euthanasia and EOL care after a citizen initiative demanding the 
legalization of euthanasia. In contrast to euthanasia, aiding in a suicide is not 
specifically stated as a criminal act in Finnish law254. However, this type of action has 
not been tested in a court of law in Finland and a physician performing this type of 
procedure might be prosecuted and convicted for a criminal deviation of good 
clinical practice62,81. 
The World Medical Association (WMA) considers euthanasia to be unethical255. 
The Finnish Medical Association is in line with the WMA and objects to the 
legalization of euthanasia255. It is stated in the national ethical guideline for physicians 
that to kill a patient deliberately is a violation of medical ethics62. After the civil 
motion demanding the legalization of euthanasia, the National Advisory Board on 
Social Welfare and Health Care Ethics (ETENE) published a statement on 
euthanasia in Finland concluding that only after reaching high quality and equal EOL 
care offered for all citizens based on their needs, it is possible to consider if changes 
in the Finnish legislation are needed to allow euthanasia91. The IAHCP and the 
EAPC have recently stated that euthanasia and PAS should not be included as part 
of the clinical practice of palliative care253,256. 
The procedure of euthanasia involves injecting the patient with barbiturates to 
induce coma, followed by neuromuscular blockers which cause respiratory muscle 
paralysis13. Death occurs quickly as a consequent anoxia and cardiac arrest13. In PAS, 
a physician provides medication for the patient to self-administer an overdose of 
barbiturates that suppresses respiration, causing a patient’s death13. 
2.3.3 Attitudes towards euthanasia and physician-assisted suicide 
Public support for euthanasia and PAS is mounting across Western Europe, while 
some decline has been observed in the USA and Eastern Europe64,257. Public 
acceptance towards euthanasia in Finland was moderate, with a slight increase during 
the past decade according to an international study published in 2013257. In national 
studies, public acceptance has increased from 50% to 82% between 1998 and 
2014258,259. Although the methods and results differ between the studies, a clear trend 
towards a more accepting atmosphere is apparent258,259. 
Several surveys demonstrate a lower amount of support from physicians for 
euthanasia and PAS when compared to support from the general public64 In our 
country, physicians’ attitudes towards euthanasia have become more accepting. In a 
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study conducted with a random sample of Finnish physicians in 2013, 46% of the 
participants answering a questionnaire supported the legalization of euthanasia 
compared with only 29% in 2003260. In another study, conducted in 2007, the 
support for euthanasia among Finnish GPs, internists and geriatrics from Southern 
Finland was only 19%261. In other Scandinavian countries, the number of physicians 
who are in favour of euthanasia ranges from 17% in Norway to 39% in Sweden, but 
these results were obtained already in 2002262. Although the attitudes have become 
more permissible, the proportion of Finnish physicians willing to perform euthanasia 
remains low (approximately 20%), which is in line with the results from other studies 
showing physicians’ reluctance to perform euthanasia or PAS260,263. In contrast to 
most European countries, a majority of physicians from Belgium, Switzerland and 
the Netherlands (77–90%) consider euthanasia and PAS to be justified in certain 
situations64. There are also studies showing that the most experienced physicians in 
palliative care have the strongest opinions in their opposition to hastening 
death264,265. The wide range of attitudes towards euthanasia and PAS is probably due 
to large social, cultural and religious variations throughout the world64,257. 
Medical students seem to accept euthanasia and PAS more frequently than 
physicians. In a study from Puerto Rico, 40% of the medical students and 20% of 
members of the medical faculty accepted euthanasia249. In another study from 
Poland, 26% of students and 17% of the physicians were in favour of legalization of 
euthanasia, but only 5% of physicians and 12% of students were willing to preform 
euthanasia or PAS266. Overall, medical students’ attitudes towards euthanasia and 
PAS vary depending on the country. Acceptance of assisted death ranges from 26 to 
88% in recent studies100,248,266-270. 
2.3.4 Complexities of hastened death 
Questions about hastening death in EOL care are complex and include ethical 
concerns that are broader than in euthanasia or PAS. The term “hastened death” is 
unspecified and has many interpretations. The termination of life-sustaining 
treatments may be confused with euthanasia and PAS among the public and 
physicians, as well as among medical students65,100. When palliative care physicians 
were asked, over half of them had experienced that palliative treatments, such as 
palliative sedation or stopping artificial hydration/nutrition, were being 
characterized as euthanasia, murder or killing by the families of patients, other 
physicians or another health care professionals271. Of these physicians, 4% had been 
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formally accused due to such decisions, but none had been convicted of homicide 
in a court of law271. 
Withholding or withdrawing treatments is commonly regarded as a part of EOL 
care, not hastening death, as previously discussed (see paragraph 2.2.3. Withholding 
and withdrawing treatment). However, these practices are often referred to as 
hastening death, even in medical literature272. European physicians have reported to 
have had an explicit intention of hastening death in 45% of all treatments that were 
withheld or withdrawn272. Alleviating symptoms with a possible life-shortening 
treatment can be seen as a more complex and ethically challenging question. In a 
large multinational study by Miccinesi et al., there was general approval for alleviating 
symptoms with a possibly life-shortening treatment26. Similar findings were 
discovered in a study by Löfmark et al., where 57–95% of physicians were willing to 
intensify the drug therapy to alleviate pain and/or other symptoms, taking into 
account the probability or certainty that this would shorten a patient's life25. On the 
other hand, in countries were euthanasia is illegal only 1–14% of physicians 
compared to 19–56% of physicians in Belgium and the Netherlands, would 
administer, prescribe or supply drugs with the explicit intention of hastening the 
EOL on the explicit request of a patient25. In a study from the UK, physicians 
reported that they had at least some intention to hasten death in 7.4% of the deaths 
evaluated273. In a study by Sprung et al., 73% of patients dying in ICUs across Europe 
forgone LSTs, but 2% underwent active shortening of the dying process via the 
administration of drugs, including opiates, benzodiazepines, muscle relaxants or 
barbiturates, as reported by the attending physician274. In another study from 
Germany, 78% of the physicians reported that they would alleviate symptoms with 
the possibility of shortening life, but only 1% would assist dying275. The use of 
medications to deliberately hasten death was found in only 0.8% of deaths in a survey 
from France276. 
The principle of double effect has been used when the act intended to do good 
(for example relief of suffering) justifies the danger of harm (e.g., hastened death). It 
is applicable in a situation in which a person is not able to avoid all harmful 
actions66,277,278. The principle is considered morally permissible if four conditions are 
met: 1) the action is not immoral in itself, 2) the action is undertaken with the 
intention of achieving the possible good effect and the possible bad effects may be 
foreseen, but must not be intended, 3) the bad effect must not be a means to the 
good effect and 4) the good effect must outweigh the bad effect (the rule of 
proportionality: the bad effect can be permitted only when there is proportionally 
grave reason for it)66,277,278. The use and dosing of opioids during EOL care is a 
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commonly used example when talking about the double effect: does the intent to 
treat pain or breathlessness outweigh the risk of potentially hastening death279,280? 
Criticism has been expressed towards using the principle of double effect as a 
justification for hastening death due to its simplicity, narrow focus and often 
ambiguity of the intension behind the action66,277,281. 
To further enhance the complexities of discussions around hastening death, it has 
been shown that the patient’s wish to hasten death does not always imply a genuine 
wish to die, but might be the result of overwhelming physical, psychological, social 
and existential suffering, all of which impacts the patient’s sense of self, dignity and 
meaning in life282,283. 
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3 AIMS OF THE STUDY 
This study was conducted to evaluate the decision-making and attitudes of physicians 
and medical students concerning the end-of-life care of cancer patients, and whether 
there have been changes in these issues over the past sixteen years.  
The specific aims were: 
 
1. To study whether medical specialty or special competency in palliative 
medicine influences end-of-life decision-making and whether other 
background factors or values affect these decisions. 
2. To evaluate whether, attitudes and values towards different aspects of 
end-of-life care or hastened death have changed over the past sixteen 
years among Finnish physicians. 
3. To reveal whether there have been changes in the decision-making 
relating to end-of-life care between 1999 and 2015. 
4. To assess whether the attitudes and values towards different aspects of 
end-of-life care differ between medical students and experienced general 
practitioners. 
5. To examine differences between medical students and experienced 
general practitioners in decision-making in end-of-life care and in factors 
influencing their decision-making. 
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4 PARTICIPANTS AND METHODS 
4.1 Participants 
The study sample consisted of three cohorts. The first cohort was a sample of 
Finnish physicians included in the 1999 survey16-18,178,284. This sample consisted of 
500 GPs, 300 surgeons, and 300 internists randomly selected from the register of the 
Finnish Medical Association and all Finnish oncologists (n=82). The second cohort 
was formed in 2015 by selecting Finnish physicians in the same way as in the first 
cohort in 1999 and enlarged with all Finnish physicians with special competency in 
palliative medicine (n=82), excluding those with a mailing proscription (n=23). In 
this second cohort, the number of oncologists rose to 158, and 13 of them also had 
cPM. The third cohort included all graduating medical students (n=639) from five 
universities in Finland (Helsinki, Kuopio, Tampere, Turku and Oulu) who answered 
the survey during the autumn of 2015 and the spring of 2016 depending on the 
graduation date at each university. Altogether, 3 148 physicians and medical students 
were asked to participate in the study. 
The survey was mailed to the physicians by post and given to the students during 
a teaching session and returned to the teacher either personally or by post. Non-
responders were reminded twice. 
In the comparison between 1999 and 2015, physicians with cPM were excluded 
from the respondents in 2015 unless they were oncologists (n=13). This was done 
because none of the physicians answering in 1999 had cPM, as it has been available 
only since 2007 in Finland. When comparing students and GPs we included only 
experienced GPs who had graduated from medical school a minimum of five years 
ago (n=222) to further improve the validity of this comparison. 
4.2 Questionnaire 
The original, complete questionnaire used as a basis for this study is presented in the 
appendix16-18,178,284. It consists of seven hypothetical patient scenarios, six of which 
were cancer patients at their EOL and one was a patient with advanced dementia. 
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For the current study, five of the cancer patient scenarios were included (patient 
scenarios 1 and 4-7 from the original questionnaire). The responders were instructed 
to answer the questions in the given order and to not change their answers once 
given. 
4.2.1 Patient scenarios 
Patient scenario 1 (numbered as scenario 1 in the publications III and IV) presented 
an 82-year-old retired forest worker, who had received a diagnosis of prostatic cancer 
3 years ago. During the past year he has received treatments for bone metastases. He 
has now been in a hospital for one month, almost totally bedridden, and needs help 
with all functions. His mental condition has been normal. His general condition has 
weakened over the past week, he is now totally bedridden, and he has received large 
doses of pain medication. Today, he has become comatose. His haemoglobin count 
has decreased to 68 g/l, while the week before it was 118 g/l. His blood pressure is 
80/40 mmHg. There is no verbal or written advance directive. The patient’s wife has 
previously said that she expects the doctor to make all treatment decisions according 
to his/her best understanding. After the patient scenario, the doctors were asked to 
choose one of the given treatment options. The concepts used in the treatment 
options were explained as follows: 1) palliative care: good nursing, sufficient 
medications for pain and other symptoms, intravenous hydration only when it is 
considered to relieve the patient’s symptoms; 2) active care: use of antibiotics, 
intravenous hydration or blood transfusions aimed at saving the patient’s life in a 
life-threatening condition; 3) intensive care: moving the patient to an intensive care 
unit. After the initial question for the patient scenario 1, four additional alternatives 
were presented, each ending with the same treatment options: a) It has been 
discovered that the patient’s faeces are black. You remember having prescribed 
ketoprophen for pain a week ago; b) The patient’s son is coming from America the 
day after tomorrow to see his father while he is still alive; c) The patient has had 
spiritual anxiety and there is a planned appointment with a minister and the Lord’s 
Supper tomorrow; d) The patient’s written advance directive has been found, in 
which the patient has expressed that all active interventions should be withheld if 
there is no hope for recovery. After asking for the treatment decisions, a Likert-type 
scale was presented to evaluate the influence of different factors (patient’s benefit, 
family’s benefit, patient’s legal protection, physician’s legal protection, ethical values, 
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patient’s age, cost of care, patient’s social status) on the decisions (from 1—very little 
influence to 5—very much influence). 
In patient scenario 4 (numbered as scenario 2 in the publication III), a 68-year-
old patient suffers from breast cancer with bone metastases. She is bedridden, and 
her general condition has rapidly collapsed. She is in a community hospital ward and 
is receiving adequate pain treatment with which she is pleased. She is depressed and 
wants to transfer to a hospice for her last days. She feels that the atmosphere on the 
ward is very restless and “institutional”. You have the right to issue a voucher for 
the costs of hospice care (290 euros per day) to be paid by the community hospital. 
The costs would be approximately double compared to those in a community 
hospital, and the chief doctor has advised you to use great discretion in issuing 
vouchers. Your solution: a) to accept the transfer b) to accept the transfer, provided 
that the patient pays the extra costs herself c) not to accept, because according to 
normal practice the patient’s care belongs to the community hospital ward, and there 
are no special problems in her care d) I don’t know e) other solution:____________. 
Patient scenario 5 (numbered as scenario 1 in the publication II), presented a 60-
year-old male patient suffering from prostate cancer with metastases. Metastases in 
the thoracic spine led to total paraparesis one month earlier. There is no hope for a 
cure. The patient is well aware of the situation. He has totally lost his will to live. 
When you are together with him alone, he asks for a sufficient dose of morphine to 
“get away”. You have denied the overdose, explaining that it is against your ethical 
principles. During the following days, you notice that the patient asks you to double 
his morphine dose because of unbearable pain. The anti-inflammatory pain 
medication is at its maximum dose and you suspect if the pain is real (this sentence 
was removed from the scenario in 2015 as it did not comply with current treatment 
guidelines for cancer pain). You suspect that increasing the dose in such a way would 
lead to the patient’s death. Your decision is which of the following: a) to raise the 
dose because the patient has the right to sufficient pain relief in this end-of-life 
(terminal) care situation; b) to try to help the patient in other ways, such as with 
antidepressants, thus continuing with morphine dosing according to given 
guidelines; c) I can’t say; or d) give another solution:________________. 
In patient scenario 6 (numbered as scenario 2 in the publication II and scenario 
2 in the publication IV), a 32-year-old female patient is brought by an ambulance to 
the emergency unit. She is accompanied by her husband who says his wife has 
inoperable brain cancer. She has been receiving maximum radiotherapy, but this was 
discontinued three weeks ago. She has deteriorated considerably during the past 
week. The patient has now had an epileptic seizure and has been unconscious since 
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the attack. After 20 minutes at the hospital, the patient stops breathing, and there is 
no pulse. Your treatment decision as a doctor on call is which of the following: a) to 
start cardiopulmonary resuscitation or b) to withhold cardiopulmonary resuscitation. 
Patient scenario 7 (numbered as scenario 1 in the publication I and scenario 3 in 
the publication IV), presented a 62-year-old male patient with lung cancer and 
metastases, who was admitted to the hospital ward and received high-dose morphine 
medication. Due to respiratory weakening, he had become comatose the night 
before. He also suffered from severe anaemia and had abundant pleural effusion and 
fever. There is no possibility of discussing the matter with the family and there is no 
advance directive. After the presentation of the patient scenario, there was a question 
about the treatment decision: Which of the following treatments already started (*) 
or planned would you withhold or withdraw? The decision responses were expressed 
on a scale from 1 (I definitely would not) to 5 (I definitely would). The treatments 
were a) antibiotics (*); b) mechanical ventilation (*); c) blood transfusion; d) pleural 
drainage; e) chest X-ray examination; f) laboratory tests; g) intravenous hydration (*); 
h) nasogastric tube (*); i) thrombosis prophylaxis (*); and j) supplementary oxygen 
(*). After the original patient scenario, two alternatives with extra information were 
provided: 1) the patient’s daughters come to you distressed and crying, expressing 
their hope that everything possible will be done to save their father’s life; 2) there is 
a written advance directive in the patient’s medical chart in which he expresses his 
wish that all active treatment should be withdrawn if there is no hope for recovery. 
After each of these alternatives the same questions (with the same treatment options 
as in the original scenario) were asked. 
4.2.2 Fear-of-death index 
After the patient scenarios, the questionnaire continued with questions concerning 
the responders’ fear-of-death (set of 11 questions, Likert 1-5). A fear-of-death index 
was calculated by summing up the responses to four questions which maximized 
Cronbach's alpha in 1999; g: I fear death, h: I’m afraid that someone close to me 
dies, i: I’m worried about the sadness brought to my family by my own death and k: 
I’m distressed to think that someday I shall not exist (range 4-20, cut point 16). 
Although, the fear-of-death index did not play an important part in the present study, 
it was included to the questionnaire with the intention to keep the questionnaire as 
similar as possible in 2015 as in 1999. 
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4.2.3 Attitudes and background factors 
Attitudes regarding several moral and ethical aspects were assessed with a 100-mm 
visual analogue scale (VAS) from “definitely agree” (0 mm) to “definitely disagree” 
(100 mm). These included statements concerning euthanasia, withdrawal of life-
sustaining treatments, assisted suicide, palliative and end-of-life care, the role of 
religion in ethical decisions, advanced care directives and health care economics 
together with physicians’ satisfaction with their own health, work and salary. 
Physicians’ personal conceptions of professional status, their own health and family, 
length of life, religion, nature and standard of living were assessed using a four-point 
Likert scale. Sociodemographic data was collected as well. 
4.2.4 Validation of the questionnaire 
The questionnaire has been previously used and validated by Hinkka et al.16-18,178,284. 
In the validation process, the questionnaire was sent to 45 physicians (health care 
practitioners and specialists) twice at two-week intervals in order to test the reliability 
of the responses to patient scenarios and the questions on attitudes and values16-
18,178,284. Thirty physicians returned two acceptable questionnaires16-18,178,284. The 
value of kappa coefficient for an acceptable scenarios or questions was determined 
to be more than 0.40, which is a commonly accepted limit for reliability16-18,178,284. 
4.3 Statistical analysis 
The answers to the hypothetical patient scenarios were re-categorized 
dichotomously for the statistical analysis. The conversion was conducted as follows 
(responses shown in brackets): In patient scenario 1 of the original questionnaire, 
“choosing palliative care” (a) and “not choosing palliative care” (b and c); In patient 
scenario 4, “willing to issue a voucher for hospice” (a) or “not willing to issue a 
voucher” (b-e); in patient scenario 6, “accept” (a) and “not to accept” (b, c and d), 
and in patient scenario 7, “ to withhold or withdraw” (4 and 5) and “not to withhold 
or withdraw or I don’t know” (1, 2 and 3). The answers on the 4-point Likert scale 
concerning values were converted to the following 2-point scale: 1-2 for “not 
important” and 3–4 for “important”. The answers on the 5-point Likert scale 
concerning the influence of different factors were converted to the following 2-point 
scale: 1–3 for “not much influence” and 4–5 for “much influence”. 
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Dichotomous variables were tested by using the Pearson chi-squared test or 
Fisher’s exact test when appropriate. Continuous variables were tested by using an 
independent-variables t-test or the Mann-Whitney U-test if the data were not 
normally distributed. Two-sided p-values of less than 0.05 were accepted as 
statistically significant. 
From patient scenario 7, measured mean distributions of the chronological 
original scenario, family’s appeal and advance directive values were clustered by 
trajectory analysis285. The trajectories were created according to the measurements 
of mean values in each responder as a continuous outcome measure. The analyses 
undertaken were latent class mixture models of quadratic trajectories including a 
random intercept and concomitant variables. Models were fitted by using the flexmix 
package of the statistical program R, version 3.3.0, from the R Foundation for 
Statistical Computing (R Development Core Team. R: A language and environment 
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 
2008, ISBN 3-900051-07-0, URL)286. Relative goodness of fit was assessed using 
Bayesian information criteria. Factors affecting the willingness to continue or start 
therapy (belonging to the trajectory groups 3 or 4) compared withholding or 
withdrawing therapy (belonging to the trajectory groups 1 or 2) were examined by 
univariate and age-adjusted logistic regression models results shown by odds ratios 
(OR) with 95% confidence intervals (CIs). Additionally, a multivariable model, 
where variables were added simultaneously into the model, was performed for 
variables with statistical significance under 0.20 in the age-adjusted model. 
A forward stepwise logistic regression was used to create models explaining the 
decision to choose palliative care in patient scenario 1, willingness to issue a voucher 
for hospice in patient scenario 4 and to increase the morphine dose in patient 
scenario 6. Background factors, life values, and attitudes, were all tested in the 
models. The p-value limit for significance was set at 0.10 to enter and 0.15 to be 
removed from the model. 
The data analysis was performed using IBM SPSS Statistics for Windows, version 
23.0 (publication I and II) and version 24.0 (publications III and IV) (Armonk, NY, 
USA, IBM Corp). 
4.4 Ethical considerations 
A cover letter including an introduction to the study and an assurance of anonymity 
and voluntariness was provided together with the questionnaire. This study was 
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approved by the Regional Ethics Committee of Tampere University Hospital, 
Finland (R15101). 
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5 SUMMARY OF RESULTS 
5.1 Characteristics of the responders (publications I-IV) 
In total, 1 763 valid responses were received, giving an overall response rate of 56%. 
Characteristics of the participants are shown in Table 3. A majority of the responders 
were women, except in the groups of surgeons in both study years and internists in 
1999. Medical students were younger than the physicians and were less often 
married. Most of the GPs worked in outpatient clinics in both years (78% in 1999 
and 85% in 2015), while the other physicians mainly worked in hospitals (66–88%). 
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5.2 Decision-making at the end-of-life 
5.2.1 Choosing palliative care over life prolongation at the end-of-life 
(publications II and IV) 
Responders’ answers for the hypothetical patient scenario representing the prostate 
cancer patient in EOL care with deteriorating overall condition (patient scenario 1) 
are summarized in Figure 1. 
Most responders (83–85%) chose a palliative care approach in the original 
scenario with no significant differences between the groups. In the alternative 
situation where the same patient probably had iatrogenic gastrointestinal (GI)-
bleeding (patient scenario 1a), the amount of palliative care approaches decreased. A 
palliative care approach was chosen significantly more often by the physicians in 
2015 than in 1999 (p=0.014) and by those with cPM than the others (p=0.049), 
whereas no significant difference between the students and the experienced GPs was 
found (55% vs 60% of the responders chose a palliative approach, p=0.230). 
Physicians answering in 1999 chose active or intensive care more frequently than in 
2015 when the patient was waiting to see his son (patient scenario 1b) or a minister 
to have a Lord’s Supper (patient scenario 1c) (p<0.001 in both). No significant 
difference was found between the answers of the experienced GPs and the students 
when the son was coming (60% vs 63% of the responders chose a palliative 
approach, p=0.406) and when an appointment with a minister was planned (71% vs 
73% of the responders chose a palliative approach, p=0.598). When an AD was 
found, almost all responders (89-95%) chose a palliative care approach. 
Some of the physicians’ opinions influencing their decisions regarding the 
prostate cancer patient in patient scenario 1 changed from 1999 to 2015. In 2015, 
patient’s benefit (96% vs 99%, p=0.001), ethical values (83% vs 93%, p<0.001) and 
patient’s (68 vs 86%, p<0.001) or physician’s legal protection (44% vs 63%, p<0.001) 
were considered more influential on the decision-making, while the family’s benefit 
(37% vs 25%, p<0.001) and patient’s age (46% vs 40%, p=0.023) were regarded as 
less influential than in 1999. 
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Logistic regression analysis from the cohorts of physicians answering in 1999 and 
2015 (excluding physicians with cPM except if they were oncologists) was carried 
out to explore the factors associated with physicians’ decisions concerning the 
prostate cancer patient with probable iatrogenic GI-bleeding and waiting to meet his 
son or a minister (patient scenarios 1a–c). The year of the survey remained as a 
significant independent factor explaining the physicians’ decision in these patient 
scenarios (patient scenario 1a OR 0.65 (CI 95% 0.48, 0.88), patient scenario 1b OR 
0.41 (95% CI 0.30, 0.56), and patient scenario 1c OR 0.47 (95% CI 0.36, 0.63)). In 
general, physicians answering in 2015 were less eager to choose active or intensive 
care. Willingness to withdraw LSTs (patient scenario 1a OR 0.92 (95% CI 0.87, 0.97), 
patient scenario 1b OR 0.94 (95% CI 0.90, 0.99), patient scenario 1c OR 0.91 (95% 
CI 0.86, 0.96)) and having postgraduate EOL training (patient scenario 1a OR 0.54 
(95% CI 0.39, 0.73), patient scenario 1b OR 0.60 (95% CI 0.45, 0.80), patient 
scenario 1c OR 0.68 (95% CI 0.51, 0.92)) were also significantly associated with a 
decreased likelihood of choosing active or intensive care in all of these scenarios. In 
addition, men more often chose a palliative care approach for the seriously ill 
prostate cancer patient even when the GI-bleeding was detected (patient scenario 1a 
OR 0.67 (95% CI 0.51, 0.88)) and when the son was coming (patient scenario 1b OR 
0.65 (95% CI 0.50, 0.84)). 
All the responders were influenced by the probable iatrogenic GI-bleeding, the 
possibility of the son seeing his father while he was still alive, and the spiritual anxiety 
of the prostate cancer patient, as active and intensive care approaches increased in 
these situations, although there were variations between the specialty groups. On the 
other hand, a discovery of a written AD clearly shifted the answers towards a 
palliative care approach. 
5.2.2 Willingness to withdraw or withhold therapies (publications I and IV) 
When the responders were asked to evaluate their willingness to withdraw or 
withhold different therapies, it was discovered that the experienced GPs were more 
willing to forgo therapies compared to the medical students. Similarly, the physicians 
with cPM were more willing to forgo therapies compared to the other physicians in 
2015. However, these differences varied between the therapies. These results are 
shown in Tables 4 and 5. 
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Table 4.  Number and proportion (%) of the physicians answering in 2015 and the medical 
students answering in 2015 and 2016 deciding to withdraw a treatment in the scenario 
representing the patient with an end-stage lung cancer (patient scenario 7). 
1Statistical comparison between physicians and students not shown in the table (see text for the 
comparison between experienced GPs and the students) 
*p < 0.05 and **p < 0.001 compared to physicians with cPM 
cPM: Special competency in Palliative Medicine, GP: General Practitioner, AD: Advance Directive 
 
Treatment 
 
Patient 
scenario 
Physicians 
with cPM 
Surgeons Internist GPs Oncologists Students1 
        
Antibiotic Original 
scenario 
41  (65) 72  (51) 78  (51) 128  (53) 45  (54) 150 (37) 
Family’s 
appeal 
33  (50) 55  (39) 55  (36) 89  (37)* 34  (37) 91 (23) 
AD 58  (87) 116  (83) 122  (82) 204  (84) 82  (89) 320 (80) 
Mechanical 
ventilation 
Original 
scenario 
63  (96) 119  (85)* 135  (89) 195  (81)* 83  (91) 300 (75) 
Family’s 
appeal 
59  (92) 113  (80)* 126  (83) 175  (72)* 76  (84) 263 (66) 
AD 67 (100) 130  (92)* 147  (98) 228  (94)* 90  (99) 373 (93) 
Intravenous 
hydration 
Original 
scenario 
43 (65) 31  (22)** 39  (26)** 85  (35)** 42  (46)* 128 (32) 
Family’s 
appeal 
26 (40) 21  (15)** 19  (13)** 58  (24)* 34  (37) 93 (23) 
AD 58 (88) 64  (46)** 84  (56)** 162  (67)* 75  (82) 267 (67) 
Nasogastric tube Original 
scenario 
62 (95) 85  (60)** 98  (65)** 161  (67)** 63  (69)** 225 (56) 
Family’s 
appeal 
60 (92) 76  (54)** 87  (58)** 126  (53)** 64  (70)* 192 (48) 
AD 64 (97) 105 (75)** 126  (84)* 203  (84)* 82  (89) 306 (77) 
Thrombos 
prophylaxis 
Original 
scenario 
55  (85) 108  (76) 105  (69)* 151  (62)* 73  (80) 219 (55) 
Family’s 
appeal 
52 (80) 104  (74) 95  (64)* 128  (53)** 67  (73) 191 (48) 
AD 63 (96) 121  (88) 127  (85)* 199  (82)* 86  (94) 322 (80) 
Supplementary 
oxygen 
Original 
scenario 
11 (16) 16  (11) 23  (15) 14  (6)* 11  (12) 18 (5) 
Family’s 
appeal 
12 (18) 14  (10) 13  (9)* 12  (5) 6  (7)* 8 (2) 
AD 20 (30) 40  (28) 46  (31) 51  (21) 27  (29) 70 (18) 
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Table 5.  Number and proportion (%) of the physicians answering in 2015 and the medical 
students answering in 2015 and 2016 deciding to withhold a treatment in the scenario 
representing the patient with an end-stage lung cancer (patient scenario 7) 
1Statistical comparison between physicians and students not shown in the table (see text for the 
comparison between experienced GPs and the students) 
*p < 0.05 and **p < 0.001 compared to physicians with cPM 
cPM: Special competency in Palliative Medicine, GP: General Practitioner, AD: Advance Directive 
 
 
In the original patient scenario of the lung cancer patient, experienced GPs 
withdrew antibiotics (55% vs 37%, p<0.001) and the nasogastric tube (67% vs 56%, 
p=0.007) more often than the medical students, and they withheld blood transfusion 
(79% vs 67%, p=0.002), pleural drainage (42% vs 21%, p<0.001) and avoided a chest 
X-ray (52% vs 41%, p=0.006) more frequently as well. Supplementary oxygen was 
 
Treatment 
 
Patient 
scenario 
Physicians 
with cPM 
Surgeons Internists GPs Oncologists Students1 
        
Blood 
transfusion 
Original 
scenario 
60  (91) 98  (70)* 108  (72)* 185  (76)* 72  (78)* 265 (67) 
Family’s 
appeal 
55  (85) 90  (64)* 85  (56)** 153  (64)* 67  (76) 225 (56) 
AD 66  (99) 132  (94) 136  (91) 227  (94) 90  (98) 367 (92) 
Pleural 
drainage 
Original 
scenario 
43  (65) 59  (42)* 85  (56) 99  (41)** 58  (64) 84 (21) 
Family’s 
appeal 
41  (63) 57  (40)* 73  (49) 89  (37)** 51  (56) 72 (18) 
AD 53  (79) 103  (73) 119  (80) 179  (74) 82  (89) 208 (52) 
Chest X-ray Original 
scenario 
51  (77) 66  (47)** 88  (58)* 119  (60)** 67  (73) 162 (41) 
Family’s 
appeal 
44  (67) 61  (43)* 74  (49)* 29  (38)** 59  (65) 144 (36) 
AD 59  (88) 111  (79) 124  (83) 194  (81) 90  (98)* 280 (70) 
Laboratory 
tests 
Original 
scenario 
49  (74) 70  (59)* 87  (57)* 121  (50)* 59  (64) 178 (45) 
Family’s 
appeal 
40  (61) 60  (43)* 67  (45)* 85  (35)** 51  (56) 144 (36) 
AD 58  (87) 115  (81) 119  (78) 190  (78) 88  (96)* 299 (75) 
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continued (94–95%), and mechanical ventilation was withdrawn (75–81%) by most 
of the responders, without significant differences between the students and the GPs. 
General willingness to withhold or withdraw therapies according to responder 
groups in 2015 is shown in Figure 2. In the original scenario, the physicians with 
cPM were significantly more willing to withhold or withdraw therapies compared to 
the other physicians in 2015 (p<0.001). The family’s appeal for everything to be done 
significantly decreased (p<0.001)) and an advance directive increased (p<0.001) the 
willingness to forgo therapies, but the difference between the physicians with cPM 
and the other physicians remained (p<0.001 and p=0.010, respectively). As it is 
presented in the Tables 4 and 5, the difference in decision-making regarding 
individual treatments between the physicians with and without cPM was most 
striking in withdrawing intravenous hydration, removing the nasogastric tube and 
withholding blood transfusions. In contrast, some decisions (e.g., withdrawing 
oxygen or antibiotics) varied only slightly. Mechanical ventilation was withdrawn by 
most of the physicians, while supplementary oxygen was frequently continued by all 
of the physicians answering in 2015. 
 
 
Figure 2.  Mean values (scale from 1 to 5) of all the ten answers in the end-stage lung cancer patient 
scenario (patient scenario 7) according to responder groups. cPM: Special competency in 
Palliative Medicine, GP: General Practitioner. 
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When responses of the physicians answering in 2015 were fitted with a trajectory 
analysis, four differently behaving groups were found. In trajectory group 1, 
responders were consistently willing to withdraw and withhold therapies, and in 
trajectory group 2, responders would probably withdraw and withhold therapies, but 
their decisions were influenced by the family’s appeal and the AD. In contrast, 
responders in trajectory group 3 were either uncertain or chose an aggressive 
approach in about half of their decisions, and they were more influenced by the AD, 
while physicians in trajectory group 4 were most hesitant to withdraw and withhold 
therapies. Factors associated with the physicians’ willingness to continue or start 
LSTs during EOL care (belonging to trajectory groups 3 or 4) were tested with 
logistic regression analysis. Younger age (OR 3.19 (95% CI 1.54–6.57)) and being an 
internist (OR 4.27 (95% CI 2.13–8.56)), a surgeon (OR 4.51 (95% CI 2.25–9.07)) or 
a GP (OR 5.60 (95% CI 2.85–11.0)) were independent factors behind the decision 
not to withhold—or to withdraw—different interventions. 
Figure 3 presents overall results concerning a patient with an inoperable 
malignant brain tumor (patient scenario 6). The proportion of the physicians 
choosing to forgo resuscitation did not change from 1999 to 2015, remaining at 84%. 
In 2015, physicians with cPM decided not to resuscitate more often than other 
physicians (p=0.025), and the experienced GPs were more willing to forgo 
resuscitation than the students (82% vs 64%, p<0.001). 
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Figure 3.  Number and proportion (%) of the responders deciding not to resuscitate the patient with 
an inoperable malignant brain tumour (patient scenario 6), willing to issue a voucher for 
hospice for the breast cancer patient (patient scenario 4) and willing to increase the 
morphine dose (patient scenario 5). Numbers and proportions are marked inside the bars. 
cPM: Special competency in Palliative Medicine. 
 
5.2.3 Complying with patient’s wish for the hospice care (publication III) 
Patient scenario 4 presented a patient with advanced breast cancer who asked for a 
hospice voucher. In 1999, physicians were more reluctant to issue a voucher than 
physicians in 2015 (p<0.001). Among physicians answering in 2015, those with cPM 
were more unwilling to issue a voucher than the others (p=0.038), while there was 
no significant difference between the students and the experienced GPs (54% vs 
48%, p=0.156). Summary of these results is presented in Figure 3. 
A logistic regression analysis from the cohorts of physicians answering in 1999 
and 2015 (excluding physicians with cPM, except if they were oncologists), was done 
to study the factors associated with the willingness to issue a voucher. The 
responders in 2015 still remained independently more willing to issue a voucher than 
the responders in 1999 (OR 2.62 (95% CI 1.96–3.50)). 
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5.2.4 Accepting morphine dosing with probable risk of hastened death 
(publication II) 
Most of the responders refused (66-91%) to increase a morphine dose to a 
potentially lethal level when the prostate cancer patient requested for it (patient 
scenario 5). However, there were clear variations between the groups as shown in 
Figure 3. The students were more reluctant than the experienced GPs (22% vs 32%, 
p=0.004), the physicians with cPM were more reluctant than the other physicians in 
2015 (p<0.001) and the physicians answering in 1999 were more reluctant than the 
physicians answering in 2015 (p<0.001). 
In 1999, leniency towards euthanasia (median VAS 37 (interquartile range (IQR) 
11-69) vs 14 (IQR 5–39), p<0.001) and assisted suicide (median VAS 27 (IQR 9–61) 
vs 11 (IQR 4–28), p<0.001) were significantly greater among those who agreed to 
increase the morphine dose, while this was true only for assisted suicide in 2015 
(median VAS 28 (IQR 2–68) vs 10 (IQR 1–49), p<0.001). Religion had a significantly 
greater influence on decision-making for those physicians who did not agree to 
double the morphine dose in 1999 (median VAS 57 (IQR 30–92) vs 77 (IQR 44–
94), p=0.040), but not in 2015 (median VAS 78 (IQR 45–98) vs 86 (IQR 49–98), 
p=0.130). From the logistic regression analysis, the most important factor that 
independently influenced physicians’ willingness to increase the morphine dose in 
the cohorts of physicians answering in 1999 and 2015 (excluding physicians with 
cPM except if they were oncologists) was not being an oncologist—OR 2.50 (95% 
CI 1.40, 4.46) for surgeons, OR 2.37 (95% CI 1.34, 4.20) for internists, and OR 2.30 
(95% CI 1.33, 3.97) for GPs. In addition, male physicians (OR 1.51 (95% CI 1.11, 
2.05)), those who were older (OR 1.02 (95% CI 1.01, 1.04)), did not believe in God 
(OR 1.64 (95% CI 1.23, 2.19)), accepted assisted suicide (OR 1.13 (95% CI 1.08, 
1.19)), had doubts about physicians’ ability to assess cancer pain (OR 0.94 (95% CI 
0.89, 0.99)), and responded in 2015 (OR 1.40 (95% CI 1.05, 1.88)) were also more 
likely to be willing to increase the morphine dose. 
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5.3 Attitudes, values and background factors 
Summary of the responders’ attitudes, values and background factors is shown in 
Tables 6 and 7. 
 
Table 6.  Attitudes of the physicians in 1999 or 2015, the physicians with cPM and the medical 
students. Attitudes are expressed on a visual analogue scale (VAS) from 0 mm 
(definitely agree) to 100 mm (definitely disagree). 
113 oncologists in 2015 had also cPM and are included in both of these groups in this table 
cPM: Special competency in Palliative Medicine, VAS: Visual Analogue Scale, IQR: Interquartile 
Range, ICU: Intensive Care Unit 
  
 Physicians 
answering in 
1999 
Physicians 
answering in 
20151 
Physicians with 
cPM1 
2015 
Medical 
students 
2015-2016 
     
Attitudes, median VAS (IQR)               
    Active euthanasia is reprehensible 17 (6-51) 25 (5-66) 12 (2-57) 58 (20-77) 
    Withdrawal of life-sustaining treatments is 
reprehensible 
89 (76-95) 93 (76-99) 98 (83-99) 93 (80-98) 
    Assisted suicide is reprehensible 14 (5-38) 13 (2-52) 46 (4-68) 38 (10-69) 
    End-of-life care is satisfying 36 (19-52) 15 (3-35) 2 (0-7) 26 (12-49) 
    People should pay costs of factitious diseases by 
themselves 
44 (27-72) 78 (46-93) 93 (80-99) 66 (40-84) 
    Advance directives have been helpful in my decisions 35 (14-54) 10 (2-29) 5 (1-23) 14 (3-30) 
    Good palliative care enables good death 17 (9-28) 4 (1-12) 5 (1-12) 4 (1-11) 
    Physicians can’t estimate cancer pain 40 (25-70) 47 (27-72) 49 (29-75) 46 (28-65) 
    Religion has influence when I make ethical decisions 65 (31-93) 81 (47-98) 82 (45-98) 88 (50-98) 
    Being a doctor gives me satisfaction 20 (11-30) 7 (2-18) 4 (1-14) 15 (4-28) 
    My health is excellent 20 (10-32) 14 (6-26) 17 (3-33) 13 (6-25) 
    I feel burn out, tired to work  84 (63-94) 89  (71-97) 92 (73-98) 85 (59-94) 
    I am pleased with my salary 72 (37-87) 22  (7-50) 15 (2-42) 13 (3-29) 
    It is waste of resources to treat patients > 80 years in 
ICU 
73 (49-86) 77  (54-93) 79 (66-98) 70 (50-85) 
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5.3.1 Background factors and attitudes of the responders (publications I-IV) 
Advance directives were most frequent among the physicians with cPM (p<0.001 
compared with all other physicians in 2015). Although the physicians in 2015 
considered advance directives to be more helpful than in 1999 (p<0.001), the 
number of physicians’ own advance directives did not change between 1999 and 
2015 (p=0.668). All the physicians with cPM had taken care of EOL patients in 
practice during the last two years. The medical students and the experienced GPs 
did not differ statistically (64% vs 63%, p=0.878) when asked about caring for EOL 
patients in practice but the experienced GPs had taken care of a family member at 
the EOL significantly more often (32% vs 50%, p<0.001). 
The physicians with cPM considered withdrawal of LSTs as less reprehensible 
(p=0.041) and EOL care as more satisfying (p<0.001) compared to other physicians. 
When the experienced GPs and the medical students were compared, EOL care was 
considered more satisfying by the GPs (median VAS 17 vs 26, p<0.001), but there 
was no difference regarding the attitudes towards withdrawal of LSTs (median VAS 
93 vs 93, p=0.588). Believing that good palliative care enables a good death increased 
from 1999 to 2015 (p<0.001), whereas there were no differences between the 
physicians with cPM vs the others (p=0.967) and the students vs the experienced 
GPs (median VAS 4 vs 4, p=0.372). The impact of ADs on ethical decisions 
increased (p<0.001), while the influence of religion decreased (p<0.001) from 1999 
to 2015. The experienced GPs thought ADs were more helpful than students, and 
religion had more influence on the decisions of the experienced GPs than on the 
decisions of the students (median VAS 5 vs 14, p<0.001 and median VAS 74 vs 88, 
p=0.001, respectively). 
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Table 7.  Background factors and life values of the physicians in 1999 or 2015, the physicians 
with cPM and the medical students. 
113 oncologists in 2015 had also in cPM and are included in both of these groups in this table 
cPM: Special competency in Palliative Medicine 
 
 
5.3.2 Values of the responders (publications I-IV) 
All of the physicians and students considered health to be an important life value 
(99–100%). The importance of family and a high standard of living both increased 
from 1999 to 2015 (p<0.001 for both), whereas the importance of success in 
professional career and faith in God decreased between 1999 and 2015 (p<0.001 and 
p=0.024, respectively). The most significant difference between the medical students 
and the experienced GPs concerning life values was the lower importance of faith in 
God among the students (51% vs 22%, p<0.001). 
 Physicians 
answering in 
1999 
Physicians 
answering in 
20151 
Physicians with 
cPM1 
2015 
Medical 
students 
2015-2016 
     
Background factors and life values, n (%)    
    Having children 600 (85) 555  (88) 59 (86) 51 (13) 
    Having own advance directive 38 (5) 38 (6) 12 (18) 31 (8) 
    Taking care of end-of-life patients in practice 
(last 2 years) 
529 (75) 418 (65) 67 (100) 256 (64) 
    Taking care of a family member in end-of-life 513 (73) 314 (49) 47 (49) 128 (32) 
    Length of life is important 412 (59) 524 (87) 52 (80) 330 (85) 
    Health is important 711 (99) 610 (99) 65 (100) 389 (100) 
    Family is important 686 (95) 607 (99) 65 (100) 386 (99) 
    Clean environment is important 666 (93) 599 (98) 64 (99) 360 (93) 
    High standard of living is important 358 (50) 398 (65) 34 (52) 262 (68) 
    Faith in God is important 338 (48) 253 (42) 25 (39) 84 (22) 
    Success in professional career is important 639 (89) 377 (62) 37 (57) 235 (60) 
 66 
5.3.3 Attitudes on assisted death (publications II and IV) 
The medical students considered euthanasia (median VAS 58 vs 24) and assisted 
suicide (median VAS 38 vs 10) to be significantly less reprehensible than the 
experienced GPs (p<0.001 for both). Euthanasia was considered more reprehensible 
in 1999 than in 2015 (p=0.008), but there was no difference concerning assisted 
suicide between these years (p=0.480). The physicians with cPM considered assisted 
suicide to be less reprehensible than the other physicians in 2015 (p=0.013), but 
there was no difference concerning euthanasia (p=0.102). 
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6 DISCUSSION 
In this thesis, EOL decisions concerning hypothetical cancer patients, possible 
changes in these decisions over time, and factors influencing them were evaluated 
among Finnish physicians and medical students. Many aspects of the decision-
making were influenced by the year of the survey (1999 vs 2015), whether physician 
had cPM or not and by the clinical experience of the responders. 
6.1 Factors influencing end-of-life decision-making 
6.1.1 Willingness to choose palliative care or to forgo treatment at the end-
of-life 
When responders were asked to choose between palliative, active or intensive care 
for the prostate cancer patient with a deteriorating overall condition (patient scenario 
1), most of them chose a palliative care approach. In the following scenarios, where 
the same patient probably had iatrogenic GI-bleeding (patient scenario 1a) and when 
the patient was waiting to see his son (patient scenario 1b) or a minister to have a 
Lord’s Supper (patient scenario 1c), the number of physicians choosing a palliative 
care approach decreased. When willingness to withhold or withdraw treatments 
concerning the metastatic end-stage lung cancer patient (patient scenario 7) was 
asked, responders were highly influenced by the family’s request for everything to be 
done. Compared to the experienced GPs, the medical students were similarly 
influenced without significant differences by the family’s appeal in the case of the 
end-stage lung cancer patient (patient scenario 7) or the presence of an AD for the 
prostate cancer patient with a deteriorating overall condition (patient scenario 1) and 
in the case of the end-stage lung cancer patient (patient scenario 7). 
A family’s opinion has been shown to have marked influence on physicians’ 
decision-making36,37,232. The findings in this thesis are in line with previous studies, 
since the family’s request for aggressive treatment significantly increased the 
physicians’ willingness to continue or start LSTs. However, in 2015, physicians 
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reported to be less influenced by the family’s benefit, which probably influenced 
their unwillingness to choose active and intensive care when the son of the seriously 
ill prostate cancer patient was coming (patient scenario 1b). This lower influence of 
the family’s benefit may be related to the rising individualism and to the increase in  
human and patient rights in Western countries50,52,53,56,57,287. 
Guilt has been shown to be one of the reasons that futile treatments are 
maintained in EOL care288. This could explain, at least to some extent, why 
approximately half of the physicians chose an active approach upon discovery of the 
GI-bleeding that was likely caused by the previously prescribed ketoprophen, 
although this shift to life-sustaining treatment was slightly less common in 2015. This 
tendency to correct possible complications of previous therapies is understandable. 
On the other hand, the principal justification for treatment should be the patient’s 
benefit rather than the feelings of guilt experienced by the physician. 
It is not surprising that an appointment with a minister shifted the treatment 
decisions to life-prolonging modalities less often in 2015 than in 1999 because 
religion was considered less influential in decision-making and fewer physicians had 
faith in God in 2015 than in 1999. Religion has also been shown to have significant 
effects on EOL decisions in general by shifting decisions towards continuing LSTs23-
25,42. 
After finding the prostate cancer patient’s AD in patient scenario 1d, almost all 
physicians chose a palliative care approach. Similarly, the presence of an AD detected 
in the case of the lung cancer patient (patient scenario 7) significantly decreased the 
willingness to start or continue LSTs. This is well in line with earlier studies showing 
that ADs help the decision-making process in EOL care, although physicians are 
concerned whether ADs genuinely express a patient’s own will36,39,40,171. 
6.1.2 Education and experience of a physician 
The medical students were less willing to withhold blood transfusions, pleural 
drainage and chest X-rays than the experienced GPs (79% vs 67%, 42% vs 21% and 
52% vs 41%, respectively). Mechanical ventilation was withdrawn, and 
supplementary oxygen continued, by most of the students and GPs alike (75% vs 
81% and 95% vs 94%, respectively). In contrast to our findings, 41% of medical 
students objected to withdrawing artificial life-support in a large Brazilian study248. 
This difference might be because the practice of withdrawing mechanical ventilation 
varies largely depending on the country and culture193. Blood transfusions have been 
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shown to be the most frequently withdrawn treatments in EOL care, both in survey 
studies and in prospective clinical studies289,290. The benefit of blood transfusions in 
EOL care is often brief and adverse effects are a risk for the patient, although they 
rarely occur210. Dyspnoea can sometimes be alleviated by pleural drainage, but the 
procedure is invasive and has a risk of a pneumothorax291. We suggest that the main 
reason why GPs are more willing to withhold these procedures is because they have 
experience with the risks and inconveniences of these interventions among frail 
patients. Further, many conditions, such as pulmonary oedema, can be detected by 
clinical examination without X-rays in EOL care and GPs might have had better 
knowledge of this. 
Students were twice as likely as the GPs to attempt resuscitation on the patient 
with an advanced brain tumour (patient scenario 6). Cancer patient survival from 
CPR declines towards zero as the cancer advances and performance status 
declines218. Thus, in the case of an advanced brain tumour patient, resuscitation can 
be considered to be futile218. The growing clinical experience of a physician probably 
offers more insight into whether CPR may or may not be futile, explaining the 
difference between GPs and students. 
Over 80% of both the students and the GPs chose palliative care for a patient 
clearly approaching death (a comatose patient with prostate cancer in patient 
scenario 1). Although the palliative care approach in this scenario could be regarded 
as obvious, our result shows that medical schools in Finland seem to offer a basic 
understanding of EOL care. This is highlighted by the similar compliance of students 
and experienced GPs to issue a voucher for hospice for the advanced breast cancer 
patient (patient scenario 4). 
GPs accepted the potential risk of hastening death by giving a high morphine 
dose more often than the students in the case of the paralyzed prostate cancer patient 
(patient scenario 5), although less than one third accepted this in both groups. In a 
study from Puerto Rico, 50% of the students and 80% of the faculty members 
considered that prescribing drugs to alleviate pain despite the risk of hastening death 
was ethical249. In another study from Poland, only 12% of the physicians, but 51% 
of the medical students, regarded that it was always wrong to exceed a defined dosage 
of morphine266. Although opioids may cause respiratory depression, even high doses 
of opioids used for symptom control do not seem to shorten the life of patients in 
EOL care292-296. Thus, the willingness of the GPs to increase the morphine dose 
might be due to an enhanced understanding of the effects of opioids. However, the 
actual acceptance of hastening death cannot be ruled out. 
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The physicians with cPM were more willing to withdraw and withhold LSTs, 
especially intravenous hydration and a nasogastric tube, compared to the other 
physician groups in a patient scenario representing end-stage lung cancer (patient 
scenario 7). We suggest that this willingness is related to the cPM itself, because its 
influence remained after multivariate analysis which took into account important 
background factors. Physicians with cPM also forwent resuscitation more often than 
the others (patient scenario 6) but were less willing to issue a voucher to a hospice 
for a breast cancer patient who wished for it (patient scenario 4). The influence of 
education is further supported by the results from the logistic regression analysis in 
which having post-graduate EOL training was significantly associated with a 
decreased likelihood of choosing active and intensive care in patient scenarios 1a, b 
and c concerning the prostate cancer patient with a deteriorating overall condition. 
Although education in palliative care increases the knowledge and skills needed to 
perform high-quality EOL care, the effectiveness of special training in palliative 
medicine on different aspects of decision-making in EOL care have been 
unknown29,31,32,112,113. It can be argued that formal training in PM endows one with 
a good ability to consider and communicate EOL decisions, probably leading to both 
more decisions to withdraw or withhold treatments and to better confidence in 
symptom control and care for the breast cancer patient in a community hospital 
ward. However, the latter issue could be criticized as taking care of a patient at the 
EOL should be multidisciplinary72. Thus, having a physician who is specialized in 
palliative and EOL care does not necessary mean that the holistic view of palliative 
care is achieved, if other professionals of the team are not familiar with the principles 
of palliative care, which could be the case in community hospitals. 
The physicians with cPM were more reluctant than the other physicians to 
increase the morphine dose to a potentially lethal level when the paralyzed prostate 
cancer patient requested it (patient scenario 5). This finding might be due to the 
better knowledge of adjacent drug therapies and other treatment modalities for pain 
control, more practical experience in the use of opioids during EOL care and 
perhaps a better awareness that a patient’s wish to hasten death does not always 
imply a genuine wish to die, but might be the result of overwhelming emotional 
suffering282,283. 
The age of a physician is a contradictory factor in decision-making24. In this 
thesis, younger age was an independent factor behind the decision not to withhold 
or to withdraw different interventions in EOL care. This is in line with multiple 
studies where older age has been associated with more decisions to withhold or 
withdraw interventions, but does not agree with the few studies where younger 
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physicians made less aggressive decisions18,23,45,236,238,239,242. Reasons behind these 
different results can only be speculated by the authors; they have not been 
investigated as part of these studies18,23,45,236,238,239,242. 
6.1.3 Changes between 1999 and 2015 
The year of the survey was an important factor explaining physicians’ decisions 
during the EOL care in this thesis. In 2015, the physicians accepted the risk of 
hastened death from increasing the morphine dose more frequently than in 1999. 
The physicians’ decisions to choose palliative care approaches significantly increased 
from 1999 to 2015, and physicians were also more willing to issue a voucher for 
hospice in 2015. Our findings may reflect increasing support of patient’s preferences, 
a decreased importance of family and religion among our responders, and better 
knowledge of the principles of palliative care49,51,82,85,120,297. Today, patient-centred 
care and shared decision-making are preferred by most physicians and 
patients49,51,120,121. Advances and benefits of palliative care are more evident and 
better known today than in the late 1990s4,6-8,10,11,298-300. 
In general, physicians accepted potentially lethal morphine dosing more 
frequently today than in 1999, although approximately two-thirds of the doctors 
were still unwilling to provide this. As discussed above, this result might be due to 
the actual acceptance of hastening death at the EOL, better knowledge regarding the 
use of opioids, or both. It is now known that clinically relevant respiratory failure is 
not a problem when opioids are titrated against cancer pain301. Since 1999, there has 
been growing evidence that the use of opioids for symptom control in advanced 
diseases has no effect on survival, and even high doses of opioids do not seem to 
shorten life during EOL care294,296. However, the potential of opioids to hasten death 
during EOL care is almost impossible to study in prospective randomized trial 
settings. In a study conducted in the Netherlands, physicians administered similar 
dosages of opioids in 1995, 2001 and 2005, but in 2005 they thought that life was 
shortened by the opioids or that their intention was to hasten death by administering 
opioids less frequently than in previous years280. Although we did not ask the 
intention behind physicians’ willingness to increase the morphine dose, it was clearly 
stated in the patient scenario that the increased dose might lead to the patient’s death. 
Therefore, we cannot rule out the possibility that this result reflects an increased 
acceptance of hastening death, while taking into account the previous studies 
showing an increased acceptance of euthanasia in Finland258-260. The oncologists 
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were most reluctant to increase the morphine dosing, and their opinion did not 
change between 1999 and 2015. This might be due to the fact that they were probably 
most familiar with the influences of opioids in clinical practice, as well as with the 
studies on this issue. These results are in line with the study by Miccinesi et al. in 
which oncologists were the least in favour of using drugs in lethal doses26. In the 
current study, the difference between the oncologists and the other physician groups 
remained in the results of the logistic regression analysis accounted for relevant 
confounding factors. 
The influence of patient’s benefit on the physicians’ decision-making rose 
between the years studied. The rise of individualism and the well-established status 
of patient’s rights today in western parts of the world might reflect to this change, as 
well as the fact that today respecting patient’s wishes is one of the main principles in 
the ethical guideline of the Finnish Medical Association50,52,53,56,57,62,287. Both patient’s 
and physician’s legal protection was considered more influential today than sixteen 
years ago. In Finland, patient’s rights regarding treatment decisions were 
incorporated into Finnish law in 1992, which has obviously emphasized the 
importance of the patient’s legal protection60. These results also raise the question as 
to whether physicians are more concerned about malpractice claims at present than 
they were sixteen years ago. The data from malpractice claims from other countries 
is conflicting, as some studies show an increasing amount of malpractice claims, 
while others show a clear decrease302,303. In contrast to these results, the law appeared 
to play a limited role in medical EOL decision-making, as doctors prioritized patient-
related clinical and ethical considerations over law in a recent study from Australia304. 
On the other hand, that study is partly in line with the current study, as ethical values 
were considered to be highly influential by our responders as well. Our findings 
emphasize the complexity of EOL decision-making and the different factors that 
affect it, as physicians consider both legal and ethical aspects to be important, and 
one does not exclude the other. 
6.2 Differences in attitudes and values 
Euthanasia was considered to be less reprehensible by the medical students 
compared to the experienced GPs and among the physicians in 2015 than in 1999. 
These findings are in agreement with previous studies showing an increased 
acceptance of euthanasia among physicians worldwide and in Finland and that 
students tend to be more in favour of euthanasia than practising 
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physicians64,249,258,260,266,305. Although we found a trend towards a lesser acceptance 
of euthanasia among physicians with cPM than without this training, this difference 
was not statistically significant, and PAS was, surprisingly, considered less 
reprehensible by the physicians with cPM compared to others. Thus, our results do 
not fully comply with earlier international studies showing that physicians who have 
the most experience in palliative care are strongest in their opposition to hastening 
death264,265,306. Finnish physicians without cPM considered PAS slightly more 
reprehensible than euthanasia and this did not change at all during the past 16 years. 
This result differs from previous studies where physicians’ acceptance of PAS 
exceeds the acceptance of euthanasia but is in line with our finding on physicians 
with cPM, as they considered PAS less reprehensible than euthanansia64. One aim 
for future research could be to determine whether these somewhat conflicting results 
are due to a true difference in the attitudes towards these two procedures or just to 
less knowledge about the process of PAS in Finland. Public attitudes towards 
assisted death have changed since the 1990s to become more permissible, leading to 
the legalization of assisted death in some countries and increased political support 
for it in Finland64,257-259. These changes in the surrounding society and general 
attitudes might have had a substantial influence on these results. Finally, when 
comparing these results to previous studies, it has to be taken into account, that we 
asked whether the responder considered euthanasia or PAS “reprehensible” or not 
on a VAS scale. This differs from surveys asking “yes or no” questions regarding the 
acceptance of legislation or the practice of assisted death. Keeping this in mind, it 
must be said that even though attitudes have become more permissible, euthanasia 
was still considered reprehensible by physicians in 2015, as the median VAS was only 
25 mm on a scale 0 (definitely agree) to 100 mm (definitely disagree). 
Religion has been confirmed to have a tremendous effect on EOL decisions and 
attitudes towards euthanasia and PAS23,25,26,248,269. This complies with our results, as 
experienced GPs had faith in God and considered religion to influence their 
decision-making in EOL care more often than did the students, whereas students 
had a greater acceptance of euthanasia and PAS. Faith in God and the influence of 
religion on decision-making also decreased during the study years. This might have 
influenced the physicians’ decision to accept the increase of the morphine dose more 
frequently in 2015 than in 1999, as faith in God was found to decrease physicians’ 
willingness to administer a potentially lethal morphine dose. Löfmark et al. 
concluded that a non-religious philosophy of life increased physicians’ willingness to 
perform euthanasia and PAS, possibly by emphasizing patient autonomy25. 
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In 2015, a clear majority of physicians and medical students thought that palliative 
care enables a good death. There was a significant increase in this opinion compared 
to the answers in 1999. This finding is not surprising because knowledge about the 
benefits of palliative care has grown in recent decades, and today it is considered a 
part of everyday care in life-threatening illnesses and a human right1,3,4,6-11,298-300. 
However, in another international study, only 51–70% of the physicians believed 
that palliative care was able to prevent the need for euthanasia and PAS26. The 
physicians with cPM considered the withdrawal of LSTs less reprehensible and EOL 
care more satisfying compared to the other physicians. This is understandable when 
taking into account the nature of palliative care in which considering the withdrawal 
of LSTs to be reprehensible could be problematic. 
6.3 Methodological considerations 
This study included physicians mainly from four specialties: general practice, internal 
medicine, surgery and oncology. In addition, physicians with cPM had different 
underlying specialties. These physician groups were selected because they are known 
to take care of cancer patients throughout the disease trajectory and especially during 
EOL care. Graduating medical students were also invited to participate in order to 
explore differences between them and the more experienced physicians. 
The overall response rate was 56%. This is a limitation of the study, although it is 
higher than in many recent studies conducted among physicians5,37,190. Response 
rates in studies conducted among medical students vary widely, from 44% in a study 
from Sweden to over 90% in studies from Poland and Austria, which places our 
response rate of 63% among students as average269,270,307. Some responder bias may 
have occurred, as it is possible that physicians who consider EOL care to be 
meaningful may have appreciated this survey, leading them to answer more 
frequently than the others. However, the study population is large and can be seen 
as a representative sample of Finnish physicians because it reflects the overall 
distribution of specialties and gender among Finnish physicians308. The latest 
statistics of Finnish physicians are from 2016, when there were approximately 29 
000 licensed physicians, of whom 21 000 were currently practising medicine308. 
Approximately 60% of all the Finnish physicians were female308. 
The follow-up period of sixteen years is long enough to detect relevant changes 
in attitudes and decision-making. In studies investigating changes in attitudes 
towards euthanasia, a time period of around ten years is the most commonly 
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used257,260,270. Some of the language used in the questionnaire was old fashioned, e.g., 
the use of the term terminal, but in order to make the comparison between the study 
years as valid as possible, we chose not to change the language. Instead, we explained 
the background of the questionnaire in the cover letter, making a remark about the 
language and terms used in the survey. 
Answers to the hypothetical patient scenarios might differ from physicians’ real 
life decision-making in clinical practice. In addition, the scenarios forced the 
responders to give simple answers without the possibility to discuss with the patient 
or family to achieve a shared decision. Thus, interactions between a patient or family 
and the physician were missing, which might influence the decisions made. We 
suggest, however, that the factors behind decision-making remain similar in real life 
situations compared with these hypothetical patient scenarios, and this is also 
supported by previous studies289,290. A survey study by Christakis et al. and an actual 
prospective study by Asch et al. both showed that blood products and haemodialysis 
were the most frequently withdrawn treatments, whereas tube feeding and 
intravenous fluids were often continued in EOL care289,290. 
The reliability of the questionnaire is highly important, as physicians’ answers may 
vary due to confounding factors that are not measured. The questionnaire was 
previously tested in a pilot study at a two-week interval, and the reliability was found 
to be sufficient (kappa coefficient 0.40 or greater)16-18,178,284. 
Although using a VAS scale to measure attitudes might have caused some 
confusion, physicians are generally familiar with its use because it is widely used to 
measure different symptoms. The VAS scale has been demonstrated to be useful in 
statistical analysis under a variety of conditions, especially when VAS responses are 
skewed to either end of the scale, as they were in many of the responses in this 
study309. This type of assessment might provide more appropriate insights into the 
complex ethical questions than simply answering yes or no. 
The study population was previously determined, as explained earlier in this 
chapter, so no power calculations were performed. In addition to conventional 
statistical analysis, a trajectory analysis was used in patient scenario 7 to take into 
account all of the optional sub scenarios in the given order (original, family’s appeal 
and advance directive). This analysis, together with the multivariable analysis from 
the most hesitant group, further supported our finding that in 2015 physicians with 
cPM were more willing to withdraw and withhold treatments compared to other 
physician groups.  
Five of the six cancer patient scenarios from the original questionnaire were 
selected to be part of this thesis. The patient scenario concerning a dementia patient 
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was not included in this thesis in order to keep the content coherent; therefore, only 
the cancer patient scenarios were incorporated into the thesis. Patient scenario 3, 
representing a patient with an advanced pancreatic cancer planning to receive 
immunization treatment, was not selected to be part of this thesis, because 
immunological treatments are currently a part of everyday practice in some cancer 
types, and the original idea of an unorthodox therapy was no longer clear in 
2015310,311. 
In this study, only cancer patients were included, hence the results can be 
generalized only to cancer patients. However, it can be argued that in EOL care the 
underlying diagnosis is not as important as the symptoms, values and wishes of the 
patient, as it has been shown that symptom burden at the EOL is quite similar across 
different illnesses312. Thus, the results from this thesis regarding the decisions-
making in EOL care may be at least partly broadened to other diagnoses beyond 
cancer. 
6.4 Practical suggestions and recommendations for the future 
The results from this thesis demonstrate that EOL decision-making varies between 
physicians and medical students depending on their background factors, personal 
values, experience and education. The decision-making of physicians also changes 
over time, constantly reflecting the changing social surroundings and medical 
atmosphere. 
Discussions among the public, policy makers and physicians are ongoing about 
the ethical justification of hastened death due to unbearable suffering. Instead of 
asking simple yes or no questions, it is important to try to understand different 
aspects and attitudes towards hastened death and EOL decision-making in a more 
complex way, as was done in this thesis. Although most of the responders believed 
that palliative care enables good death, not every physician seems to be convinced 
that palliative care could prevent the need for euthanasia and PAS worldwide. More 
studies, especially with in-depth methods, are needed to further explore hastened 
death in years to come to enable societies to build a solid and consistent foundation 
for legislation around the multilateral and ethically challenging subject of hastened 
death. 
The attitudes, experience and education of a physician seems to play an important 
part in their EOL decision-making. Self-reflection and acknowledging one’s own 
attitudes and values influencing medical decision-making is crucial. These findings 
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call for continuous education about palliative care and decision-making from the 
beginning of medical school and continuing in the post-graduate training of different 
specialties who face dying patients in their everyday practice. In this education, it is 
of utmost important to include different medical, ethical and legal aspects of EOL 
decision-making to ensure that equal access to high-quality EOL care is achievable 
for every patient and their family. However, palliative care consultations might be 
needed for complex cases of decision-making in EOL care. Palliative care is a holistic 
and interdisciplinary approach where different professionals work together as a team. 
Therefore, these educational aspects should be thought of a larger perspective than 
just for physicians. For example, nurses and social workers should be incorporated 
into multidisciplinary education about EOL decision-making. In Finland, the 
Ministry of Education and Culture has founded a project to develop education in 
palliative care in both the under- and post-graduate training of nurses and 
physicians313. The results of this thesis could be useful when describing educational 
needs and planning palliative medicine education for all stages in the trajectory of 
becoming and being a physician. 
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7 SUMMARY AND CONCLUSIONS 
This study was carried out to evaluate end-of-life decisions and the factors 
influencing these decisions among Finnish physicians and medical students 
(publications I-IV) as well as the possible changes in these decisions and influencing 
factors over the past sixteen years (publications II and III). The evaluation was based 
on a survey consisting of five hypothetical cancer patient scenarios concerning end-
of-life care together with questions on attitudes towards different aspects of end-of-
life care, sociodemographic characteristics and professional factors.  
 
The main findings are as follow: 
 
1. The physicians with special competency in palliative medicine made less 
aggressive decisions in end-of-life care compared to other physicians in 
general. The difference varied between therapies but was most striking 
with regard to the use of intravenous hydration, nasogastric tubes and 
blood transfusions. All of the physicians were influenced by the family’s 
request and an advance directive. 
2. The physicians considered euthanasia, but not assisted suicide, to be less 
reprehensible in 2015 than in 1999, and physicians in 2015 stated more 
often that palliative care enables a good death. When making end-of-life 
decisions, the physicians regarded the patient’s benefit, ethical values and 
the legal protection of the patient or physician to be more influential, 
while the family’s benefit was regarded as less influential in 2015 than in 
1999. 
3. In 2015, the physicians accepted the risk of hastened death from an 
increased morphine dose more frequently than in 1999. Physicians’ 
decisions to choose palliative care approaches in end-of-life care and their 
willingness to issue a voucher for hospice significantly increased from 
1999 to 2015. 
4. The medical students considered euthanasia and assisted suicide to be 
less reprehensible than the experienced GPs, whereas religion had a 
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stronger influence on the decisions among the GPs. Both the medical 
students and the experienced GPs frequently thought that withdrawal of 
life-sustaining treatments was not reprehensible and that good palliative 
care can enable a good death. 
5. The experienced GPs were more willing to accept the risk of hastened 
death and withheld or withdrew different therapies in end-of-life care 
more often than the medical students. There was no difference between 
the students and the experienced GPs when choosing a palliative care 
approach in EOL situations or in the willingness to issue a voucher for 
hospice. 
 
The characteristics, attitudes, values, experience and education of physicians and 
medical students play a significant part in their end-of-life decision-making; 
therefore, it is of the utmost importance to include ethical, medical and juridical 
aspects of decision-making, end-of-life care and palliative medicine in the under- and 
postgraduate medical education and to study these aspects in prospective clinical 
trials in the future.  
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9 APPENDIX 
The questionnaire 
 
Answer the questions based on the following patient scenarios in the given order. 
Choose one of the three treatment options given (palliative, active intensive). 
Circle the right option. Do not change your answer once decided. 
Palliative care: good nursing, sufficient medications for pain and other symptoms, 
intravenous hydration only when it is considered to relieve patient’s symptoms 
Active care: use of antibiotics, intravenous hydration or blood transfusions aimed 
at saving the patient’s life in a life-threatening condition 
Intensive care: moving the patient to intensive care unit (ICU) 
 
Patient scenario1: An 82-year-old retired forest worker, who had received a 
diagnosis of prostatic cancer 3 years ago. During the past year he received 
treatments for bone metastases. He has now been in hospital for one month, 
almost totally bedridden, and needs help with all functions. His mental condition 
has been normal. His general condition has weakened over the past week, he is 
now totally bedridden, and he has received large doses of pain medication. Today, 
he has become comatose. His haemoglobin count has decreased to 68 g/l, while 
the week before it was 118 g/l. His blood pressure is 80/40 mmHg. There is no 
verbal or written advance directive. The patient’s wife has previously said that she 
expects the doctor to make all treatment decisions according to his/her best 
understanding.  Is your treatment decision 
a) palliative care   b) active care  c) intensive care 
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There are four alternative hypothetical situations linked to the previous scenario 
A) You are told by the nurse that it has been discovered that the patient’s faeces 
are black. You remember having started ketoprophen for pain a week ago. Is your 
treatment decision 
a) palliative care   b) active care  c) intensive care 
 
B) You are told by the nurse that the patient’s son is coming from America the day 
after tomorrow to see his father while he is still alive. Is your treatment decision 
a) palliative care   b) active care  c) intensive care 
 
C) You are told by the nurse that the patient has had spiritual anxiety and there is a 
planned appointment with a minister and the Lord’s Supper tomorrow. Is your 
treatment decision 
a) palliative care   b) active care  c) intensive care 
 
D) You are told by a family member that there is a written advance directive in 
which patient has expressed that all active interventions should be withhold if 
there is no hope for recovery. Is your treatment decision 
a) palliative care   b) active care  c)intensive care 
 
Evaluate the influence of the following factors on your decision on a scale 1-5 
 very little 
influence 
   very much 
influence 
Family’s benefit 1 2 3 4 5 
Patient’s benefit 1 2 3 4 5 
Patient’s legal rights 1 2 3 4 5 
Physician’s legal rights 1 2 3 4 5 
Ethical values 1 2 3 4 5 
Patient’s age 1 2 3 4 5 
Costs of care 1 2 3 4 5 
Patient’s social status 1 2 3 4 5 
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Patient scenario 2: An 82-year-old man has suffered from progressive dementia 
for three years. He has been diagnosed as suffering from Alzheimer’s disease. He is 
brought to the emergency department at 2 am with life-threatening 
gastrointestinal bleeding. He lives in a nursing home, has urinary and faecal 
incontinence, needs help washing and dressing and does not recognize his 
daughter. His blood pressure is 70/40 mm Hg and his heart rate 120 beats/min. 
The patient cannot communicate, and his family and physician cannot be reached. 
The nurse’s aide who accompanied him to the emergency department is not 
familiar with the patient. There is no information available as to his wishes or 
those of his family concerning treatment in this situation. Is your treatment 
decision 
b) palliative care   b) active care  c) intensive care 
 
Evaluate the influence of the following factors on your decision on a scale 1-5 
 very little 
influence 
   very much 
influence 
Family’s benefit 1 2 3 4 5 
Patient’s benefit 1 2 3 4 5 
Patient’s legal rights 1 2 3 4 5 
Physician’s legal rights 1 2 3 4 5 
Ethical values 1 2 3 4 5 
Patient’s age 1 2 3 4 5 
Costs of care 1 2 3 4 5 
Patient’s social status 1 2 3 4 5 
 
Patient scenario 3: A 45-year-old woman suffers from pancreatic cancer with 
multiple metastases in the liver. There are no possibilities for active treatment. In 
three months she has becomecachectic. Now she is in your ward in end-of-life 
(terminal) care. Her friends are planning to take her to another city (distance 300 
km) to consult a private doctor to get immunization treatment. The patient and 
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her friends have expressed criticism of the official medical treatment and made 
accusations of a delay in diagnosis.  
As the doctor responsible for her care you 
a) accept the plan (as the last glimmer of hope) without criticizing it, because 
there is no medical treatment which you can order her 
b) you have a negative attitude to the plan and tell this to the patient 
properly and justify your opinion with medical facts 
c) I don’t know 
d) other solution:_________________________________________________ 
 
The same patient is in any case in your ward and is receiving immunization therapy 
ordered by another physician. The therapy includes a special diet, which incurs 
about 20 euros additional cost per day. 
a) you refuse to carry through the diet 
b) the patient can have the diet, but she has to pay the extra costs 
c) the patient can have the diet, because her presumed life expectation is 
very short 
d) other decision:_________________________________________________ 
 
Patient scenario 4: A 68-year-old patient suffers from breast cancer with bone 
metastases. She is bedridden and her general condition has rapidly collapsed. She 
is in a community hospital ward and is receiving adequate pain treatment with 
which she is pleased. She is depressed and wants to transfer to a hospice for her 
last days. She feels that the atmosphere on the ward is very restless and 
“institutional”. You have the right to issue a voucher for the costs of hospice care 
(290 euros per day) to be paid by the community hospital. The costs would be 
approximately double compared to those in a community hospital, and the chief 
doctor has advised you to use great discretion in issuing vouchers. Your solution: 
a) to accept the transfer  
b) to accept the transfer, provided that the patient pays the extra costs 
herself 
c) not to accept, because according to normal practice the patient’s care 
belongs to the community hospital ward and there are no special 
problems in her care 
d) I don’t know 
e) other solution:_________________________________________________ 
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Patient scenario 5: A 60-year-old male patient is suffering from prostatic cancer 
with metastases. Metastases in the thoracic spine led to total paraparesis 1 month 
earlier. There is no hope for a cure. The patient is well aware of the situation. He 
has totally lost his will to live. When you are together with him alone, he asks for a 
sufficient dose of morphine to “get away”. You have denied the overdose, 
explaining that it is against your ethical principles. During the following days, you 
notice that the patient asks you to double his morphine dose because of 
unbearable pain. The anti-inflammatory pain medication is at its maximum dose 
and you suspect if the pain is real (this sentence was removed from the scenario in 
2015 as it did not comply with current treatment guidelines for cancer pain). You 
suppose that increasing the dose in such a way would lead to the patient’s death. 
Your decision is which of the following:  
a) to raise the dose because the patient has the right to sufficient pain relief 
in this end-of-life (terminal) care situation 
b) to try to help the patient in other ways, such as with antidepressants, thus 
continuing with morphine dosing according to given guidelines 
c) I can’t say 
d) give another solution:___________________________________________ 
 
Patient scenario 6: A 32-year-old female patient is brought by ambulance to the 
emergency unit. She is accompanied by her husband who says his wife has 
inoperable brain cancer. She has been receiving maximum radiotherapy, but this 
was discontinued 3 weeks ago. She has deteriorated considerably during the past 
week. The patient has now had an epileptic seizure and has been unconscious 
since the attack. After 20 min at the hospital the patient stops breathing, and 
there is no pulse. Your treatment decision is which of the following: 
a) to start cardiopulmonary resuscitation 
b) to withhold cardiopulmonary resuscitation 
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Patient scenario 7: A 62-year-old male patient with pulmonary cancer and 
metastases. He was admitted to hospital ward and received high-dose morphine 
medication. Due to respiratory weakening, he had become comatose the night 
before. He also suffered from severe anaemia and had abundant pleural effusion 
and fever. Which of the following treatments already started (*) or planned would 
you withhold or withdraw? You have no possibility of discussing the matter with 
the family and there is no advance directive. 
Would you withhold or withdraw the following treatments; express your decision 
on a scale 1-5 
  I definitely 
would not 
withhold or 
withdraw* 
   I definitely 
would 
withhold or 
withdraw* 
a) antibiotics (*) 1 2 3 4 5 
b) mechanical 
ventilation (*) 
1 2 3 4 5 
c) blood 
transfusion 
1 2 3 4 5 
d) pleural 
drainage 
1 2 3 4 5 
e) chest x-ray 
examination 
1 2 3 4 5 
f) laboratory 
tests 
1 2 3 4 5 
g) intravenous 
hydration (*) 
1 2 3 4 5 
h) nasogastric 
tube (*) 
1 2 3 4 5 
i) nasogastric 
tube (*) 
1 2 3 4 5 
j) supplementary 
oxygen (*) 
1 2 3 4 5 
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Next there is two alternatives with extra information for the scenario above:  
A) the patient’s daughters come to you distressed and crying, expressing 
their hope that everything possible will be done to save their father’s life. 
Which of the following treatments already started (*) or planned would 
you withhold or withdraw? 
 
  I definitely 
would not 
withhold or 
withdraw* 
   I definitely 
would 
withhold or 
withdraw* 
a) antibiotics 
(*) 
1 2 3 4 5 
b) mechanical 
ventilation 
(*) 
1 2 3 4 5 
c) blood 
transfusion 
1 2 3 4 5 
d) pleural 
drainage 
1 2 3 4 5 
e) chest x-ray 
examination 
1 2 3 4 5 
f) laboratory 
tests 
1 2 3 4 5 
g) intravenous 
hydration (*) 
1 2 3 4 5 
h) nasogastric 
tube (*) 
1 2 3 4 5 
i) nasogastric 
tube (*) 
1 2 3 4 5 
j) supplementa
ry oxygen (*) 
1 2 3 4 5 
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B) there is a written advance directive in the patient’s medical chart in which 
he expresses his wish that all active treatment should be withdrawn if 
there is no hope for recovery. Which of the following treatments already 
started (*) or planned would you withhold or withdraw? 
 
  I definitely 
would not 
withhold or 
withdraw* 
   I definitely 
would 
withhold or 
withdraw* 
a) antibiotics (*) 1 2 3 4 5 
b) mechanical 
ventilation (*) 
1 2 3 4 5 
c) blood 
transfusion 
1 2 3 4 5 
d) pleural 
drainage 
1 2 3 4 5 
e) chest x-ray 
examination 
1 2 3 4 5 
f) laboratory 
tests 
1 2 3 4 5 
g) intravenous 
hydration (*) 
1 2 3 4 5 
h) nasogastric 
tube (*) 
1 2 3 4 5 
i) nasogastric 
tube (*) 
1 2 3 4 5 
j) supplementary 
oxygen (*) 
1 2 3 4 5 
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Next there are questions regarding your opinions. Asses your opinion with a 
straight line to the scale on the place which describes your opinion best.  
1) Euthanasia is reprehensible 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
2) Withdrawal of life-sustaining treatments is reprehensible 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
3) Assisted suicide is reprehensible 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
4) End-of-life care is satisfying 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
5) People should pay costs of factitious diseases by themselves 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
6) Advance directives have been helpful in my decisions 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
7) Good palliative care enables good death 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
8) Physicians can’t estimate cancer pain 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
9) Religion has influence when I make ethical decisions 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
10)Being a doctor gives me satisfaction 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
11)My health is excellent 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
12)I feel burn out, tired to work 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
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13)I’m pleased with my salary 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
14)It is waste of resources to treat patients > 80 years in ICU 
I definitely agree    I definitely disagree 
I------------------------------------------------------------------------------------I 
  
 111 
Here some opinions and views towards death is presented. Choose the alternative 
that is closest to your own thinking. (A five point Likert: 1=definitely agree, 
2=agree to some extent, 3=I don’t know, 4=I don’t quite agree, 5= definitely 
disagree 
  I definitely 
agree 
   I definitely 
disagree 
A) Death is like a long 
dream 
 
1 2 3 4 5 
B) Dying means 
suffering 
1 2 3 4 5 
C) Dying is not tragic 
for the one dying 
but for those who 
remain 
1 2 3 4 5 
D) Death comes 
always too soon 
1 2 3 4 5 
E) Our existence does 
not end at death 
1 2 3 4 5 
F) Death is always in 
”higher hands” 
1 2 3 4 5 
G) I fear death 1 2 3 4 5 
H) I’m afraid that 
someone close to 
me dies 
1 2 3 4 5 
I) I’m worried about 
the sadness 
brought to my 
family by my own 
death 
1 2 3 4 5 
J) Sometimes I 
imagine what it 
would be like at 
my own funeral 
1 2 3 4 5 
K) I’m distressed to 
think that 
someday I shall 
not exist 
1 2 3 4 5 
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Please answer to the following questions as asked. When options, circle the best 
option.  
Age:_____________________________  
Gender:  female male 
Year of graduation:__________________________ 
The amount of administrative work:_________hours/week 
 Main working place: out-patient unit hospital other, please specify:____ 
Marital status:__________________________________ 
Number of children:_____________________________ 
Have you done own advance directive:   yes no 
Have you had professional clinical supervision:  yes no 
Are in a chief-position in your main job:   yes no 
Do you have financial responsibility:   yes no 
Have you taken care of end-of-life (terminal) patients  
in practice during the last two years:   yes no 
Have you taken care of a family member or a close  
friend in end-of-life:     yes no 
Have you participated to post-graduate end-of-life  
training (only for physicians):    yes no 
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Finally same life values. Choose an option that best describes your own thinking. 
 
 not important 
at all 
not so 
important 
quite 
important 
very 
important 
Lenght of life 
 
1 2 3 4 
Health 1 2 3 4 
Family 1 2 3 4 
Clean environment 1 2 3 4 
Hight standart of 
living 
1 2 3 4 
Faith in God 1 2 3 4 
Success in 
professional career 
1 2 3 4 
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Does special education in palliative
medicine make a difference in end-of-life
decision-making?
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Abstract
Background: Characteristics of the physician influence the essential decision-making in end-of-life care. However,
the effect of special education in palliative medicine on different aspects of decision-making in end-of-life care
remains unknown. The aim of this study was to explore the decision-making in end-of-life care among physicians
with or without special competency in palliative medicine (cPM).
Methods: A questionnaire including an advanced lung cancer patient-scenario with multiple decision options in
end-of-life care situation was sent to 1327 Finnish physicians. Decisions to withdraw or withhold ten life-prolonging
interventions were asked on a scale from 1 (definitely would not) to 5 (definitely would) – first, without additional
information and then after the family’s request for aggressive treatment and the availability of an advance directive.
Values from chronological original scenario, family’s appeal and advance directive were clustered by trajectory
analysis.
Results: We received 699 (53%) responses. The mean values of the ten answers in the original scenario were 4.1 in
physicians with cPM, 3.4 in general practitioners, 3.4 in surgeons, 3.5 in internists and 3.8 in oncologists (p < 0.05 for
physicians with cPM vs. oncologists and p < 0.001 for physicians with cPM vs. others). Younger age and not being
an oncologist or not having cPM increased aggressive treatment decisions in multivariable logistic regression
analysis. The less aggressive approach of physicians with cPM differed between therapies, being most striking
concerning intravenous hydration, nasogastric tube and blood transfusions. The aggressive approach increased by
the family’s request (p < 0.001) and decreased by an advance directive (p < 0.001) in all physicians, regardless of
special education in palliative medicine.
Conclusion: Physicians with special education in palliative medicine make less aggressive decisions in end-of-life
care. The impact of specialty on decision-making varies among treatment options. Education in end-of-life care
decision-making should be mandatory for young physicians and those in specialty training.
Keywords: Decision-making, Terminal care, Education, Palliative medicine, Life support care
Background
Rapid developments in medicine have allowed many in-
terventions for patients with very advanced diseases. At
the same time, the difficulty of choosing worthwhile
therapies for each patient has led to the use of
non-beneficial treatments among dying patients at their
end-of-life (EOL) [1]. In contrast, well-timed palliative
care improves patients’ quality of life and symptom con-
trol and reduces invasive procedures and costs [2–8].
Appropriate decision-making is mandatory in
high-quality EOL-care to prevent non-beneficial treat-
ments and relieve suffering. The decisions include, but
are not limited to, statements on cardiopulmonary re-
suscitation, parenteral fluids, and diagnostic tests. This
decision-making is a challenging process involving many
ethical, legal, medical and psychological aspects [9–16].
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Physicians’ decisions vary concerning different interven-
tions. In a Scandinavian study, 57% of intensive care phy-
sicians would continue intravenous hydration, but only 5%
of them measured blood glucose during EOL-care [17].
Physicians also decide to withdraw therapies less fre-
quently than to withhold them, probably because they feel
withdrawal is more difficult and ethically problematic
[18–21].
In addition to medical facts and personal characteris-
tics, education and specialty of the physician influence
the complex decision-making in EOL [11]. Although
education in palliative care increases the knowledge and
skills needed to perform high-quality EOL-care [22–27],
the effectiveness of special training in palliative medicine
(PM) on different aspects of decision-making in
EOL-care remains unknown.
Most patients wish their closest ones to be involved in
EOL decision-making, and discussions with the family
are essential [28–30]. The families’ opinions are also
shown to influence physicians’ decisions [12, 31, 32], al-
though discordance between patients’ wishes, caregivers’
preferences and caregivers’ predictions of patients’ pref-
erences may exist [28, 33]. Advance directives reinforce
patients’ participation and help with decision-making
[31, 32, 34]. However, there are variations in how ad-
vance directives are understood and taken into account
[12, 35–37].
The aim of our study was to examine whether special
education in PM affects decision-making in EOL-care,
as evaluated by a hypothetical patient scenario with dif-
ferent alternatives. The impact of family requests, writ-
ten advance directives, and physicians’ background
factors on their decisions were analysed.
Methods
Participants
A postal survey with a questionnaire was provided to
1327 Finnish physicians in autumn 2015. The sample
consisted of 500 general health care practitioners (GPs),
300 surgeons, and 300 internists randomly selected from
the register of the Finnish Medical Association. The
sample size is similar to our previous studies done six-
teen years ago and is based on the distribution of differ-
ent specialities in Finland, which has remained largely
unchanged over the years studied [10–12, 38, 39]. In
addition, the questionnaire was send to all Finnish on-
cologists (n = 158) and all physicians with a special com-
petency in PM (n = 82), excluding those with a mailing
proscription (n = 23). Two reminders were send to
nonrespondents.
A cover letter including an introduction to the study
and an assurance of anonymity and voluntariness was
mailed together with the questionnaire. This study was
approved by the Regional Ethics Committee of Tampere
University Hospital, Finland (R15101).
Special competency in palliative medicine
In Finland, postgraduate training in PM leads to a certi-
fication for special competency in PM (cPM) awarded by
the Finnish Medical Association [40]. Finnish physicians
are allowed to start this postgraduate training after
working at least 2 years as a physician. This special
training consists of 150 h of theoretical education in dif-
ferent aspects of PM, 200 patient interactions in pallia-
tive care, 2 years of clinical practice including a working
period in a specialized palliative care unit for a mini-
mum of 3 months, and a final written examination.
Questionnaire
The questionnaire has been previously used and vali-
dated with Finnish physicians. A pilot study was done in
January 1999. The questionnaire was sent to 45 physi-
cians (health care practitioners and specialists) twice at
two-week intervals in order to test the reliability of the
responses to patient scenarios and the questions on atti-
tudes and values. Thirty physicians returned two accept-
able questionnaires. The value of kappa coefficient for
an acceptable scenarios or questions was determined to
be more than 0.40, which is a commonly accepted limit
for reliability. [10–12, 38]
The questionnaire includes seven hypothetical patient
scenarios together with questions concerning re-
sponders’ background, personal features, and attitudes.
In this study, we included one of the patient scenarios
designed to study doctors’ treatment decisions in the
EOL-care. In addition, questions about the responders’
own advance directives, experience in EOL-care among
relatives, treatment of EOL patients within 2 years, avail-
ability of professional supervision, chief position and fi-
nancial responsibility at work together with age and sex
were used as background factors. The parts of the ques-
tionnaire used in this study are available as an
Additional file 1.
Case scenario
The scenario presented a 62-year-old male patient with
pulmonary cancer and metastases. He was admitted to
hospital ward and received high-dose morphine medica-
tion. Due to respiratory weakening, he had become co-
matose the night before.
He also suffered from severe anaemia and had abun-
dant pleural effusion and fever.
After the presentation of the patient scenario, there
was a question about the treatment decision: Which of
the following treatments already started (*) or planned
would you withhold or withdraw? In the first situation,
there was no possibility of discussing the matter with
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the family and there was no advance directive. The deci-
sion responses were expressed on a scale from 1 (I defin-
itely would not) to 5 (I definitely would). The treatments
were a) antibiotics (*); b) mechanical ventilation (*); c)
blood transfusion; d) pleural drainage; e) chest x-ray
examination; f ) laboratory tests; g) intravenous hydration
(*); h) nasogastric tube (*); i) thrombosis prophylaxis (*);
and j) supplementary oxygen (*).
After the original patient scenario, two alternatives
with extra information were provided: 1) the patient’s
daughters come to you distressed and crying, express-
ing their hope that everything possible will be done
to save their father’s life; 2) there is a written advance
directive in the patient’s medical chart in which he
expresses his wish that all active treatment should be
withdrawn if there is no hope for recovery. After each
of these alternatives the same questions (with the
same treatment options as in the original scenario)
were asked. Questions were asked to be answered in
the given order and not to change answers once
decided.
Statistical analysis
Different responder groups were compared by t-test for
normally distributed continuous variables (Fig. 1) and by
chi-square or Fisher’s exact tests when appropriate for
categorical variables (Tables 2 and 3). The answers on
the 5-step Likert scale in the scenarios were converted
to a 2-step scale: 1–3, “would not withdraw or withhold
and don’t know” and 4–5, “would withdraw or with-
hold”. Measured mean distributions of the chronological
original scenario, family’s appeal and advance directive
values were clustered by trajectory analysis [41]. The tra-
jectories were created according to the measurements of
mean values in each responder as a continuous outcome
measure. The analyses undertaken were latent class mix-
ture models of quadratic trajectories including a random
intercept and concomitant variables. Models were fitted
Fig. 1 Mean values of all ten answers concerning willingness to withhold or withdraw therapies (scale from 1 = definitely would not to 5 = definitely
would) in the patient case according to different scenarios and physician groups
Piili et al. BMC Palliative Care  (2018) 17:94 Page 3 of 11
by using the flexmix package [42] of the statistical pro-
gram R, version 3.3.0, from the R Foundation for Statis-
tical Computing (R Development Core Team. R: A
language and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria,
2008, ISBN 3–900,051–07-0, URL). Relative goodness of
fit was assessed using Bayesian information Criteria.
Factors (Table 4) affecting the willingness to continue
or start therapies (belonging to trajectory groups 3 or 4)
compared to withhold or withdraw therapies (belonging
to trajectory groups 1 or 2) were examined by univariate
and age-adjusted logistic regression models results
shown by odds ratios (OR) with 95% confidence inter-
vals (CI). Additionally, a multivariable model, where var-
iables were added simultaneously into the model, was
performed for variables with statistical significance
under 0.20 in age-adjusted model. Two-sided p-values of
less than 0.05 were accepted as statistically significant.
Data-analyses were performed using IBM SPSS Statistics
for Windows, Version 23.0. Armonk, NY: IBM Corp. Re-
leased 2014.
Results
Responders
Altogether, 699 valid responses were achieved (re-
sponse rate 53%). The response rate ranged from 82%
among physicians with cPM to 47% among surgeons.
Characteristics of the responders are presented in
Table 1. A majority of the responders were women,
except in the group of surgeons. The median age of
the responders was 52 years (interquartile range 43–
58), with slight variations between the groups. Most
of the GPs worked at out-patient clinics (85%), while
the others mainly worked at hospitals (66–87%).
Overall willingness to withhold or withdraw therapies
The mean values of all ten answers according to the
three alternatives in the case scenario are shown in
Fig. 1. Physicians with cPM were most willing to
withhold and withdraw interventions, especially com-
pared to GPs, internists and surgeons. The family’s
appeal significantly increased the willingness to start
or continue life-prolonging therapies in all physician
groups, whereas the advance directive decreased it
(p < 0.001 compared to the original scenario).
Decisions concerning individual treatments
Physicians with cPM were more willing to withdraw
and withhold most of the individual interventions,
compared to the others (Tables 2 and 3). This differ-
ence in decision-making was most striking in with-
drawing intravenous hydration, removing nasogastric
tube and withholding blood transfusions. In contrast,
some decisions (e.g., withdrawing oxygen or antibi-
otics) varied only slightly between the physicians
with cPM and others. Mechanical ventilation was
withdrawn by most of the physicians, while supple-
mentary oxygen was frequently continued by all
responders.
The daughters’ request for “everything to be done”
(the family’s appeal) increased the willingness to con-
tinue or start each life-prolonging treatment, with the
only exception the use of oxygen among cPMs. The
daughters’ request had the largest influence on the
decisions concerning intravenous hydration and diag-
nostic tests (Table 2).
The availability of the advance directive markedly
moved decisions towards withdrawing and withhold-
ing treatments. Although the differences between re-
sponder groups diminished, the physicians with cPM
and the oncologists still had the least aggressive ap-
proach. Nearly all physicians withdrew mechanical
ventilation, discontinued thrombosis prophylaxis and
withheld blood transfusion. However, over one third
of the physicians without cPM continued intravenous
hydration, and supplementary oxygen was frequently
continued by all physicians.
Table 1 Characteristics of the participants
Competency in PM Surgeons Internists GPs Oncologists Total
Number (% of total) 67 (10) 142 (20) 153 (22) 245 (35) 92 (13) 699 (100)
Response rate, % 82 47 51 49 63 53
Female, n (%) 57 (85) 47 (33) 81 (53) 173 (71) 73 (79) 431 (62)
Median age (IQR) 55 (49–58) 52 (44–59) 53 (46–59) 49 (38–57) 49 (41–56) 52 (43–58)
Age distribution, n (%)
< 35 0 (0) 4 (3) 4 (3) 42 (17) 2 (2) 52 (7)
35–49 20 (30) 52 (37) 51 (33) 84 (34) 46 (50) 253 (36)
> 49 47 (70) 86 (61) 98 (64) 119 (49) 44 (48) 394 (56)
Years from graduation, median (IQR)a 27 (21–32) 26 (17–34) 26 (20–32) 21 (9–31) 22 (14–29) 25 (15–32)
PM, Palliative Medicine, GP, General Practitioner, IQR, Interquartile Range
aFor nine participants year of graduation was not available
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Trajectory analysis and factors associated with aggressive
treatment decisions
When answers were fitted with a trajectory analysis, four
differently behaving groups were found (Fig. 2). In the tra-
jectory group 1, responders were consistently willing to
withdraw and withhold therapies, and in the trajectory
group 2, physicians would probably withdraw and withhold
therapies, but their decisions were influenced by the family’s
appeal and the advance directive. In contrast, responders
encompassed in the trajectory group 3 were either uncer-
tain or chose an aggressive approach in about half of their
decisions, and they were more influenced by the advance
directive, while physicians in the trajectory group 4 were
most hesitant to withdraw and withhold therapies.
Table 2 Number and proportion (%) of physicians deciding to withdraw a treatment in the patient scenario according to physician
groups
Treatment Scenario Competency in PM Surgeons Internist GPs Oncologists P-valuea
Antibiotic Original scenario 41 (65) 72 (51) 78 (51) 128 (53) 45 (54) 0.399
Family’s appeal 33 (50) 55 (39) 55 (36) 89 (37)* 34 (37) 0.353
Advance directive 58 (87) 116 (83) 122 (82) 204 (84) 82 (89) 0.641
Mechanical ventilation Original scenario 63 (96) 119 (85)* 135 (89) 195 (81)* 83 (91) 0.008
Family’s appeal 59 (92) 113 (80)* 126 (83) 175 (72)* 76 (84) 0.002
Advance directive 67 (100) 130 (92)* 147 (98) 228 (94)* 90 (99) 0.011
Intravenous hydration Original scenario 43 (65) 31 (22)** 39 (26)** 85 (35)** 42 (46)* < 0.001
Family’s appeal 26 (40) 21 (15)** 19 (13)** 58 (24)* 34 (37) < 0.001
Advance directive 58 (88) 64 (46)** 84 (56)** 162 (67)* 75 (82) < 0.001
Nasogastric tube Original scenario 62 (95) 85 (60)** 98 (65)** 161 (67)** 63 (69)** < 0.001
Family’s appeal 60 (92) 76 (54)** 87 (58)** 126 (53)** 64 (70)* < 0.001
Advance directive 64 (97) 105 (75)** 126 (84)* 203 (84)* 82 (89) 0.001
Thrombos prophylaxis Original scenario 55 (85) 108 (76) 105 (69)* 151 (62)* 73 (80) < 0.001
Family’s appeal 52 (80) 104 (74) 95 (64)* 128 (53)** 67 (73) < 0.001
Advance directive 63 (96) 121 (88) 127 (85)* 199 (82)* 86 (94) 0.013
Supplementary oxygen Original scenario 11 (16) 16 (11) 23 (15) 14 (6)* 11 (12) 0.019
Family’s appeal 12 (18) 14 (10) 13 (9)* 12 (5) 6 (7)* 0.011
Advance directive 20 (30) 40 (28) 46 (31) 51 (21) 27 (29) 0.189
PM, Palliative Medicine, GP, General Practitioner
aGlobal p-value across all physician groups
*p < 0.05 and **p < 0.001 pair-wise comparison to physicians with special competency in PM
Table 3 Number and proportion (%) of physicians deciding to withhold an intervention in the patient scenario according to
physician groups
Treatment Scenario Competency in PM Surgeons Internists GPs Oncologists P-valuea
Blood transfusion Original scenario 60 (91) 98 (70)* 108 (72)* 185 (76)* 72 (78)* 0.011
Family’s appeal 55 (85) 90 (64)* 85 (56)** 153 (64)* 67 (76) < 0.001
Advance directive 66 (99) 132 (94) 136 (91) 227 (94) 90 (98) 0.134
Pleural drainage Original scenario 43 (65) 59 (42)* 85 (56) 99 (41)** 58 (64) < 0.001
Family’s appeal 41 (63) 57 (40)* 73 (49) 89 (37)** 51 (56) < 0.001
Advance directive 53 (79) 103 (73) 119 (80) 179 (74) 82 (89) 0.030
Chest X-ray Original scenario 51 (77) 66 (47)** 88 (58)* 119 (60)** 67 (73) < 0.001
Family’s appeal 44 (67) 61 (43)* 74 (49)* 29 (38)** 59 (65) < 0.001
Advance directive 59 (88) 111 (79) 124 (83) 194 (81) 90 (98)* 0.001
Laboratory tests Original scenario 49 (74) 70 (59)* 87 (57)* 121 (50)* 59 (64) 0.002
Family’s appeal 40 (61) 60 (43)* 67 (45)* 85 (35)** 51 (56) < 0.001
Advance directive 58 (87) 115 (81) 119 (78) 190 (78) 88 (96)* 0.006
PM, Palliative Medicine, GP, General Practitioner
aGlobal p-value across all physician groups
*p < 0.05 and **p < 0.001 pair-wise comparison to physicians with special competency in PM
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Factors associated with the physicians’ willingness to
continue or start life-prolonging therapies during
EOL-care (belonging to trajectory groups 3 or 4) com-
pared to withhold or withdraw therapies (belonging to
trajectory groups 1 or 2) are shown in Table 4. By multi-
variable analysis, younger age and being an internist,
surgeon or GP were independent factors behind the de-
cisions not to withhold - or to withdraw – different in-
terventions. In contrast, gender, being in chief-position,
having financial responsibility, or a physician’s own ad-
vance directive and experience in EOL-care among rela-
tives did not have independent influence.
Discussion
We found that physicians with cPM were more willing to
withdraw and withhold life-prolonging therapies, espe-
cially intravenous hydration and a nasogastric tube, in a
patient scenario representing EOL-care. The family’s re-
quest increased the aggressive approach in all physicians,
whereas the availability of an advance directive decreased
this. Younger age and being an internist, surgeon or GP
without cPM were independent factors for responses
reflecting willingness to start or continue life-prolonging
treatments in multivariable regression analysis.
In this study, the overall willingness to withhold and
withdraw therapies in EOL-care was higher in physicians
with cPM, measured by mean values of all the answers
and in a multivariable regression analysis, although oncol-
ogists and cPMs differed only slightly. We used trajectory
analysis to take into account all the scenarios in the given
order and found a similar pattern across all four groups.
Therefore, the groups starting from a low willingness to
withhold or withdraw therapies in the original scenario
were finally chosen to be presented in the multivariable
analysis. In light of previous studies [43–45], it is under-
standable that physicians with formal training in PM have
good ability to consider and communicate the EOL deci-
sions, probably leading to more decisions to withdraw and
Fig. 2 Distribution of the responses (scale from 1 = definitely would not to 5 = definitely would) in the original scenario, family’s appeal and
advance directive in the trajectory analysis
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withhold treatments. We suggest that this willingness is
related to the cPM itself as its influence remained also
after multivariate analysis taking into account some im-
portant background factors in our study. We have to state,
however, that we don’t know all the attitudes, which might
drive physicians to special education in PM and whether
these factors also predispose to withholding and with-
drawing life-sustaining treatments.
As our case represented a cancer patient, it is not sur-
prising that responses among physicians with cPM and
oncologists were quite similar, although there were dif-
ferences concerning individual interventions. The rela-
tive unwillingness of GPs to make decisions for a
palliative approach is a bit concerning, since a vast ma-
jority of dying patients in Finland are cared for by GPs.
This result was independent of the GPs’ younger age.
Our results highlight the need for education in PM start-
ing from medical school and continuing throughout spe-
cialty training. In addition, palliative care consultations
have shown to be beneficial and they should be offered
to all specialities to help complex decision-making in
EOL-care [6, 46–48].
Younger age was associated with unwillingness to
withhold and withdraw therapies in our study. Age
seems to be a contradictory factor in decision-making
[49]. In some studies, including our own, older age has
been associated with more decisions to withhold or
withdraw interventions [50, 51], while in others, younger
physicians or trainees make less aggressive decisions
[52–54]. Younger physicians have less experience in
Table 4 Factors associated with the willingness to continue or start life prolonging therapies (belonging to trajectories 3 or
4) compared to withhold or withdraw therapies (belonging to trajectories 1 or 2) in the patient scenario presented by
univariate, age-adjusted and multivariable analysis
Univariate Age-adjusted Multivariate
n OR (95% CI) p OR (95% CI) p OR (95% CI) p
Age continuous, years 692 0.96 (0.95–0.98) < 0.001
Age < 0.001 0.002
25–35 52 4.71 (2.35–9.44) 3.19 (1.54–6.57)
35–49 253 1.49 (1.08–2.05) 1.46 (1.03–2.06)
50–67 387 1.00 1.00
Sex 0.796 0.433
Female 425 1.04 (0.77–1.41) 0.88 (0.64–1.21)
Male 267 1.00 1.00
Chief-position 0.013 0.208
No 480 1.51 (1.09–2.11) 1.25 (0.88–1.76)
Yes 205 1.00 1.00
Financial responsibility 0.006 0.083 0.183
No 562 1.75 (1.17–2.62) 1.44 (0.95–2.19) 1.35 (0.87–2.08)
Yes 120 1.00 1.00 1.00
Own advance directive 0.604 0.932
No 638 1.17 (0.65–2.09) 1.03 (0.57–1.86)
Yes 49 1.00 1.00
End-of-life care among relatives 0.066 0.322
No 336 1.32 (0.98–1.79) 1.17 (0.86–1.59)
Yes 352 1.00 1.00
Physician group < 0.001 < 0.001 < 0.001
Competency in PM 66 1.00 1.00 1.00
Oncologists 92 1.63 (0.78–3.40) 1.39 (0.66–2.93) 1.61 (0.75–3.46)
Internists 150 3.92 (2.00–7.67) 3.85 (1.96–7.57) 4.27 (2.13–8.56)
Surgeons 142 4.53 (2.30–8.90) 4.37 (2.21–8.64) 4.51 (2.25–9.07)
GPs 242 6.27 (3.29–12.0) 5.34 (2.78–10.3) 5.60 (2.85–11.0)
Significant results (p < 0.05) bolded and nearly significant (p < 0.10) shown by italic font
Age-adjusted significant (p < 0.05) or nearly significant (p < 0.10) variables included into the multivariate model. Missing values were not analyzed
PM, Palliative Medicine, GP, General Practitioner
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EOL-care, but on the other hand, PM is currently in-
cluded in the curriculum of many medical schools, in-
creasing younger colleagues’ awareness of the benefits of
palliative care. After 1999 two out of the five medical
schools in Finland has included an undergraduate cur-
riculum in PM fulfilling the European recommendations
[55, 56]. Our results are in line with other studies show-
ing that gender does not influence the decision-making
[51, 54]. Some of the other background factors (such as
experience in EOL-care with loved ones or a physician’s
own advance directive) did not influence the
decision-making in our study, but are not included in
previous studies.
Our results imply, that decisions to withhold or with-
draw therapies in a clinical practise is mainly driven by
medical education and clinical experience of a physician
and preferences of a patient rather than doctor’s personal
life experience or attitudes.
Advance directive and a healthcare proxy or the family’s
opinion have been shown to have marked influence on
physicians’ decision-making [12, 31, 35, 57, 58], but there
are no earlier studies about this for palliative care physi-
cians. Our study is in line with previous ones [31, 32],
since the family’s request for aggressive treatments signifi-
cantly increased physicians’ willingness to continue or
start life-prolonging therapies, and advance directive de-
creased this. This finding was constant through different
physician groups including physicians with cPM. Commu-
nication and shared decision-making are very important
in EOL-care [20, 49–54, 57, 58], but futile therapies
should not be used (even if families have requested them),
as stated by the Finnish National Supervisory Authority
for Welfare and Health [59]. Therefore, this clear influ-
ence of family requests on decision-making is controver-
sial and perhaps an issue needing more attention in the
education of PM, which should also introduce legal as-
pects and official recommendations on decision-making.
Knowing a patient’s own will helps in decision-making
[31, 32], and an advance directive naturally moves the de-
cisions towards a palliative approach. However, the con-
tent of an advance directive presented here did not
describe the patient’s will in detail, which is often the case
in the real world as well. The understanding of “active
treatments” probably influenced the decisions concerning
individual therapies in the present study and calls for
more detailed advanced care planning and advance direc-
tives in clinical practice.
The differences in decision-making between physicians
with cPM and others were most striking for nasogastric
tube and intravenous hydration. Surgeons, internists and
to a lesser extent GPs were unwilling to withdraw hydra-
tion, even when an advance directive was found. Artificial
nutrition or medically assisted hydration has not been
shown to improve survival, quality of life or symptoms in
EOL-care, although the evidence about this is scarce [60–
64]. There are studies, however, raising concerns about
the potential harms, such as increased respiratory secre-
tions, related to hydration during EOL [65]. Although the
use of artificial nutrition or intravenous hydration in
EOL-care remains controversial, the case scenario in our
study represented a dying patient in which these therapies
can be considered non-beneficial. The pros and cons of
these therapies are included in the formal training in PM,
but are probably quite unfamiliar to other physicians.
Supplementary oxygen was the least withdrawn treat-
ment in our study, even among physicians with cPM. This
result is in line with reports showing that oxygen is used
in more than 70% of patients in EOL-care [66, 67], al-
though the evidence to support this is lacking [68–70].
Perhaps this unwillingness to withdraw oxygen is related
to the presumption of its benefit and harmlessness, al-
though it may cause dryness of the mouth and aggravate
communication.
In our study antibiotics were withdrawn by about half of
the physicians. Use of antibiotics in EOL is controversial,
but there is some evidence that antibiotics might relieve
symptoms without serious side-effects, which might ex-
plain the unwillingness to withdraw them [71, 72]. Inter-
nists and GPs were more unwilling to withdraw
thrombosis prophylaxis compared to others, probably due
to their familiarity with the indications of anticoagulation
in the general population. There are no controlled studies
to guide when to stop anticoagulation in palliative care,
but as our case represented a dying person, withdrawing it
can be considered reasonable [73].
The benefits of transfusions in palliative care are expe-
rienced briefly and remain controversial [74]. In our
study, the physicians with cPM withheld blood transfu-
sions more frequently than others, although the avail-
ability of an advance directive increased the willingness
to over 90% in all groups.
Pleural drainage can alleviate dyspnoea, but this is an in-
vasive procedure including some risks in EOL-care [75].
Surgeons and GPs were most eager to perform this pro-
cedure, which probably reflects their willingness to per-
form chest X-rays as well. In a Scandinavian study,
intensive care physicians withheld laboratory tests [17]
more often than all the physicians in our study, which is
somewhat surprising. Changing from cure to care might
be more complex in a common hospital ward compared
to an intensive care unit (ICU), where withdrawing
life-supporting treatments commonly leads to relatively
rapid patient death.
Limitations
Some limitations of this study need to be acknowledged.
Our response rate (53%) is higher than in many of the
recent surveys [31, 37, 76], but still sets a limitation.
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Although there might be some nonresponse bias, our
responders can be considered a representative sample of
Finnish physicians providing insight into their
decision-making. The distribution of physician groups in
the study equals the distribution of different specialities in
Finland [39]. Similarly, the high proportion of female re-
spondents in our study is understandable, since 60% of
physicians in Finland are women and female dominance is
true among all the specialities studied excluding surgeons
[39]. Answers to hypothetical scenarios might differ from
physicians’ decision -making in real life situations. In
addition, the scenario forced the responder to give simple
“yes” or “no” answer without the possibility for example to
discuss with the family to achieve shared decision. Further
studies on physicians’ decision-making in clinical practice
are needed, although this might be difficult to study in
large physician groups, as each clinical circumstance is
very different. We suggest, however, that the factors be-
hind decision-making remain similar in real life situations
and in our hypothetical scenarios. Finally, most of the
treatments in our case clearly intend to prolong life (e.g.,
mechanical ventilation), while some of them may be partly
considered as supporting ones (e.g., pleural drainage).
Similarly, oxygen or transfusions may be given for symp-
tom relief only or to prolong life, which should be
distinguished.
Therefore, “palliative” or “life-prolonging” intent may be
questioned in some decisions, but we suggest that the
overall tendency to withdraw or withhold therapies in our
study reflects reasonable decision-making in EOL-care.
The intention itself behind these decisions is an interest-
ing subject for future studies.
Conclusions
Physicians with special education in palliative medicine
are more willing to withdraw and withhold life-prolonging
therapies in EOL-care. This is especially true concerning
decisions on hydration, artificial nutrition and transfu-
sions. Families’ request and advance directives have a sig-
nificant influence on decision-making in all physicians.
Younger age and specialty of a physician are main
factors influencing the willingness to start or continue
life-prolonging treatments. Therefore, education about
decision-making in EOL-care should be mandatory at
medical schools and in the training of all the special-
ities facing dying patients. Palliative care consultations
might be needed for complex cases of decision -mak-
ing in EOL-care.
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Abstract
Background: The ethics of hastened death are complex. Studies on physicians’ opinions about assisted dying
(euthanasia or assisted suicide) exist, but changes in physicians’ attitudes towards hastened death in clinical
decision-making and the background factors explaining this remain unclear.
The aim of this study was to explore the changes in these attitudes among Finnish physicians.
Methods: A questionnaire including hypothetical patient scenarios was sent to 1182 and 1258 Finnish physicians in
1999 and 2015, respectively. Two scenarios of patients with advanced cancer were presented: one requesting an
increase in his morphine dose to a potentially lethal level and another suffering a cardiac arrest. Physicians’ attitudes
towards assisted death, life values and other background factors were queried as well. The response rate was 56%.
Results: The morphine dose was increased by 25% and 34% of the physicians in 1999 and 2015, respectively (p < 0.
001). Oncologists approved the increase most infrequently without a significant change between the study years (15% vs.
17%, p = 0.689). Oncological specialty, faith in God, female gender and younger age were independent factors associated
with the reluctance to increase the morphine dose. Euthanasia, but not assisted suicide, was considered less
reprehensible in 2015 (p = 0.008). In both years, most physicians (84%) withheld cardiopulmonary resuscitation.
Conclusion: Finnish physicians accepted the risk of hastening death more often in 2015 than in 1999. The physicians’
specialty and many other background factors influenced this acceptance. They also regarded euthanasia as
less reprehensible now than they did 16 years ago.
Keywords: Clinical ethics, Decision-making, End-of-life care, Euthanasia
Background
Discussions about the ethical justification of hastened
death due to unbearable suffering are ongoing. Assisted
death through euthanasia or physician-assisted suicide
(PAS) has been legalized in seven countries (five states
in the United States of America) thus far [1]. In addition,
public support for euthanasia and PAS is mounting all
over Western Europe, while some decline has been ob-
served in the United States of America and Eastern Europe
[1, 2]. Today, there are debates about the legalization of
euthanasia in many countries, including Finland, where the
government is currently considering options after a civil
motion demanding the legalization of euthanasia. At
the same time, the importance of palliative care and
patient-centred decision- making has been increasingly
recognized among health care professionals and the gen-
eral public in European countries including Finland [3–9].
Palliative care, by definition, intends to neither hasten
nor postpone death [10]. The International Association for
Hospice and Palliative Care and the European Association
for Palliative Care have recently stated that euthanasia and
PAS should not be included as part of the clinical practice
of palliative care [11, 12]. Attitudes among physicians
towards assisted death are not widely studied, but sev-
eral surveys do demonstrate a lower amount of support
from physicians for euthanasia and PAS when com-
pared to support from the general public [1].
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Questions about hastening death in end-of-life care
are complex and may include ethical concerns broader
than just euthanasia or PAS. Although clear definitions
have been specified for euthanasia and PAS [12], which
lead to a clearly assisted death, the term “hastened death”
is unspecified and has many interpretations. The termin-
ation of life-sustaining treatments may be confused with
euthanasia and PAS among the public and physicians [13].
The term “double effect” has been used when the act
intended to do good (e.g., relief of suffering) justifies the
foreseeable danger of harm (e.g., hastened death) [14].
The use and dosing of opioids during end-of-life care is a
commonly used example when talking about the double
effect: does the intent to treat pain or breathlessness out-
weigh the risk of potentially hastening death [15, 16]?
However, there is growing evidence that even though
high doses of opioids may cause respiratory depression
[17–19], they do not seem to hasten death during
end-of-life care [20, 21]. In a large multinational study
by Miccinesi et al., there was general approval for alle-
viating symptoms with a possibly life-shortening treat-
ment [22]. In another study from the United Kingdom
(UK), physicians reported that they had at least some
intention to hasten death in 7.4% of the deaths evalu-
ated [23]. Physicians’ attitudes towards hastened death
through a dual effect and the background factors influ-
encing these decisions remain largely unknown.
The aims of our study were to elucidate how, if at all,
the attitudes and values towards assisted death among
Finnish physicians have changed over the past 16 years
and to determine the attitudes and background factors
affecting physicians’ willingness to accept hastened death
in a hypothetical patient scenario.
Methods
Participants
A postal survey was conducted in spring 1999 and in
autumn 2015. In both years, the questionnaire was sent
to 500 general practitioners (GPs), 300 surgeons, and
300 internists randomly selected from the register of
the Finnish Medical Association and to all Finnish oncolo-
gists (n = 82 in 1999 and n = 158 in 2015). Reminders were
sent twice to non-respondents. A cover letter including an
introduction to the study and an assurance of anonymity
was mailed together with the questionnaire. It was also
stated in the cover letter, that answering to the question-
naire was completely voluntary. This study was approved
by the Regional Ethics Committee of Tampere University
Hospital, Finland (R15101).
Questionnaire
The questionnaire included seven hypothetical patient
scenarios. Following the patient scenarios, attitudes re-
garding several moral and ethical aspects were assessed
with a 100-mm visual analogue scale (VAS) from “definitely
agree” (0 mm) to “definitely disagree” (100 mm). These
included, for example, statements concerning euthanasia,
palliative care, the role of religion in ethical decisions, ad-
vanced care directives and health care economics together
with physicians’ satisfaction with their own health, work
and salary (Tables 2 and 3). Physicians’ personal concep-
tions of professional status and their own health, family life,
religion, and nature and standard of living were assessed
using a four-point Likert scale (Table 2). The questionnaire
has been previously used and validated with Finnish physi-
cians [24–26].
Patient scenarios
In this study, we included two patient scenarios:
In scenario 1, a 60-year-old male patient is suffering
from prostatic cancer with metastases. Metastases in
the thoracic spine led to total paraparesis 1 month
earlier. There is no hope for a cure. The patient is
well aware of the situation. He has totally lost his
will to live. When you are together with him alone,
he asks for a sufficient dose of morphine to “get
away”. You have denied the overdose, explaining that
it is against your ethical principles. During the fol-
lowing days, you notice that the patient asks you to
double his morphine dose because of unbearable
pain. The anti-inflammatory pain medication is at its
maximum dose and you suspect if the pain is real
(this sentence was removed from the scenario in
2015 as it did not comply with current treatment
guidelines for cancer pain). You suppose that in-
creasing the dose in such a way would lead to the
patient’s death. Your decision is which of the follow-
ing: a) to raise the dose because the patient has the
right to sufficient pain relief in this end-of-life (ter-
minal) care situation; b) to try to help the patient in
other ways, such as with antidepressants, thus con-
tinuing with morphine dosing according to given
guidelines; c) I can’t say; or d) give another
solution:_______________________.
In scenario 2, a 32-year-old female patient is brought
by ambulance to the emergency unit. She is accompanied
by her husband who says his wife has inoperable brain
cancer. She has been receiving maximum radiotherapy,
but this was discontinued 3 weeks ago. She has deterio-
rated considerably during the past week. The patient has
now had an epileptic seizure and has been unconscious
since the attack. After 20 min at the hospital the patient
stops breathing, and there is no pulse. Your treatment
decision is which of the following: a) to start cardiopul-
monary resuscitation (CPR) or b) to withhold CPR.
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Statistical analysis
The answers concerning the doubling of the morphine dose
in scenario 1 were converted to two options: “I accept” (re-
sponse a) and “I do not accept” (other solutions). The an-
swers on the 4- point Likert scale concerning values were
converted to the following 2-point scale: 1–2 for “not
important” and 3–4 for “important”.
Two-scale background factors and values were tested
using the Pearson chi-square test.
Continuous variables were tested using an indepen-
dent-variables t-test or the Mann-Whitney U- test if the data
were not normally distributed. Two-sided p-values less than
0.05 were considered as statistically significant.
Logistic regression analysis
A forward stepwise logistic regression was used to create
a model explaining the decision to increase the morphine
dose. Background factors, life values, and attitudes, shown
in Table 2, were all included in the model. The p-value
limit for significance was set at 0.10 to enter and 0.15 to
remove from the model.
Data analyses were performed using IBM SPSS Statis-
tics for Windows, Version 23.0 (Armonk, NY: IBM Corp.
Released 2014).
Results
In total, 1373 valid responses were received (response
rate 56%). Characteristics of the physicians according
to the year of response are shown in Table 1. Com-
pared to respondents in 1999, respondents in 2015
were older (p < 0.001), had longer working experience
(p < 0.001) and were more often women (p < 0.001).
Change in attitudes
The attitudes, personal factors and life values of the
responding physicians in 1999 and 2015 are shown
in Table 2.
Euthanasia and withdrawal of life-sustaining treatments
were considered slightly less reprehensible in 2015 than in
1999, whereas attitudes towards assisted suicide did not
change significantly. In 2015, physicians more often be-
lieved that good palliative care enables a good death and
found end-of-life care satisfying, although they were less
often actually involved in end-of-life care than the respon-
dents in 1999. Advance directives were considered more
helpful in 2015, although physicians still rarely had their
own advance directives. The impact of physicians’ back-
ground factors, faith in God, and religion on ethical deci-
sions decreased between 1999 and 2015. The length of
life, family, and cleanliness of environment were thought
to be more important in 2015, while success in their pro-
fessional career was less important.
Change in decision-making
In the case in scenario 1, physicians were significantly
more willing to increase the morphine dose in 2015
(n = 219, 34%) than in 1999 (n = 180, 25%) (p < 0.001).
This willingness increased in all groups of physicians,
except among oncologists, who were also the most
unwilling to do this in both years (Fig. 1). In contrast,
84% of the physicians decided to withhold CPR in case sce-
nario 2 in both years. There were no significant changes
regarding this decision about CPR among the different
physician groups between the study years.
Factors associated with physicians’ willingness to increase
the morphine dose
Difference in the attitudes of physicians who accepted
and those who did not accept the doubling of the mor-
phine dose in both years studied are shown in Table 3.
In 1999, leniency towards euthanasia and assisted sui-
cide was significantly greater in those who accepted the
dose increase, while this was true only for assisted suicide
in 2015.
Religion had a significantly larger influence on
decision-making in physicians who accepted the mor-
phine dose increase in 1999 but not in 2015.
Factors and attitudes that independently influenced
physicians’ willingness to increase the morphine dose
from the logistic regression analysis are shown in Table 4.
Not being an oncologist was the most striking factor
associated with physicians’ willingness to increase the
morphine dose. In addition, physicians who were male,
were older, did not believe in God, accepted assisted sui-
cide, had doubts about physicians’ ability to assess cancer
pain, and responded in 2015 were also more likely to be
willing to increase the morphine dose. However, physicians’
decisions about CPR for the patient in scenario 2 and
their attitudes towards euthanasia or withdrawal of
life-sustaining treatments did not influence their deci-
sion to accept the escalation of the morphine dose.
Discussion
Our study shows that some Finnish physicians’ attitudes
and life values have changed substantially during the last
16 years. Their approval of euthanasia has slightly in-
creased, whereas their acceptance of physician-assisted
suicide (PAS) has remained low. In an end-of-life patient
case scenario, physicians show an increasing willingness
to give a high morphine dose, which might potentially
hasten death. In logistic regression analysis, not being an
oncologist, being male, and not believing in God were
the most important background factors associated with
physicians’ willingness to increase the morphine dose.
In our study Finnish physicians were less opposed to
euthanasia now than they were 16 years ago. This find-
ing is in agreement with previous studies showing
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increased acceptance of euthanasia in Europe as well as
in Finland [1, 2]. However, attitudes towards euthanasia
were measured with a continuous visual analogue scale
(VAS) on a scale from 0 mm (reprehensible) to 100 mm
(not reprehensible) in our study rather than with a di-
chotomous question (i.e., if the physician accepts or does
not accept euthanasia).
Although using a VAS scale might have caused some
confusion, doctors are generally familiar with its use.
This type of assessment might provide more appropriate
insight into this complex ethical question. Of note, the
VAS median value in 2015 was still only 25 mm and the
absolute difference compared to the value in 1999 was
8 mm. Thus, our results highlight the controversial atti-
tude towards euthanasia, which might not be found in
earlier studies; for example, a previous study showed
that 46% of Finnish physicians supported legalization of
euthanasia [2].
In contrast to other studies [1], Finnish physicians
considered PAS even more reprehensible than euthan-
asia and this has not changed at all during the past 16
years. Determining whether this somewhat conflicting
result is due to a true difference in the attitudes towards
these two procedures or just less knowledge about the
process of PAS in Finland could be an aim of future
research.
Table 2 Attitudes, background factors and life values of the physicians in 1999 and 2015
1999 2015 P-values*
Attitudes, median VAS (IQR)
Active euthanasia is reprehensible 17 (6–51) 25 (5–66) 0.008
Withdrawal of life-sustaining treatments is reprehensible 89 (76–95) 93 (76–99) < 0.001
Assisted suicide is reprehensible 14 (5–38) 13 (2–52) 0.480
End-of-life care is satisfying 36 (19–52) 15 (3–35) < 0.001
People should pay costs of factitious diseases by themselves 44 (27–72) 78 (46–93) < 0.001
Advance directives have been helpful in my decisions 35 (14–54) 10 (2–29) < 0.001
Good palliative care enables good death 17 (9–28) 4 (1–12) < 0.001
Physicians can’t estimate cancer pain 40 (25–70) 47 (27–72) 0.042
Religion has influence when I make ethical decisions 65 (31–93) 81 (47–98) < 0.001
Being a doctor gives me satisfaction 20 (11–30) 7 (2–18) < 0.001
My health is excellent 20 (10–32) 14 (6–26) < 0.001
I feel burn out, tired to work 84 (63–94) 89 (71–97) < 0.001
I’m pleased with my salary 72 (37–87) 22 (7–50) < 0.001
It is waste of resources to treat patients > 80 years in ICU 73 (49–86) 77 (54–93) < 0.001
Background factors and life values, n (%)
Having children 600 (85) 555 (88) 0.057
Having own advance directive 38 (5) 38 (6) 0.668
Taking care of end-of-life patients in practice (last 2 years) 529 (75) 418 (65) < 0.001
Taking care of a family member in end-of-life 513 (73) 314 (49) < 0.001
Being afraid of death (Fear-of-death index) 580 (80) 544 (86) 0.006
Length of life is important 412 (59) 524 (87) < 0.001
Health is important 711 (99) 610 (99) 0.027
Family is important 686 (95) 607 (99) < 0.001
Clean environment is important 666 (93) 599 (98) < 0.001
High standard of living is important 358 (50) 398 (65) < 0.001
Faith in God is important 338 (48) 253 (42) 0.024
Success in professional career is important 639 (89) 377 (62) < 0.001
VAS visual analogue scale
IQR interquartile range
ICU intensive care unit
*Mann-Whitney u-test for attitudes and Pearson Chi-Square for background factors and life values
Attitudes are expressed on a visual analogue scale (VAS) from 0 mm (definitely agree) to 100 mm (definitely disagree)
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We asked if euthanasia or assisted suicide were repre-
hensible or not with a VAS scale to evaluate the personal
ethical attitudes of the physicians rather than their opin-
ions on the general justification of these issues. Therefore,
our results represent somewhat different aspect of these
issues compared to the findings of studies that inquired
about physicians’ opinions on the legalization of euthan-
asia or PAS. This might partly explain the differences in
the results of the present and previous studies [1, 2].
According to this study, Finnish physicians do not
consider withdrawal of life-supporting treatments repre-
hensible. Although there was a statistically significant
change between the study years, the absolute difference
was only 4 mm. Our results are in line with the results
from a large, international study by Löfmark et al. where
72–86% of the physicians surveyed reported experien-
cing foregoing life-supporting treatment and only 1–6%
reported never being willing to do so [27].
Table 3 Attitudes of physicians who were willing or unwilling to increase the morphine dose in 1999 and 2015
1999
Increasing the morphine dose
2015
Increasing the morphine dose
Attitudes, median VAS (IQR) Yes No P-value* Yes No P-value*
Active euthanasia is reprehensible 37 (11–69) 14 (5–39) < 0.001 33 (5–72) 24 (4–64) 0.162
Withdrawal of life-sustaining treatments is reprehensible 92 (83–96) 88 (72–95) 0.003 95 (80–99) 93 (75–98) 0.133
Assisted suicide is reprehensible 27 (9–61) 11 (4–28) < 0.001 28 (2–68) 10 (1–49) < 0.001
End-of-life care is satisfying 38 (19–51) 34 (18–52) 0.683 16 (2–30) 14 (3–45) 0.363
People should pay costs of factitious diseases by themselves 40 (23–65) 47 (29–75) 0.047 78 (49–94) 77 (47–93) 0.341
Advance directives have been helpful in my decisions 31 (10–55) 36 (15–54) 0.199 12 (2–29) 10 (2–28) 0.723
Good palliative care enables good death 19 (10–25) 16 (9–29) 0.833 4 (1–13) 4 (1–13) 0.869
Physicians can’t estimate cancer pain 35 (22–70) 41 (27–71) 0.056 44 (23–69) 50 (29–74) 0.006
Religion has influence when I make ethical decisions 77 (44–94) 57 (30–92) 0.040 86 (49–98) 78 (45–98) 0.130
Being a doctor gives me satisfaction 21 (11–29) 19 (11–30) 0.456 7 (1–19) 7 (2–18) 0.928
My health is excellent 21 (10–35) 20 (10–31) 0.273 15 (5–27) 14 (06–25) 0.751
I feel burn out, tired to work 84 (68–93) 84 (62–94) 0.701 88 (75–96) 89 (70–97) 0.843
I’m pleased with my salary 77 (51–90) 70 (35–87) 0.082 22 (8–50) 22 (7–51) 0.759
It is waste of resources to treat patients over 80 years of
age in ICU
70 (48–86) 73 (49–87) 0.262 82 (54–94) 75 (54–91) 0.107
VAS visual analogue scale
IQR interquartile range
ICU intensive care unit
*Mann-Whitney U-test
Attitudes expressed on a visual analogue scale (VAS) from 0 mm (definitely agree) to 100 mm (definitely disagree)
Fig. 1 Proportion of respondents who were willing to increase the morphine dose among different physician groups in 1999 and 2015
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Knowledge about the benefits of palliative care has
grown in recent decades, and it is considered a part of
everyday care in life-threatening illnesses [10, 28, 29].
Therefore, it is not surprising that almost all of the re-
spondents in 2015 considered palliative care as a way of
enabling a good death. However, in another study only
51–70% of physicians believed that palliative care was
able to prevent the need for euthanasia and PAS [22].
Although advanced care planning has shown a positive
impact on the quality of end-of-life care [30, 31], the
prevalence of advance directives varies largely. In the
United States, the prevalence of advance directives seems
to have increased from approximately 10% up to 21–55%
among the elderly in the last 10 years [32, 33], while a
Finnish study from 2004 showed that only 12% of the
home-dwelling elderly had a living will [34]. In our study,
physicians found the advance directives of the patients
now more helpful than they were in 1999, but having an
advance directive of their own was still uncommon among
doctors in 2015 even though they were older and more
experienced than in 1999. This finding might reflect a
division between personal life values and experiences
in clinical work.
In general, physicians accepted potentially lethal mor-
phine dosing more frequently now than in 1999, although
approximately two-thirds of the doctors were still unwilling
to provide this. This result might be due to actual accept-
ance of hastening death at the end-of-life, better knowledge
regarding the use of opioids or both. It is now known that
clinically relevant respiratory failure is not a problem when
opioids are titrated against cancer pain [35]. Since 1999,
there has been growing evidence that the use of opioids for
symptom control in advanced diseases has no effect on sur-
vival and even high doses of opioids do not seem to shorten
life during end-of-life care [20, 21]. In a study conducted in
the Netherlands, physicians administered similar dosages of
opioids in 1995, 2001 and 2005; however, compared
with previous years, in 2005, they thought that life was
shortened by opioids or their intension was to hasten
death by administering opioids less frequently [16]. On
the other hand, high doses of opioids do cause respiratory
depression [17–19], and the potential of opioid to hasten
death during end-of-life care is almost impossible to study
with prospective randomized trials. Although we did not
ask the intention behind physicians’ willingness to increase
the morphine dose, it was clearly stated in the patient
Table 4 Different background factors, life values and attitudes explaining physicians’ decision to increase the morphine dose
(n = 323) versus not (n = 767) in forward logistic regression analysis
n OR (95% CI) P-value
Year of the survey
1999 578 ref.
2015 512 1.40 (1.05, 1.88) 0.024
Sex
Female 534 ref.
Male 556 1.51 (1.11, 2.05) 0.009
Age 1090 1.02 (1.01, 1.04) 0.007
Own advance directive
No 1026 ref.
Yes 64 1.74 (1.00, 3.03) 0.051
Faith in God
Important 489 ref.
Not important 601 1.64 (1.23, 2.19) 0.001
Assisted suicide is reprehensible (VAS) 1090 1.13 (1.08, 1.19) < 0.001
Physicians can’t estimate cancer pain (VAS) 1090 0.94 (0.89, 0.99) 0.021
Physician groups 0.014
Oncologists 120 ref.
Surgeons 252 2.50 (1.40, 4.46) 0.002
Internists 268 2.37 (1.34, 4.20) 0.003
GPs 450 2.30 (1.33, 3.97) 0.003
ref, reference
VAS, visual analogue scale
GP, general practitioner
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scenario that increasing the dose might lead to the patient’s
death. Oncologists were most reluctant to provide the dose
increase, and their opinion did not change between 1999
and 2015. However, they were probably the most familiar
with the influences of opioids in clinical practice as well as
the studies on this issue. Our results reflect that surgeons,
internists and GPs have become increasingly willing to has-
ten death according to a patient’s wishes today than they
were 16 years ago, although improved knowledge on the
low risk of using opioids during end-of-life care probably
influenced our results.
Our results are in line with the study by Miccinesi et al.
in which oncologists were the least in favour of using
lethal drugs [22]. In our study, the difference between
oncologists and other physician groups remained in the
results of the logistic regression analysis. These findings
might be observed because oncologists take care of these
patients on a more regular basis and are perhaps aware
that a patient’s wish to hasten death does not always imply
a genuine wish to die, but might be the result of over-
whelming emotional suffering [36], which could be re-
lieved by therapy.
Religion has been confirmed to have a tremendous
effect on end-of-life decisions and attitudes towards
euthanasia and PAS [1, 22, 27]. In the present study,
faith in God was also found to decrease physicians’ will-
ingness to administer potentially lethal morphine dose.
The number of physicians who had faith in God is lower
in the present survey than in 1999, which might be one
reason for the increasing support for euthanasia and has-
tened death. In a previously mentioned study, Löfmark et
al. concluded that a non-religious philosophy of life
increased physicians’ willingness to perform euthanasia
and PAS, possibly by emphasizing patient autonomy [27].
Advance directives were relatively uncommon among
physicians, but having one seemed to increase the willing-
ness to double the morphine dose; however, the influence
of advance directives did not quite reach statistical signifi-
cance in our logistic regression analysis. To our know-
ledge, the influence of doctors’ own advance directives on
end-of-life decisions has not been previously reported.
We suggest that completing an advance directive for
oneself may lead to greater acceptance of death, even if
this is hastened in a situation without hope for a cure.
Male sex and older age were independently associated
with physicians’ willingness to double the morphine dose.
Previous studies on these factors are somewhat controver-
sial. Females have been shown to be less supportive towards
ending life without explicit request from the patient, but
also to be more supportive of alleviating pain and other
symptoms regardless of the possible life-shortening effects
[22, 26]. In general, younger physicians accept PAS more
often but are less willing to withdraw life-prolonging treat-
ments than older physicians [2, 22, 26]. The exact reasons
why age and sex are related to the tendency to administer
potentially lethal morphine dose in our study remains un-
known, but perhaps more experienced physicians do not
believe that such a morphine dose would actually kill
the patient. Furthermore, men are reported to approve
of assisted death more often than women in the general
population [1].
Developments in medicine have allowed many interven-
tions for patients with very advanced diseases, but the low
survival rates for cardiopulmonary resuscitation (CPR) in
the cancer population have not changed [37]. Further-
more, advanced care planning, which increases the preva-
lence of do-not-resuscitate orders, is probably a more
common practice today than in the 1990’s [31, 38]. In our
study, physicians’ willingness to start CPR in a patient
with very advanced cancer was relatively low and did not
change over the study years, in a contrast to the more eth-
ically difficult and complex attitude regarding hastening
death. Of interest, the decision about CPR did not influ-
ence physicians’ willingness to hasten death through the
dual effect of a high morphine dose. We suggest that phy-
sicians’ willingness to hasten death is mainly related to
their personal attitudes and values rather than medical
facts, which probably guide the decision to withhold CPR.
Finally, we should state that changes in the surrounding
society, general attitudes and clinical decision-making in
Finland and Europe since the 1990s might have had a sub-
stantial influence on our results. In a large international
study, the use of lethal doses of drugs after the explicit re-
quest of a patient with a terminal illness and uncontrolled
symptoms was accepted by 35–78% of physicians, depend-
ing on the country [22]. This large range describes the cul-
tural influence on the difficult decision to hasten death,
but the numbers are quite similar to those found in our
study. Public attitudes towards assisted death have chan-
ged since the 1990s to become more permissible, which
has led to legalization of assisted death in some countries
and increased political support for it in Finland [1, 2]. At
the same time, knowledge and awareness of palliative care
have grown in Finland through national and international
recommendations [39–41]. However, this has happened
later than in some other European countries such as the
UK [3, 4]. In addition, patient autonomy and shared de-
cision- making in treatment-choices are increasingly em-
phasized as important ethical principles throughout
Western countries [5, 6, 42]. Patients’ rights regarding treat-
ment decisions were incorporated into Finnish law in 1992,
and respecting the patient’s wishes is currently one of the
main principles in the ethical guidelines of the Finnish Med-
ical Association [8, 9]. This social and cultural context to-
gether with the shift from paternalism towards a more
patient-centred approach in clinical decision-making prob-
ably influenced the responding physicians’ considerations on
the reprehensibility of hastened death and their willingness
Piili et al. BMC Medical Ethics  (2018) 19:40 Page 8 of 10
to comply with patients’ requests in the ethically complex
situation in our study [6, 43].
Strengths and limitations of the study
Limitations of this study need to be acknowledged. Our
response rate (56%) is a limitation even though our study
population is large and the response rate is higher than
that in many recent studies [44–46]. The study population
is also a representative sample, as it reflects the overall
distribution of specialities and gender among Finnish
physicians [47]. The follow-up period is long enough to
detect relevant changes in attitudes and decision-making.
Answers to the hypothetical scenarios might differ from
the decisions made in clinical practice, but these questions
are difficult to study in real life situations.
Conclusions
Considering a hypothetical case scenario, Finnish physi-
cians accepted the risk of hastening death more often in
2015 than in 1999. The specialty of the physician, gender,
and faith in God strongly influenced their acceptance to
this practice. Oncologists were the most reluctant of all
the specialists studied to hasten death. Euthanasia, but not
assisted suicide, was considered slightly less reprehensible
in 2015. Relieving suffering, while considering the justi-
fication to hasten death, is a complex ethical question.
Therefore, both training in medical ethics and medicine
are needed for high quality end-of-life care.
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ABSTRACT
Objectives Physicians’ decision-making in end-
of-life (EOL) care includes many medical, ethical 
and juridical aspects. We studied the changes of 
these decisions over time and factors influencing 
them.
Methods A postal survey including two 
hypothetical patient scenarios was sent to 1258 
Finnish physicians in 2015 and to 1182 in 1999. 
The attitudes, values and background factors of 
the physicians were also enquired.
Results The response rate was 56%. The 
physicians’ decisions to choose palliative 
approaches over active or intensive care 
increased from 1999 to 2015 when a terminally 
ill prostate cancer patient had probable 
iatrogenic gastrointestinal bleeding (53% 
vs 59%, p=0.014) and waited to meet his 
son (46% vs 60%, p<0.001) or a minister 
(53% vs 71%, p<0.001). Training in EOL care 
independently increased palliative approaches. 
Patient’s benefit (96% vs 99%, p=0.001), 
ethical values (83% vs 93%, p<0.001) and 
patient’s (68% vs 86%, p<0.001) or physician’s 
(44% vs 63%, p<0.001) legal protection were 
considered more influential to the decisions in 
2015, while the family’s benefit was regarded 
as less influential to the decisions than it was in 
1999 (37% vs 25%, p<0.001). Physicians were 
more willing to give a hospice voucher for an 
advanced breast cancer patient in 2015 (34% vs 
58%, p<0.001).
Conclusions Our findings may reflect the 
transition to a stronger emphasis on patient-
centred care and a stronger tendency to avoid 
futile therapies that have only short-term goals. 
The results highlight that education in all aspects 
of EOL care should be incorporated into the 
post-graduate training of medical specialties that 
take care of dying patients.
INTRODUCTION
Individualism has been rising in western 
countries.1 2 This can also be seen in 
medicine, where shared decision-making 
and patient-centred care are now preferred 
by most physicians and patients.3–5
However, concerns have been raised 
about the excessive autonomy of patients, 
which can result in costly, ineffective 
and even futile treatments.6 The right of 
the patient to be involved in treatment 
decisions was included in Finnish law in 
1992.7 However, the Finnish National 
Supervisory Authority for Welfare and 
Health has stated that ineffective or 
futile therapies should not be used even 
though the patient requests them.8 Physi-
cians have to strike a balance between the 
wishes of the patient and family, legal and 
ethical aspects and evaluate the benefit, 
harm and cost of the care. This makes 
decision-making very challenging.
Decision-making in end-of-life (EOL) 
care involves many ethical, legal, medical 
and psychological aspects, and physicians’ 
background characteristics, specialties, 
attitudes and values play a part in this 
complex process.9–15 The specialty of a 
physician impacts their decision-making, 
as oncologists have been shown to be 
more opposed to accepting the risk of 
hastening death by using high doses of 
drugs for symptom control compared 
with other specialties, but they are more 
willing to withhold or withdraw futile 
treatments in EOL care.12 16 17 Reli-
gion is shown to be associated with the 
unwillingness to withdraw life-supportive 
care,16 18 19 whereas age and gender of the 
physician are inconsistent factors in the 
decision-making.11 17 19–21
Decision-making should be consis-
tent in the same types of clinical situa-
tions regardless of the physician who is 
responsible for the care of the patient. 
The surrounding society and atmosphere 
do change over time, which might also 
influence medical decisions. As the values 
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and attitudes of the physician have a great impact on 
the decision-making, it is important to know whether 
these have changed over the years and how the possible 
changes affect the decisions that physicians make 
regarding EOL care. A better understanding of the 
background factors and changes in decision-making 
will help to define important educational aspects of 
decision-making in EOL care and will help to produce 
practical guidelines to provide high-quality and equal 
care to all patients.
The aim of this study was to identify whether physi-
cians’ decision-making has changed over the past 
16 years and to explore the factors influencing and 
explaining these decisions.
METHODS
Participants
A postal survey with a similar questionnaire was 
conducted in 1999 and 2015 with Finnish physi-
cians. In both years, the sample included 500 general 
practitioners (GPs), 300 surgeons and 300 internists 
who were randomly selected from the register of the 
Finnish Medical Association, together with all Finnish 
oncologists (n=82 in 1999 and n=158 in 2015). 
Non-responders were reminded twice. A cover letter 
including an introduction to the study, an assurance 
of anonymity and a statement of voluntariness was 
mailed together with the questionnaire.
Questionnaire
Seven hypothetical patient scenarios were presented 
in the questionnaire. Following the patient scenarios, 
attitudes regarding several moral and ethical aspects 
were assessed with a 100 mm visual analogue scale 
from ‘definitely agree’ (0 mm) to ‘definitely disagree’ 
(100 mm). These included, for example, statements 
concerning euthanasia, palliative care, the role of 
religion in ethical decisions, advanced directives and 
healthcare economics, together with physicians’ satis-
faction with their own health, work and salary. There 
were also questions concerning the responders’ back-
ground and personal features.
Changes in these attitudes have been reported 
earlier.22 The questionnaire has been previously used 
and validated with Finnish physicians.10 11
Patient scenarios
We included two patient scenarios in this study:
Scenario 1 presented an 82-year-old retired forest 
worker, who had received a diagnosis of prostatic 
cancer 3 years ago. During the past year, he received 
treatments for bone metastases. He has now been in 
hospital for 1 month, almost bedridden, and needs 
help with all functions. His mental condition has been 
normal. His general condition has weakened over the 
past week, he is now bedridden, and has received large 
doses of pain medication. Today, he has become coma-
tose. His haemoglobin count has decreased to 68 g/L, 
while the week before it was 118 g/L. His blood pres-
sure is 80/40 mm Hg. There is no verbal or written 
advance directive. The patient’s wife has previously 
said that she expects the doctor to make all treatment 
decisions according to his/her best understanding. 
After the scenario, the doctors were asked to choose 
one of the given treatment options. The concepts used 
in the treatment options were explained as follows: (a) 
palliative care: good nursing, sufficient medications 
for pain and other symptoms, and intravenous hydra-
tion only when it is considered to relieve the patient’s 
symptoms; (b) active care: use of antibiotics, intrave-
nous hydration or blood transfusions aimed at saving 
the patient’s life in a life-threatening condition and (c) 
intensive care: moving the patient to an intensive care 
unit. After the initial question for scenario 1, four addi-
tional alternatives were presented, each ending with 
the same treatment options: (a) It has been discov-
ered that the patient’s faeces are black. You remember 
having prescribed ketoprofen for pain a week ago; (b) 
The patient’s son is coming from America the day after 
tomorrow to see his father while he is still alive; (c) The 
patient has had spiritual anxiety and there is a planned 
appointment with a minister and the Lord’s Supper 
tomorrow and (d) The patient’s written advance direc-
tive has been found, in which the patient has expressed 
that all active interventions should be withheld if there 
is no hope for recovery. After asking for the treatment 
decisions, a Likert-type scale was presented to evaluate 
the influence of different factors (patient’s benefit, 
family’s benefit, patient’s legal protection, physician’s 
legal protection, ethical values, patient’s age, cost of 
care and patient’s social status) on the decisions (from 
1—very little influence to 5—very much influence).
In scenario 2, a 68-year-old patient suffers from 
breast cancer with bone metastases. She is bedridden 
and her general condition has rapidly collapsed. She 
is in a community hospital ward and is receiving 
adequate pain treatment with which she is pleased. She 
is depressed and wants to transfer to a hospice for her 
last days. She feels that the atmosphere on the ward is 
very restless and ‘institutional’. You have the right to 
issue a voucher for the costs of hospice care (€290 per 
day) to be paid by the community hospital. The costs 
would be approximately double compared with those 
in a community hospital, and the chief doctor has 
advised you to use great discretion in issuing vouchers. 
Your solution: (a) to accept the transfer, (b) to accept 
the transfer, provided that the patient pays the extra 
costs herself, (c) not to accept, because according 
to normal practice, the patient’s care belongs to the 
community hospital ward, and there are no special 
problems in her care, (d) I don’t know and (e) other 
solution.
Responders were instructed at the outset to answer 
the questions in sequence from beginning to the end 
and not to change their answers later.
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Statistical analysis
In the patient scenarios, the answers were converted 
into two options. In patient scenario 1: choosing palli-
ative care (response a) or choosing active and inten-
sive care (responses b and c). In patient scenario 2: 
willing to give a voucher for hospice (response a) or 
not willing to give a voucher (other responses). The 
answers on the 4-point Likert scale concerning values 
were converted to the following 2-point scale: 1–2 
for ‘not important’ and 3–4 for ‘important’, and the 
answers on the 5-point Likert scale concerning the 
influence of different factors were converted to the 
following 2-point scale: 1–3 for ‘not much influence’ 
and 4–5 for ‘much influence’.
The two-scale patient scenarios, background factors 
and values were tested using the Pearson χ2 test. 
Two-sided p values that were less than 0.05 were 
considered to be statistically significant.
The models explaining the decision to choose pallia-
tive care in patient scenario 1 and willingness to give a 
voucher for hospice in patient scenario 2 were created 
using forward stepwise logistic regression. Models 
were created from the scenarios that had a statistically 
significant difference between the study years.
Background factors, life values and attitudes were all 
included in the model.22 The p value for significance 
was set at 0.10 to enter and 0.15 to remove from the 
model.
The data analysis was performed using IBM SPSS 
Statistics for Windows, V.23.0
RESULTS
Responders
The characteristics of the responders are presented in 
table 1. Altogether 1373 valid responses were obtained. 
In 1999, the responders were younger (p<0.001), had 
shorter working experience (p<0.001) and were more 
often men (p<0.001) compared with the responders 
in 2015. Oncologists reported having participated in 
post-graduate EOL training significantly more often 
(p<0.001) than other physicians (58% vs 22%).
Change in decision-making
The overall changes in decision-making in the different 
patient scenarios according to physician group are 
presented in table 2. Statistically significant changes 
towards the palliative care approach were found when 
the terminally ill prostate cancer patient had prob-
able iatrogenic gastrointestinal (GI) bleeding (scenario 
1a), his son was coming to see him in 2 days (scenario 
1b) and he had a Lord’s Supper with a minister 
planned for the next day (scenario 1c). The oncolo-
gists’ approach remained unchanged during the years 
studied. When an advance directive was found, most 
physicians (86%–94%) consistently chose a palliative 
care approach in both of the years studied. All of the 
physicians’ groups were more willing to give a voucher 
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Table 3 Factors reported by the physicians to have inﬂuenced 
their decisions concerning the care of the terminally ill prostate 
cancer patient
Having much inﬂuence 1999 2015 P value*
Patient’s beneﬁt 700 (96%) 628 (99%) 0.001
Family’s beneﬁt 265 (37%) 166 (25%) <0.001
Patient’s legal protection 493 (68%) 545 (86%) <0.001
Physician’s legal protection 319 (44%) 401 (63%) <0.001
Ethical values 599 (83%) 638 (93%) <0.001
Patient’s age 335 (46%) 255 (40%) 0.023
Costs of care 68 (9%) 61 (10%) 0.861
Patient’s social status 13 (2%) 5 (1%) 0.106
*Pearson χ2 test.
for hospice to the patient with advanced breast cancer 
in 2015 than in 1999.
Physicians’ opinions on the factors influencing their 
decisions
Physicians’ opinions on the factors influencing their 
decisions concerning the terminally ill prostate cancer 
patient are summarised in table 3. Patient’s benefit, 
ethical values and patient’s or physician’s legal protec-
tion were more influential on the physicians’ deci-
sion-making in 2015, while the influence of family’s 
benefit and patient’s age decreased.
Factors associated with physicians’ decisions
The results from the logistic regression analysis of 
the decisions concerning the terminally ill prostate 
cancer patient with probable iatrogenic GI bleeding 
and who was waiting to meet his son or a minister 
(scenarios 1a–c) are presented in table 4. The year of 
the survey remained a significant independent factor 
explaining the physicians’ decision in every scenario. 
In general, the physicians answering in 2015 were less 
eager to choose active or intensive care. The willing-
ness to withdraw life-sustaining treatments and having 
post-graduate EOL training were also significantly 
associated with a decreased likelihood of choosing 
active and intensive care in these scenarios. In addi-
tion, men more often chose a palliative care approach 
for the terminally ill prostate cancer patient when GI 
bleeding was detected and when his son was coming.
Table 5 presents the results from the logistic regres-
sion analysis for the factors associated with the will-
ingness to give a hospice voucher to the breast cancer 
patient with advanced disease (scenario 2). In the anal-
ysis, the responders in 2015 were more willing to give 
a voucher than the responders in 1999.
DISCUSSION
Physicians in 2015 chose a palliative care approach 
more often than those in 1999 for the terminally ill 
prostate cancer patient when he had probable iatro-
genic GI bleeding and when he was waiting to meet his 
son or a minister in the next few days. The physicians 
thought that their decision-making was more influ-
enced by patient’s benefit, ethical values and patient’s 
or physician’s legal protection and less by family’s 
benefit and patient’s age than did the physicians in 
1999. They were also more willing to give a voucher 
for hospice when the patient with advanced breast 
cancer wished for it during her EOL care.
Palliative care as defined by the WHO aims to 
improve the quality of life of patients and their families 
when facing life-threatening illness, it neither hastens 
nor postpones death.23
In our study, most of the physicians chose a palli-
ative care approach for the prostate cancer patient 
in the EOL care situation when no additional ethical 
complexities were present. This basic decision-making 
did not change between the years studied, showing 
the general medical acceptability of palliative care in 
this hypothetical case scenario. Further, after finding 
the patient’s advance directive stating that active 
treatments should be withheld if there is no hope for 
recovery, almost all physicians chose a palliative care 
approach, without difference between the years exam-
ined. This is well in line with earlier studies showing 
that advance directives help decision-making in EOL 
care, although physicians are concerned whether 
advance directives genuinely express a patient’s own 
will.24 25
When two short-term goals (meeting the son or 
a minister in the next few days) and a suspicion of 
iatrogenic bleeding were presented, the proportion 
of the physicians choosing a palliative care approach 
decreased, but significantly less in 2015 than in 1999. 
These scenarios forced responding physicians to make 
ethically demanding decisions. One can argue that 
life-sustaining interventions might be ethically justi-
fied as a part of the palliative care to achieve these 
patient-centred short-term goals. On the other hand, 
more aggressive life-prolonging interventions in 
this case scenario might lead to overwhelming and 
prolonged suffering, together with the substantial 
costs of futile treatments.
In 2015, physicians were less influenced by family’s 
benefit, which probably reflects their unwillingness to 
choose active and intensive care when the son of the 
terminally ill prostate cancer patient was coming. The 
lower influence of the family’s benefit may be due to 
rising individualism in western countries.1 2
Religion has earlier been shown to have tremendous 
effect on EOL decisions.16 18 19 21 26 We have previ-
ously shown that physicians had less faith in God and 
considered religion to be less influential in ethical deci-
sions in 2015 than they did previously.22 Thus, it is not 
surprising that an appointment with a minister shifted 
the treatment decisions to life-prolonging modalities 
less often in 2015 than in 1999. Guilt has been shown to 
be one of the reasons why futile treatments are carried 
on in EOL care.27 This could explain, at least to some 
extent, why approximately half of the physicians chose 
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Table 5 Different background factors and attitudes explaining the willingness to give a voucher for hospice (n=488) versus not (n=610) 
for the patient with advanced breast cancer (scenario 2) in forward logistic regression analysis
n OR (95% CI) P value
Year of the survey <0.001
  1999 582 ref.
  2015 516 2.62 (1.96 to 3.50)
Withdrawal of life-sustaining treatments is reprehensible (VAS*) 1098 1.06 (1.00 to 1.12) 0.051
People should pay costs of factitious diseases by themselves (VAS*) 1098 1.07 (1.02 to 1.13) 0.004
Physicians can’t estimate cancer pain (VAS*) 1098 0.93 (0.89 to 0.98) 0.006
My health is excellent (VAS*) 1098 1.10 (1.04 to 1.18) 0.003
It is waste of resources to treat patients over 80 years of age in intensive care units (VAS*) 1098 1.07 (1.01 to 1.12) 0.017
Gender 0.084
  Female 541 ref.
  Male 557 0.78 (0.59 to 1.03)
Age (years) 1098 0.98 (0.96 to 0.99) 0.003
Post-graduate end-of-life training 0.089
  No 811 ref.
  Yes 287 0.76 (0.56 to 1.04)
Physician groups 0.007
  Oncologists 121 ref.
  Surgeons 254 0.92 (0.55 to 1.54) 0.760
  Internists 271 0.93 (0.57 to 1.52) 0.761
  GPs 452 0.58 (0.37 to 0.91) 0.018
*VAS, visual analogue scale (0 deﬁnitely agree and 10 deﬁnitely disagree). One unit is equivalent to 10 mm on a 100 mm VAS.
GPs, general practitioners; ref., reference.
an active approach on discovery of GI bleeding that 
was likely caused by the previously prescribed keto-
profen, although this shift to life-sustaining treatment 
was slightly less common in 2015. Nevertheless, the 
principal justification for every treatment should be the 
patient’s benefit, not the physician’s attitudes and feel-
ings in everyday decision-making. One of the reasons 
for the increased tendency to choose a palliative care 
approach in 2015 might be a better understanding of 
palliative care, which leads to the avoidance of futile 
therapies in EOL care even in ethically complex situ-
ations. This assumption was further supported by the 
analysis of background factors for decision-making, 
which revealed an association between training in EOL 
care and choosing a palliative care approach.
Using logistic regression analysis, we also inves-
tigated whether the changes between the years were 
genuine. It appeared that the significant differences 
in decision-making still remained after taking into 
account confounding factors. In addition, some other 
important factors that influenced the decisions were 
discovered, including the constant effect of post-grad-
uate EOL training. As a whole, physicians who consid-
ered the withdrawal of life-sustaining treatments to 
be less reprehensible chose a palliative care approach 
more often in all scenarios. This is understandable 
when taking into account the nature of palliative care, 
in which considering the withdrawal of life-sustaining 
treatments to be reprehensible could be problematic.
The age of the physician seems to be a conflicting 
factor in EOL decision-making.19 In our previous 
study, younger age was associated with an unwilling-
ness to withhold or withdraw therapies,17 but in this 
study, age did not explain the decisions to choose a 
palliative care approach. Male gender was associated 
with the palliative decision when the prostate cancer 
patient had probable GI bleeding and when his son 
was coming the next day. The influence of gender is 
also unclear in EOL decision-making, as some studies 
have shown that female physicians are more in favour 
of active treatments and in some studies, there is no 
gender-dependent difference in withholding or with-
drawing life-sustaining treatments.11 17 19 20 28
Only approximately 10% of the respondents in 
both years considered costs of care to influence their 
decisions, and the patient’s social status was even less 
influential. Some studies do report that a patient’s 
financial resources influence physicians’ deci-
sion-making,29 while our results probably reflect the 
Finnish healthcare system, where the cost of care is 
covered by the society with tax money. The influence 
of a patient’s age decreased during the years studied. 
This finding is likely due to the advances in medicine 
in recent years. In contrast to older studies where 
age significantly influenced patient survival in crit-
ical illnesses,30 31 the survival of cancer patients was 
not associated with age in a recent study by Martos-
Benítez el al.32
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The influence of patient’s benefit to physicians’ 
decision-making rose to 99% from an already high 
percentage of 96%, while family’s benefit decreased 
from 37% to 25% between the years studied. The 
rise of individualism in western parts of the world 
might reflect this change, as well as the fact that today 
respecting the patient’s wishes is one of the main prin-
ciples in the ethical guidelines of the Finnish Medical 
Association.1 2 33 Both patient’s and physician’s legal 
protection was considered more influential now than 
16 years ago. In Finland, patient’s rights regarding 
treatment decisions were incorporated into Finnish law 
in 1992,7 which has obviously impacted the high level 
of influence of the patient’s legal protection. Thus, our 
results also raise a question as to whether physicians 
are more concerned about malpractice claims now 
than they were 16 years ago. The data from malprac-
tice claims are conflicting, as some studies show an 
increasing amount of malpractice claims, while in 
others, there is a clear decrease.34 35 In contrast to our 
results, the law appeared to play a limited role in EOL 
medical decision-making with doctors prioritising 
patient-related clinical and ethical considerations in a 
recent study from Australia.36 On the other hand, that 
study is partly in line with our study, as ethical values 
were also considered to be highly influential by our 
responders. Our findings emphasise the complexity 
of EOL decision-making and the different factors that 
affect it, as physicians consider both legal and ethical 
aspects to be important, and one does not exclude the 
other.
Physicians in 2015 were more willing to give a 
voucher for hospice when the breast cancer patient in 
EOL care wished for it. The increase in a palliative 
care approach for the terminally ill prostate cancer 
patient might reflect the tendency to avoid futile ther-
apies even when contrasting with the patient’s wishes. 
This increasing willingness to give a hospice voucher 
may, in turn, be a reflection of the rise in patient-cen-
tred care where there is a focus on shared deci-
sion-making complying with patient’s preferences.4 5 37 
The difference between the study years remained in 
the logistic regression analysis concerning the patient 
with advanced breast cancer. However, GPs were more 
unwilling to give a voucher compared with oncologists. 
In Finland, most of the dying patients are taken care of 
in community hospitals by GPs. Thus, our finding may 
reflect the better knowledge of GPs about the facilities 
in the community hospitals or the financial realities 
in the communities. On the other hand, oncologists 
may face the most difficult cases in EOL care, leading 
to a willingness to offer specialised palliative care in a 
hospice. Our results call for ongoing communication 
between the specialties to build-up palliative care path-
ways with optimally arranged EOL care based on the 
needs of every individual patient.
The limitations of this study need to be acknowl-
edged. Our response rate (56%) is a limitation due to 
possible non-response bias even though our study popu-
lation was a large and representable sample of Finnish 
physicians. Because the follow-up period is long, it 
was possible to detect relevant changes in attitudes, 
values and decision-making. Physicians responding 
questions regarding hypothetical scenarios might give 
different answers compared with their actual decisions 
in clinical practice, but we suggest that the answers do 
sufficiently reflect real-life decision-making. However, 
future research should try to evaluate the basis of deci-
sion-making in the clinical practice of EOL care and 
whether education in palliative care influences these 
decisions.
CONCLUSION
Compared to 1999, physicians in 2015 were more 
reluctant to choose active life-prolonging treatments 
over palliative care approaches for short-term goals in 
EOL care. However, they were more willing to give 
a voucher for hospice when a patient requested it. 
Patient’s benefit, ethical values and patient’s or physi-
cian’s legal protection were more influential on the 
physicians’ decision-making in 2015, while the influ-
ence of family’s benefit and patient’s age decreased. 
Our findings may reflect changes in general attitudes 
and the medical atmosphere towards patient-centred 
care and the decreased importance of family and reli-
gion in Finnish society, together with a better knowl-
edge of the principles of palliative care.
The results highlight the importance of education 
of EOL care, including not only the medical facts but 
also the ethics related to decision-making. All of these 
aspects should be incorporated into post-graduate 
training in specialties that take care of dying patients.
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Abstract. Background/Aim: Appropriate decision-making in
end-of-life (EOL) care is essential for both junior and senior
physicians. The aim of this study was to compare the decision-
making and attitudes of medical students with those of
experienced general practitioners (GP) regarding EOL-care.
Materials and Methods: A questionnaire presenting three
cancer patient scenarios concerning decisions and ethical
aspects of EOL-care was offered to 500 Finnish GPs and 639
graduating medical students in 2015-2016. Results: Responses
were received from 222 (47%) GPs and 402 (63%) students.
The GPs withdrew antibiotics (p<0.001) and nasogastric
tubes (p=0.007) and withheld resuscitation (p<0.001), blood
transfusions (p=0.002) and pleural drainage (p<0.001) more
often than did the students. The students considered
euthanasia and assisted suicide less reprehensible (p<0.001
in both) than did the GPs. Conclusion: Medical students were
more unwilling to withhold and withdraw therapies in EOL-
care than were the GPs, but the students considered
euthanasia less reprehensible. Medical education should
include aspects of decision-making in EOL-care. 
There is a growing demand for palliative care in Europe due
to the increase in noncommunicable diseases (1). Therefore,
physicians should have basic skills needed to change the goal
of the treatment from life-prolonging therapies to end-of-life
(EOL)-care.
Appropriate decisions needed for high-quality EOL-care
involve, for example, statements regarding cardiopulmonary
resuscitation (CPR), hydration, and diagnostic tests. Many
physician-related factors (e.g., age, experience and personal
attitudes) have been shown to influence these decisions (2-4).
In addition, the changing public attitudes towards EOL-care
and euthanasia influence the complexity of these issues (5).
The physicians’ decisions regarding life-sustaining treatments
vary between different treatment modalities (6-8). In a survey
of American internists, blood products and haemodialysis were
among the most likely withdrawn therapies, while mechanical
ventilation and intravenous fluids were more commonly
continued (6). Withdrawing treatment is generally experienced
as more difficult than withholding them (9). 
The education and experience of a physician have been
shown to influence decision-making in EOL-care (8, 10).
Although newly-graduated physicians often feel unprepared
for providing EOL-care, they face the complexity of the
decision-making process just as the senior physicians (11,
12). However, the difference between graduating medical
students and physicians in making these decisions remains
to be studied.
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The aim of this study was to evaluate and compare the
decision-making and attitudes of medical students and
experienced GPs regarding several aspects of EOL-care of
cancer patients. The results could be useful for the planning of
medical education concerning decision-making in EOL-care.
Materials and Methods
Participants. In autumn 2015, a postal survey with a questionnaire was
sent to 500 GPs who were randomly selected from the registry of the
Finnish Medical Association [details published earlier by Piili et al.
(8, 13)]. The survey was sent twice to non-respondents. A
questionnaire with the same hypothetical patient scenarios was offered
to all Finnish medical students during their last year of medical school
(Table I). All five universities with a faculty of medicine (Tampere,
Helsinki, Turku, Kuopio and Oulu) participated in the study during the
autumn of 2015 and the spring of 2016 depending on the graduation
date at each university. The questionnaire was given to 639 students
during a teaching session and returned to the teacher either personally
or by post. Valid responses to the questionnaire were obtained from
402 (63%) and 245 (49%) of the students and GPs, respectively. After
excluding GPs who had graduated less than five years ago, 222 (47%)
GPs were included in this study. This study was approved by the
Regional Ethics Committee of Tampere University Hospital, Finland
(R15101).
Questionnaire. The questionnaire included seven patient scenarios,
of which three were used in this study. In addition, there were
several questions concerning the attitudes and background factors
of the respondents. Attitudes towards several ethical and personal
aspects were assessed with a 100-mm visual analogue scale (VAS)
from “definitely agree” (0 mm) to “definitely disagree” (100 mm).
These included, for example, statements concerning euthanasia,
palliative care, the role of religion and advance directives in the
decision-making process. The respondents were instructed to answer
the questions in the given order and to not change their answers
once given. This questionnaire has been previously used and
validated among Finnish physicians (2-4).
Patient scenarios. Scenario 1: An 82-year-old forest worker was
diagnosed with prostate cancer 3 years ago. During the past year,
he has received treatments for bone metastases. He has now been
hospitalized for a month, is almost totally bedridden, and needs help
with all activities. His mental condition has been normal. His
general condition has weakened during the past week to the point
where he is now totally bedridden and is receiving large doses of
pain medication. Today, he became comatose. His haemoglobin
count is 68 g/l, while a week ago it was 118 g/l. His blood pressure
is 80/40 mmHg. There is no verbal or written advance directive. The
patient’s wife has previously said that she expects the doctor to
make all treatment decisions according to his/her best
understanding. After the scenario, the doctors were asked to choose
one of the given treatment options. The concepts used in the
treatment options were explained as follows: a) palliative care: good
nursing, sufficient medication for pain and other symptoms, and
intravenous hydration only when suggested to provide relief of the
patient’s symptoms; b) active care: use of antibiotics and
intravenous hydration or blood transfusions aimed at saving the
patient’s life in a life-threatening condition; c) intensive care:
transfer of the patient to an intensive care unit (ICU).
Scenario 2: A 32-year-old female patient is brought by ambulance
to the emergency unit. She is accompanied by her husband who says
his wife has inoperable brain cancer. She has been receiving
maximum radiotherapy, but this was discontinued three weeks ago.
She has deteriorated considerably during the past week. The patient
has now had an epileptic seizure and has been unconscious since
the attack. After 20 min at the hospital, the patient stops breathing,
and there is no pulse. Your treatment decision as a doctor on call is
one of the following: a) to start cardiopulmonary resuscitation
(CPR) or b) to withhold CPR. 
Scenario 3: A 62-year-old male patient with lung cancer and
metastases was admitted to the hospital ward and received high-
dose morphine medication. Due to respiratory weakening, he had
become comatose the night before. He also suffered from severe
anaemia and had abundant pleural effusion and fever. After the
presentation of the patient scenario, there was a question about the
treatment decision: Which of the following treatments already
started (*) or planned would you withhold or withdraw? The
decision responses were expressed on a scale from 1 (I definitely
would not) to 5 (I definitely would). The treatments were a)
antibiotics (*); b) mechanical ventilation (*); c) blood transfusion;
d) pleural drainage; e) chest X-ray examination; f) laboratory tests;
g) intravenous hydration (*); h) nasogastric tube (*); i) thrombosis
prophylaxis (*); and j) supplementary oxygen (*).
Statistical analysis. The answers were re-categorized dichotomously
for the statistical analysis for the Scenarios 1 and 3. The conversion
was conducted as follows (responses shown in brackets): In the
Scenario 1, “choosing palliative care” (a) and “not choosing
palliative care” (b and c) and in the Scenario 3, “withhold or
withdraw” (4 and 5) and “to not withhold or withdraw” (1, 2 and
3). The comparison of the students and the GPs was performed
using the Pearson Chi-Square test for the dichotomous variables
(Figure 1 and Table II) and Mann-Whitney U test for the continuous
variables (Table III). P-values less than 0.05 were accepted as
statistically significant. The data analysis was performed using IBM
SPSS Statistics for Windows, version 24.0.
Results
Characteristics of the participants are presented in Table I.
All the students were under 50 years old, while over half of
the GPs had reached this age. The GPs’ median time from
graduation was 23 years (range=5-40 years).
Treatment decisions in end-of-life care. The decisions of the
students and GPs in patient scenarios 1 and 2 are shown in
Figure 1. The GPs were more likely not to resuscitate the
patient with an inoperable brain tumour (scenario 2), while the
majority of both the students and the GPs chose the palliative
care in the comatose patient with prostate cancer (scenario 1).
Willingness to withhold or withdraw therapies. The GPs
were more likely to withdraw or withhold therapies than the
students in a patient with an end-stage lung cancer (Table II).
This difference was significant in withdrawing antibiotics
and the nasogastric tube, and withholding blood transfusion,
pleural drainage and taking a chest X-ray. 
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Attitudes. The students considered euthanasia and assisted
suicide significantly less reprehensible than did the GPs
(p<0.001 in both) as shown in Table III. Religion had a
stronger influence on ethical decisions among the GPs than
it did among the students. Most of the GPs and the students
did not feel burn out, assessed their own health as excellent
and achieved satisfaction from being a doctor. 
Discussion
The graduating medical students were less willing to
withdraw or withhold therapies such as resuscitation in EOL-
care compared to experienced GPs. On the other hand, they
considered euthanasia and assisted suicide less reprehensible
than did the GPs. 
In our study, the GPs were generally more willing to
withdraw or withhold possible life-prolonging treatments
than the medical students. Our results are in line with the
study by Rivera and co-workers in which internal medicine
faculty members accepted withholding or withdrawing life-
sustaining therapy more often than the students (14).
However, to our knowledge, there are no previous detailed
surveys on medical students’ opinions regarding life-
prolonging therapies during EOL-care. 
According to our results, the GPs were more willing than
the students to withhold blood transfusions, pleural drainage
and chest X-rays in a patient scenario representing EOL-
care. The benefit of blood transfusions in EOL-care is often
brief and adverse effects may occur (15). Dyspnoea can
sometimes be alleviated by pleural drainage, but the
procedure is invasive (16). We suggest that the main reason
that GPs are more willing to withhold these procedures is
because they have experience on the risks and
inconveniences of these interventions among frail patients.
The GPs also withdrew antibiotics more frequently than the
medical students. Antibiotics might occasionally be
beneficial in EOL-care, but it is unclear whether students
were aware of this or whether their decision was due to the
difficulty in withdrawing therapies (17). Interestingly, the
nasogastric tube was withdrawn more frequently by the GPs
than the students, whereas there was no difference between
the groups in withdrawing intravenous hydration. Neither
intravenous hydration nor artificial feeding have been shown
to improve survival or symptom control in EOL-care (18-
22). Almost half of the students and one third of GPs would
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Figure 1. Proportions of students and general practitioners (GPs) choosing palliative-care approach for the comatose prostate cancer patient
(scenario 1) and deciding not to resuscitate the patient with inoperable malignant brain tumour (scenario 2).
Table I. Characteristics of the participants.
                                                        Students             General practitioners
Number                                      402                                 222
Response rate                            63%                               47%
Female, n (%)                            248         (62%)              157         (71%)
Age, median years (range)        26         (23-46)              51         (30-65)
Age distribution, n (%)
  <25                                           40          (10%)                0            (0%)
  25-34                                       347         (86%)               26          (12%)
  35-49                                        15           (4%)                80          (36%)
  ≥50                                            0            (0%)               116         (52%)
not withdraw antithrombotic medication in EOL-care,
although they are likely to be unbeneficial. Thus, these issues
should be included in both undergraduate and postgraduate
education in palliative medicine.
In a Brazilian study, 46% of medical students did not object
to withdrawing artificial life support (23), while 75% of the
medical students were willing to withdraw mechanical
ventilation in our study. The variability among countries
regarding the withdrawal of mechanical ventilation probably
explains this difference (24). However, the students seem to
comply with the practices of experienced physicians in Finland
as 81% of the GPs also withdrew mechanical ventilation.
In our study, twice as many students (36%) as GPs (18%)
were ready to attempt CPR on the patient with advanced
brain tumour. Although advances in medicine may also
benefit patients with very advanced diseases, the rate of
hospital discharge after CPR for cancer patients is still only
approximately 10% (25). Using this same patient scenario,
we have previously demonstrated a correlation between
younger age and attempted CPR among Finnish physicians
(2). The growing clinical experience of a physician probably
offers more insight into whether CPR may or may not be
futile. On the other hand, over 80% of both the students and
the GPs chose palliative care in a patient clearly approaching
in vivo 33: 903-909 (2019)
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Table II. Numbers and proportions of the students and the general practitioners (GPs) deciding to withdraw or withhold therapies in the scenario
representing a patient with an end-stage lung cancer (scenario 3).
                                                                                                                        Students                                              GPs                                      p-Values*
                                                                                                                                                                                                                            
Decision to withdraw
Antibiotics                                                                                               150              (37%)                            120            (55%)                            <0.001
Mechanical ventilation                                                                           300              (75%)                            176            (81%)                              0.095
Intravenous hydration                                                                             128              (32%)                              75            (34%)                              0.543
Naso-gastric tube                                                                                    225              (56%)                            147            (67%)                              0.007
Thrombosis prophylaxis                                                                         219              (55%)                            137            (63%)                              0.056
Supplementary oxygen                                                                             18                (5%)                              13              (6%)                              0.440
Decision to withhold
Blood transfusion                                                                                    265             (67%)                            172            (79%)                              0.002
Pleural drainage                                                                                        84              (21%)                              92            (42%)                            <0.001
Chest X-ray                                                                                             162              (41%)                            114            (52%)                              0.006
Laboratory tests                                                                                       178              (45%)                            114            (53%)                              0.060
*Pearson Chi-Square test.
Table III. Attitudes of students and general practitioners (GPs). 
                                                                                                                        Students                                              GPs                                     p-Values**
Attitudes, median VAS* (IQR)
Active euthanasia is reprehensible                                                           58              (20-77)                            24              (3-66)                          <0.001
Withdrawal of life-sustaining treatments is reprehensible                     93              (80-98)                            93            (77-98)                            0.588
Assisted suicide is reprehensible                                                             38              (10-69)                            10              (2-51)                          <0.001
End-of-life care is satisfying                                                                    26              (12-49)                            17              (3-36)                          <0.001
People should pay costs of factitious diseases by themselves               66              (40-84)                            76            (47-95)                          <0.001
Advance directives have been helpful in my decisions                          14                (3-30)                              5              (2-22)                          <0.001
Good palliative care enables good death                                                   4                (1-11)                              4              (1-10)                            0.372
Physicians can’t estimate cancer pain                                                     46              (28-65)                            50            (28-72)                            0.053
Religion influences me when I make ethical decisions                          88              (50-98)                            74            (43-96)                            0.001
Being a doctor gives me satisfaction                                                       15                (4-28)                              8              (2-19)                          <0.001
My health is excellent                                                                              13                (6-25)                            14              (6-24)                            0.708
I feel burn out, tired of work                                                                   85              (59-94)                            85            (66-95)                            0.250
I’m pleased with my salary                                                                      13                (3-29)                            18              (7-45)                          <0.001
It is a waste of resources to treat patients >80 years in ICU                 70              (50-85)                            78            (59-93)                            0.001
*Attitudes expressed on a visual analogue scale (VAS) from 0 mm (definitely agree) to 100 mm (definitely disagree). **Mann-Whitney U-test.
VAS: Visual analogue scale; IQR: interquartile range; ICU: intensive care unit.
death (comatose patient with prostate cancer in scenario 1).
Although the palliative care approach in this scenario could
be regarded as obvious, our result shows that medical
schools in Finland seem to offer a basic understanding of
EOL-care.
In Western Europe, attitudes towards euthanasia and PAS
have become more accepting among the public and, to a
lesser extent, among physicians and medical students (5, 13,
23, 26). In our study, the students considered euthanasia and
assisted suicide less reprehensible than the GPs. In a study
from Puerto Rico, 40% of the medical students and 20% of
members of the medical faculty accepted euthanasia (14),
while only 26% of students and 17% of the physicians
accepted euthanasia in a Polish study (27). Our results are
not only in line with those of previous studies, but also
highlight this difference in the changing atmosphere towards
hastened death. We suggest, that the students’ lack of clinical
experience, younger age, as well as being less influenced by
the impact of religion on their decisions may explain their
greater acceptance of euthanasia as these factors have been
associated with increased acceptance among the public and
physicians (5, 13, 28).
Our aim was not to affirm right or wrong answers to the
questions presented, although some basic skills in decision-
making during EOL-care were evaluated. Nevertheless, the
majority of dying patients are taken care by GPs in Finland,
and just graduated junior doctors are expected to work as a
GP. Our results offer some insight into the educational needs,
because the decision-making in EOL-care should include the
same clinical principles for every patient regardless of the
experience of a physician. Medical students have been found
to feel underprepared to have discussions about EOL-care
with a patient (11, 12, 29). Furthermore, their knowledge
about assisted dying, DNR orders, advance directives and
many aspects of palliative medicine is still known to be
inadequate (30-33). On the other hand, undergraduate
curricula in palliative medicine increases students’
knowledge on palliative care (34, 35) and their attitudes
towards EOL-care change after an observational experience
in hospice (36). This calls for well-planned educational
programmes in palliative medicine in every medical school
and continuous postgraduate education. The medical and
ethical principles of the complex decision-making in the
EOL-care are the cornerstones of this education. 
Some limitations of our study must be acknowledged. The
response rates (63% for the students and 47% for the GPs)
limits the generalizability of our results, though they are
higher than in many previous surveys of physicians (37). Our
survey presenting hypothetical patient scenarios may also
elicit different answers compared to the decisions made in
clinical practice. However, it would be difficult to study
these questions in a real-life setting and we suggest that the
answers do reflect the general tendencies that contribute to
decision-making. Finally, the GPs are a heterogenous group
of physicians, which might lessen the comparability between
the GPs and the students. To improve the validity of this
comparison, we included only experienced GPs.
Conclusion
GPs are more willing to withhold or withdraw therapies
suspected of being futile in EOL-care than graduating
students, although this difference varies between the
treatments. In contrast, students consider euthanasia less
reprehensible than do the GPs. Our results call for systematic
undergraduate and postgraduate education in palliative
medicine, including the medical and ethical aspects of
decision-making in EOL-care. 
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